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Background: The Obsessive–Compulsive Treatment Efficacy randomised controlled Trial emerged from a
research recommendation in National Institute for Health and Care Excellence obsessive–compulsive
disorder (OCD) guidelines, which specified the need to evaluate cognitive–behavioural therapy (CBT)
treatment intensity formats.
Objectives: To determine the clinical effectiveness and cost-effectiveness of two low-intensity CBT
interventions [supported computerised cognitive–behavioural therapy (cCBT) and guided self-help]:
(1) compared with waiting list for high-intensity CBT in adults with OCD at 3 months; and (2) plus
high-intensity CBT compared with waiting list plus high-intensity CBT in adults with OCD at 12 months.
To determine patient and professional acceptability of low-intensity CBT interventions.
Design: A three-arm, multicentre, randomised controlled trial.
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Setting: Improving Access to Psychological Therapies services and primary/secondary care mental health
services in 15 NHS trusts.
Participants: Patients aged ≥ 18 years meeting Diagnostic and Statistical Manual of Mental Disorders-Fourth
Edition criteria for OCD, on a waiting list for high-intensity CBT and scoring ≥ 16 on the Yale–Brown
Obsessive Compulsive Scale (indicative of at least moderate severity OCD) and able to read English.
Interventions: Participants were randomised to (1) supported cCBT, (2) guided self-help or (3) a waiting
list for high-intensity CBT.
Main outcome measures: The primary outcome was OCD symptoms using the Yale–Brown Obsessive
Compulsive Scale – Observer Rated.
Results: Patients were recruited from 14 NHS trusts between February 2011 and May 2014. Follow-up data
collection was complete by May 2015. There were 475 patients randomised: supported cCBT (n = 158);
guided self-help (n = 158) and waiting list for high-intensity CBT (n = 159). Two patients were excluded
post randomisation (one supported cCBT and one waiting list for high-intensity CBT); therefore, data were
analysed for 473 patients. In the short term, prior to accessing high-intensity CBT, guided self-help
demonstrated statistically significant benefits over waiting list, but these benefits did not meet the
prespecified criterion for clinical significance [adjusted mean difference –1.91, 95% confidence interval (CI)
–3.27 to –0.55; p = 0.006]. Supported cCBT did not demonstrate any significant benefit (adjusted mean
difference –0.71, 95% CI –2.12 to 0.70). In the longer term, access to guided self-help and supported
cCBT, prior to high-intensity CBT, did not lead to differences in outcomes compared with access to high-
intensity CBT alone. Access to guided self-help and supported cCBT led to significant reductions in the
uptake of high-intensity CBT; this did not seem to compromise patient outcomes at 12 months. Taking a
decision-making approach, which focuses on which decision has a higher probability of being cost-effective,
rather than the statistical significance of the results, there was little evidence that supported cCBT and
guided self-help are cost-effective at the 3-month follow-up compared with a waiting list. However, by the
12-month follow-up, data suggested a greater probability of guided self-help being cost-effective than a
waiting list from the health- and social-care perspective (60%) and the societal perspective (80%), and of
supported cCBT being cost-effective compared with a waiting list from both perspectives (70%). Qualitative
interviews found that guided self-help was more acceptable to patients than supported cCBT. Professionals
acknowledged the advantages of low intensity interventions at a population level. No adverse events
occurred during the trial that were deemed to be suspected or unexpected serious events.
Limitations: A significant issue in the interpretation of the results concerns the high level of access to
high-intensity CBT during the waiting list period.
Conclusions: Although low-intensity interventions are not associated with clinically significant
improvements in OCD symptoms, economic analysis over 12 months suggests that low-intensity
interventions are cost-effective and may have an important role in OCD care pathways. Further research to
enhance the clinical effectiveness of these interventions may be warranted, alongside research on how
best to incorporate them into care pathways.
Trial registration: Current Controlled Trials ISRCTN73535163.
Funding: This project was funded by the National Institute for Health Research (NIHR) Health Technology
Assessment programme and will be published in full in Health Technology Assessment; Vol. 21, No. 37.
See the NIHR Journals Library website for further project information.
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Plain English summary
Obsessive–compulsive disorder (OCD) is a common disorder that makes people anxious and unhappy,interferes with everyday activities and rarely improves without treatment. The treatment recommended
for OCD is a talking treatment, called cognitive–behavioural therapy (CBT). There are not enough CBT
therapists and waiting lists are long. Our study aimed to see if using a self-help approach (either a book
or a computer program), supported for a short time by a mental health practitioner, would be better than
waiting for CBT.
Of the 473 people with OCD who took part, one-third were given a self-help book, one-third were given
an OCD computer program and one-third stayed on a waiting list for CBT. In the short term (3 months),
we found no worthwhile improvements in symptoms in people using the self-help book or OCD computer
program. We also found no differences in symptoms in the longer term (12 months). However, fewer
people who had either the book or the computer program went on to have CBT and both the book and
the computer program were better value for money than CBT. Patients told us during interviews that they
liked the guided self-help more than the computer program. Practitioners thought that the interventions
could benefit patients and provide choice and flexibility.
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Scientific summary
Background
Obsessive–compulsive disorder (OCD) is characterised by intrusive, unwanted, recurrent and distressing
thoughts, images or impulses (i.e. obsessions) and repetitive actions or rituals (compulsions), which serve to
reduce the distress and anxiety evoked by the obsessions. OCD has an estimated lifetime prevalence of
2–3%. In the absence of adequate treatment, OCD will usually follow a chronic course and is associated
with reduced quality of life and a substantial impairment of role.
The UK National Institute for Health and Care Excellence (NICE) guidelines make recommendations for
the management of OCD using a stepped-care approach. Steps 3–6 recommend treatment options
for people with OCD that range from low-intensity, guided self-help to more intensive psychological and
pharmacological interventions. Cognitive–behavioural therapy (CBT), including exposure and response
prevention, is the recommended psychological treatment.
Although high-intensity CBT is ‘current best practice’ according to NICE OCD clinical guidelines,
access to such CBT can still involve significant delays. The requirement to visit a therapist for treatments
is also poorly suited to the needs of some patients (e.g. patients who are housebound or in rural
locations, patients with caring responsibilities or patients whose OCD makes it difficult for them to be
with people).
There is clearly a potential role for low-intensity interventions as part of a stepped-care model. However,
current evidence concerning low-intensity interventions, such as computerised cognitive–behavioural
therapy (cCBT) or guided self-help, cannot provide accurate estimates of clinical effectiveness and
cost-effectiveness. No studies have compared different low-intensity interventions, nor do we know
the numbers of people who will not improve with low-intensity interventions and will require
high-intensity CBT.
The core question for patients, clinicians and policy-makers is ‘what is the role of low-intensity
interventions for OCD in relation to usual care (i.e. referral to a waiting list for high-intensity CBT)?’.
Implicit in the stepped-care model is the idea that giving patients on the waiting list access to low-intensity
interventions prior to high-intensity CBT could potentially augment care by:
l improving patient outcomes either through more rapid improvement in clinical outcomes prior to
high-intensity CBT or by augmenting the effect of high-intensity CBT in the longer term
l reducing costs either by reducing the number of patients who need to access high-intensity CBT or by
reducing general health-care utilisation in the short and longer term.
Objectives
The Obsessive–Compulsive Treatment Efficacy randomised controlled Trial (OCTET) emerged from a
research recommendation in the NICE OCD guidelines that specified the need to evaluate CBT treatment
intensity formats among adults with OCD.
In response, the Health Technology Assessment programme commissioned research on low-intensity
interventions for OCD, with specific reference to cCBT and guided self-help compared with a waiting list
for high-intensity CBT.
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Our aims were to determine:
l the clinical effectiveness and cost-effectiveness of two low-intensity CBT interventions (supported cCBT
and guided self-help) compared with a waiting list for high-intensity CBT in adults with OCD at
3 months
l the clinical effectiveness and cost-effectiveness of two low-intensity interventions (supported cCBT and
guided self-help) plus high-intensity CBT compared with a waiting list plus high-intensity CBT at
12 months
l the acceptability of the two low-intensity CBT interventions among patients and professionals.
Methods
Design
A multicentre, randomised controlled trial with economic and process evaluation. Participants were
randomised to supported cCBT or guided self-help prior to high-intensity CBT, compared with a waiting list
for high-intensity CBT. The primary outcome was OCD symptoms, as measured by Yale–Brown Obsessive
Compulsive Scale – Observer Rated (Y-BOCS-OR) at 3, 6 and 12 months. Researchers collecting outcomes
were blind to treatment allocation.
Setting
Improving Access to Psychological Therapies (IAPT), primary or secondary care mental health services in
15 NHS trusts.
Inclusion criteria
l Adults aged ≥ 18 years.
l On a waiting list for high-intensity CBT.
l Met Diagnostic and Statistical Manual of Mental Disorders-Fourth Edition (DSM-IV) criteria for OCD,
assessed using six OCD questions from the Mini-International Neuropsychiatric Interview.
l Scored ≥ 16 on the Yale–Brown Obsessive Compulsive Scale – Self-Report.
l Reported an ability to read English at an age level of ≥ 11 years.
Exclusion criteria
l Actively suicidal.
l Organic brain disease.
l Current psychosis.
l A diagnosis of alcohol or substance dependence using DSM-IV criteria.
l Currently receiving psychological treatment for OCD.
l Literacy or language difficulties to an extent that would preclude participants from reading written or
web-based materials, or conversing with a health professional.
Recruitment/participants
Participants were identified by psychological wellbeing practitioners (PWPs) or via screening waiting lists in
IAPT, primary or secondary care mental health services. Eligible patients providing written informed consent
were randomised through a central randomisation service provided by York Clinical Trials Unit, minimised
by OCD severity, antidepressant medication, duration of OCD (0–5 years; 6–10 years; > 10 years) and
depression severity.
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Interventions
Participants were randomised to one of three arms:
1. Supported cCBT: OCFighter (www.ccbt.co.uk) is a commercial cCBT program for OCD. OCFighter
consists of a nine-step CBT approach (focused on exposure and response prevention) to help people
with OCD to design, carry out and monitor their treatment and progress. Participants randomised to
OCFighter were given an access ID and password to log in to the system and advised to use the
program at least six times over a 12-week period. Participants received six 10-minute brief scheduled
telephone calls from a PWP.
2. Guided self-help consisted of a self-help book (focused on exposure and response prevention),
Overcoming OCD: A Workbook, written by the trial team. Participants received weekly guidance from
a PWP for one initial session of 60 minutes (either face to face or by telephone, depending on patient
preference) followed by up to 10 30-minute sessions over a 12-week period.
3. The control group was a waiting list for high-intensity CBT.
Main outcome measures
The primary outcome was a measure of OCD symptoms, as measured using the Y-BOCS-OR. Secondary
outcomes included quality of life, self-reported OCD symptoms, psychological well-being, depression,
anxiety, functioning and satisfaction at 3, 6 and 12 months. Economic measures included health-related
quality of life [using the European Quality of Life-5 Dimensions-3 levels to calculate quality-adjusted
life-years (QALYs)] and resource use from the health- and social-care perspective and societal perspective
(which additionally included productivity losses and out-of-pocket expenses and savings).
Results
Improving Access to Psychological Therapies services in 15 NHS trusts were recruited and 204 PWPs
trained to deliver the interventions. Patients were recruited from 14 NHS trusts between February 2011
and May 2014. Follow-up data collection was complete by May 2015. A total of 475 patients were
randomised, with 158 allocated to guided self-help, 158 to supported cCBT and 159 to the waiting list for
high-intensity CBT. Two patients were excluded post randomisation (one supported cCBT and one waiting
list for high-intensity CBT); therefore, data were analysed for 473 patients [supported cCBT (n = 157),
guided self-help (n = 158) and waiting list for high-itensity CBT (n = 158)]. Retention was 81% at the
3-month follow-up, 75% at the 6-month follow-up and 71% at the 12-month follow-up. Of the 473
patients, 95% were white, 60% were female and the mean age was 33 years. Just over 50% reported
previous professional help for OCD, around half were currently using antidepressant medication and 55%
had suffered from OCD for ≥ 10 years. The mean baseline Y-BOCS-OR score was 25 (indicating severe
OCD) and the mean Patient Health Questionnaire-9 score was 12 (indicating moderate depression).
Low-intensity intervention uptake was reasonable: 66% accessed guided self-help and 61% supported
cCBT, with the mean number of sessions 4.1 (guided self-help) and 2.3 (supported cCBT).
A significantly higher number of patients allocated to the waiting list for high-intensity CBT started CBT
prior to the 3-month outcome assessment than those with supported cCBT and guided self-help.
In the short term, prior to accessing high-intensity CBT, guided self-help demonstrated statistically
significant benefits over waiting list, but these benefits did not meet the prespecified criterion for clinical
significance [adjusted mean difference –1.91, 95% confidence interval (CI) –3.27 to 0.55; p = 0.006].
In contrast, supported cCBT did not demonstrate any statistically or clinically significant benefit (adjusted
mean difference –0.71, 95% CI –2.12 to 0.70).
Over a 12-month period, access to guided self-help and supported cCBT, prior to high-intensity CBT,
did not lead to differences in outcomes compared with access to high-intensity CBT alone. Access to either
of the low-intensity interventions does not augment the effect of high-intensity CBT in the longer term.
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Early access to either of the low-intensity interventions led to significant reductions in the uptake of
high-intensity CBT over the full 12 months of OCTET, with 86% of the patients allocated to a waiting list
for high-intensity CBT starting CBT by the end of the trial, compared with 62% in the supported cCBT
group and 57% in the guided self-help group. These reductions in high-intensity CBT utilisation do not
seem to compromise patient outcomes at 12 months.
In economic analyses, guided self-help was more expensive to deliver than supported cCBT, although both
are cheaper than a course of high-intensity CBT. Health- and social-care costs, and broader societal costs,
including productivity losses and out-of-pocket expenditure and savings, were not significantly different
between the three groups at either 3 or 12 months. Differences in European Quality of Life-5 Dimensions
and associated QALY scores were minor in magnitude. There were no significant differences in QALYs.
Taking a decision-making approach, which focuses on which decision has a higher probability of being
cost-effective, rather than the statistical significance of the results, there was little evidence that supported
cCBT and guided self-help were more cost-effective at the 3-month follow-up than a waiting list. However,
by the 12-month follow-up (primary end point), the data suggest that there was a greater probability of
guided self-help being cost-effective compared with a waiting list from the health- and social-care
perspective (60%) and the societal perspective (80%), and of cCBT being cost-effective compared with a
waiting list from both perspectives (70%).
The data suggested some small differences in satisfaction at 3 months, with patients most satisfied with
guided self-help and least satisfied with supported cCBT.
Qualitative studies explored the acceptability of both supported cCBT and guided self-help from
the perspective of patients, and the feasibility and acceptability of delivering the interventions from the
perspective of the PWPs. The results suggested that the provision of low-intensity psychological interventions
may confer substantial benefits in terms of increasing the accessibility of psychological treatments for this
population. Both guided self-help and supported cCBT increased service flexibility, overcame intervention
access barriers and sustained, where desired, a sense of anonymity or privacy in care. Guided self-help
attracted stronger support than supported cCBT, mainly because of technical difficulties of cCBT
compounded by significance placed on interpersonal contact. PWPs were consistent in acknowledging
the advantages of low-intensity interventions at a population level. Both guided self-help and supported
cCBT were advocated to overcome long-standing barriers to the delivery of mental health care, improving
accessibility via enhanced service flexibility and patient choice.
No adverse events occurred during the trial that were deemed to be suspected or unexpected serious events.
Conclusions
In designing OCTET, we hypothesised that providing patients on the waiting list access to low-intensity
interventions prior to high intensity CBT could have two positive effects:
1. augmenting patient outcomes through either:
i. more rapid improvement in clinical outcomes prior to high-intensity CBT or
ii. augmenting the effect of high-intensity CBT in the longer term.
2. increasing efficiency of service delivery, either by reducing the numbers of patients who need to access
high-intensity CBT or by reducing general health-care utilisation in the short and longer term, without
compromising patient outcomes.
We found no evidence that low-intensity interventions led to clinically significant improvements in OCD
symptoms compared with the waiting list, prior to high-intensity CBT.
SCIENTIFIC SUMMARY
NIHR Journals Library www.journalslibrary.nihr.ac.uk
xxvi
We did not find evidence that low-intensity interventions augmented the effects of high-intensity CBT over
the longer term.
In terms of service efficiency, both low-intensity interventions were also associated with a reduced uptake of
high-intensity CBT. The lack of differences in clinical outcomes over 12 months suggests that, on average,
provision of low-intensity interventions is potentially efficient and does not lead to poor outcomes.
Taking a decision-making approach, which focuses on which decision has a higher probability of being
cost-effective, rather than the statistical significance of the results, economic evidence suggests that the
provision of both low-intensity interventions could be cost-effective compared with the waiting list prior to
high-intensity CBT at conventional levels of willingness-to-pay for QALYs, with a > 50% chance of being
cost-effective compared with the waiting list for high-intensity CBT.
Implications for health care compared with the waiting list for
high-intensity cognitive–behavioural therapy
l Despite the lack of clinically significant differences in outcomes, the economic analyses suggest an
important role for low-intensity interventions in the care pathway for OCD. Following receipt of either
low-intensity intervention, a proportion of patients do not progress to high-intensity CBT. There is
no evidence that this leads to poorer outcomes in this group of patients and the overall health- and
social-care costs associated with these patients are not different. Both low-intensity interventions
appear cost-effective compared with high-intensity CBT.
l Providing low-intensity CBT as part of a care pathway may reduce pressure on high-intensity
psychological therapy services, without any obvious disbenefit for patients.
l The two low-intensity interventions differ in the pattern of results. Guided self-help showed
statistically significant reductions in OCD symptoms, and patients were more satisfied than those
receiving supported cCBT in the short term. However, supported cCBT may be more cost-effective.
From a service perspective, focusing on one low-intensity intervention would simplify delivery and the
associated training and infrastructure needs. However, the qualitative patient acceptability data do
suggest that providing options may be preferable to meet variation in patient preferences for
low-intensity interventions.
Recommendations for research
l Given the cost-effectiveness analysis, then, it would be prudent to implement low-intensity
interventions at sites where waiting lists are disproportionally high. If services are to implement
low-intensity interventions for OCD into routine practice, high-quality health services and delivery
research is required to integrate these interventions into the care pathway and to identify those
patients likely to derive greater benefit. Qualitative analysis has highlighted individual variability of
intervention acceptability and large-scale quantitative analysis of engagement predictors are
now required.
l Neither intervention showed clinically significant effects at 3 months within the prespecified margin;
however, given the magnitude of effect that was shown with guided self-help, we advocate caution
of the wholesale rejection of low-intensity interventions delivered within a stepped-care model, as
advocated by NICE. Further development and rigorous evaluation of more effective low-intensity
interventions is required, particularly in relation to guided self-help. Our qualitative work demonstrates
that those aspects of the interventions might benefit from modifications to enhance uptake.
l If more effective low-intensity interventions can be developed, there would be a case for trials to
actively compare low-intensity interventions with high-intensity CBT head to head (rather than the
sequential delivery tested within OCTET). This could evaluate whether or not enhanced low-intensity
interventions can achieve equivalent (or at least non-inferior) outcomes to high-intensity CBT.
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Chapter 1 Introduction
Obsessive–compulsive disorder
Obsessive–compulsive disorder (OCD) is characterised by:
l intrusive, unwanted, recurrent and distressing thoughts, images or impulses (i.e. obsessions)
l repetitive actions/rituals (i.e. compulsions), which serve to reduce the distress and anxiety evoked by
the obsessions.
Typical examples of obsessions include excessive doubts regarding the maintenance of safety and security
(e.g. fears of failing to lock doors, or turning off electrical or gas appliances), intrusive thoughts, images or
impulses of contaminating or harming others, or repugnant, sexual thoughts of abusing others.
Typical compulsions include repetitive washing or cleaning, and checking or repeating numbers, words or
phrases. The majority of people with OCD understand that their thoughts and rituals are senseless.
Prior to the Diagnostic and Statistical Manual of Mental Disorders-Fifth Edition,1 OCD was grouped as an
anxiety disorder, but it is now incorporated into a separate chapter on OCD and related disorders.
For a definitive diagnosis, obsessions and compulsions (or both) must:
l be distressing
l impair functioning
l be time-consuming (> 1 hour per day).
There are only a few minor differences in the criteria for OCD between the Diagnostic and Statistical
Manual of Mental Disorders Editions III, III Revised and IV (DSM-IV),2 and the International Classification of
Diseases, Tenth Edition.3
Obsessive–compulsive disorder has an estimated lifetime prevalence of 2–3%4 and, in the absence of
adequate treatment, will usually follow a chronic course. OCD is associated with reduced quality of life
and substantial impairment of role, specifically work, social, home and family/relationship functioning.5
In addition to the individual costs, the economic burden of OCD is high, with an estimated US$8.4M
being attributed to the direct and indirect costs of the illness in the USA.6 The World Health Organization
rates OCD as one of the top 10 leading causes of disability worldwide.7 High levels of comorbidity are
associated with OCD, most notably other anxiety disorders, depression, impulse control disorders and
substance misuse.8 There is significant evidence to suggest that people with OCD are often left untreated
or are inappropriately or inadequately treated, with consistent reports of a marked time delay between
OCD onset and diagnosis. One study found a 10-year gap between onset and seeking professional help,
and 17 years between onset and receipt of an effective intervention.9
Context of the Obsessive–Compulsive Treatment Efficacy
randomised controlled Trial
To understand the rationale for the Obsessive–Compulsive Treatment Efficacy randomised controlled Trial
(OCTET), we first describe the following contextual issues:
l cognitive–behavioural therapy (CBT) and low-intensity psychological interventions
l National Institute for Health and Care Excellence (NICE) guidelines for OCD
DOI: 10.3310/hta21370 HEALTH TECHNOLOGY ASSESSMENT 2017 VOL. 21 NO. 37
© Queen’s Printer and Controller of HMSO 2017. This work was produced by Lovell et al. under the terms of a commissioning contract issued by the Secretary of State for Health.
This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals provided that
suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be addressed to: NIHR
Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton
SO16 7NS, UK.
1
l service delivery models for psychological therapies in the UK
l summary of the evidence for low-intensity interventions for OCD.
Cognitive–behavioural therapy and low-intensity interventions
Therapist-delivered CBT, including exposure and response prevention (ERP), is a mainstay of psychological
treatment for OCD.10 CBT is a ‘talking therapy’ that aims to change unhelpful thoughts and behaviour.
ERP are specific CBT techniques used in the treatment of OCD. Exposure therapy involves confronting the
feared stimuli until fear subsides, through a process known as extinction. Response prevention means
resisting the need to ritualise (i.e. perform a compulsive reaction).
One of the major problems related to the management of OCD is access to CBT, with many patients
traditionally facing significant delays and spending large amounts of time on waiting lists for this
treatment. This reflects a lack of trained therapists and the significant amount of therapist time traditionally
seen as necessary for each individual treatment.
There has been significant interest in ways of overcoming this issue that are sustainable for health-care
systems. A key development has involved ‘low-intensity’ interventions. Although there is a lack of
consensus over precise definitions, common features of low-intensity interventions include:11
l typically CBT based
l communicate CBT principles in accessible ways and delivered in flexible forms (e.g. telephone, e-mail)
l involve a health technology (e.g. a computer package or book) to deliver key ‘active ingredients’
of therapy
l usually delivered by a low-intensity worker [psychological wellbeing practitioner (PWP)]
l use fewer resources (in terms of therapist time) than conventional CBT.
Low-intensity interventions can be used by patients unsupported (reducing therapist time to zero).
However, they are often used in a ‘guided’ or ‘supported’ form, with some therapist time, often with a
therapist who is fully trained but has less experience than a conventional CBT therapist. Two key forms of
low-intensity interventions are ‘guided self-help’ (use of a book providing instruction in CBT principles),
often supported via telephone by a professional; and computerised CBT (cCBT), using computer- or
web-based systems to provide instruction in CBT principles, again supported by a professional.
An advantage of low-intensity interventions that use health technologies (cCBT) or are delivered by
technology (telephone) is that they are more readily accessed by those who are unable to attend
scheduled clinic appointments because of geographical, social, physical or psychological difficulties.
Low-intensity interventions complement, rather than replace, existing CBT provision. The way in which
conventional therapist-delivered CBT and low-intensity treatments are delivered as part of a system of care
is the subject of the next section.
National Institute for Health and Care Excellence guidelines
The NICE guidelines for OCD12 recommend management using a ‘stepped-care’ approach.13 Stepped care
is viewed as a potential solution to poor access to traditional treatments by increasing the efficiency of
service provision and better-matching treatment to patient need.
In stepped-care models, different ‘steps’ or levels of treatment intensity exist. However, there are two ways
in which patients are assigned to different steps.
1. Stepped care: a sequential approach in which all patients move through steps in a systematic way
irrespective of illness severity, patient need or choice. Under this model all patients will initially receive
low-intensity treatments and only ‘step up’ if and when these first-line interventions fail.
INTRODUCTION
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2. Stratified care: a targeted approach in which patients are assessed and referred to an appropriate step
of treatment based on severity, complexity or other agreed criteria. Patients can thus access an
appropriate level of treatment and, if needed, access a more intensive intervention without first having
had to receive a lower-intensity treatment.14
Although these can be considered as alternatives, models of care can include aspects of both models
(i.e. the majority of patients use the stepped model, but patients with certain characteristics are stratified).
The NICE model uses stratification based on (1) severity of OCD symptoms and (2) functional impairment.
The model consists of six steps divided into three stages: awareness (step 1), recognition and assessment
(step 2) and treatment (steps 3–6). Our focus is on steps 3–6.
l At step 3, adults with OCD with mild functional impairment, low-intensity psychological (CBT)
treatments are recommended. Low-intensity treatments are delivered by a PWP and defined as
< 10 hours of therapist time per patient. Treatments include (1) brief individual CBT using structured
self-help materials, (2) individual CBT delivered by telephone or (3) group CBT.
l At step 4, adults with OCD who have moderate functional impairment (or who have mild functional
impairment, but have failed to engage or improve with lower-intensity treatments) will usually be
offered a selective serotonin reuptake inhibitor and/or higher-intensity CBT delivered by a high-intensity
therapist (HIT).
l Step 5 is recommended for those with severe functional impairment and delivered within secondary
care by mental health professionals with expertise in OCD. Treatment recommendations include a
combination of a selective serotonin reuptake inhibitor and CBT.
l Step 6 is reserved for people presenting with severe and chronic functional impairment, treatment
refractory, and/or a risk to self or others. Specialist inpatient treatment and care may be offered at
this step.
The NICE guidelines for OCD have been in existence since 2005.12 An evidence update was set for
February 2014, but no significant evidence was identified to change the recommendations. During the
completion of the evidence update, the effectiveness of technology-enhanced treatment for OCD was
identified as an evidence gap and, as a result, was registered on the UK Database of Uncertainties about
the Effects of Treatments.15
Service delivery models for psychological therapies in the UK
Psychological interventions for OCD are usually delivered in Improving Access to Psychological Therapies
(IAPT) services.16 IAPT commenced in 2007 with the aim of achieving a better balance between supply of
psychological therapies and demand.
Since its inception, > 5000 new psychological therapists have been trained. IAPT training, which follows a
national curriculum, produces two types of therapists:
1. low-intensity therapists, also known as PWPs
2. HITs.
Psychological wellbeing practitioners are tasked with facilitating a range of low-intensity interventions
including guided self-help, cCBT and psychoeducational groups for mild to moderate depression and
anxiety disorders. HITs provide predominantly CBT interventions for moderate to severe cases. The amount
of time allocated to individuals varies but, on average, PWPs provide 3–4 hours of therapeutic support per
person over 6–8 weeks, whereas HITs provide weekly 60-minute sessions over 8–16 weeks.
Given the NICE guidelines, it would be sensible to assume that low-intensity interventions for OCD
(guided self-help or cCBT) would be supported by a PWP and provided in IAPT services for people with
mild functional impairment.
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However, the NICE model is not being implemented precisely, as designed in practice,17 for a number
of reasons:
l In most IAPT services, people with OCD are referred directly to, and treated by, HITs regardless of their
illness severity. OCD is perceived as a complex mental health disorder and hence the PWP IAPT
National Curriculum18 does not address OCD knowledge or treatment.
l Although the NICE guidelines recommend low-intensity interventions for mild OCD, there is evidence
that people with OCD with mild functional impairment do not present to services. Consequently,
a substantial proportion of patients seen by IAPT practitioners will be experiencing OCD with at least a
moderate level of functional impairment.
l Discrepancies exist between the definitions of low-intensity treatments adopted by IAPT services and
NICE. Although there is no formal consensus regarding the precise number of therapist hours required
by low-intensity interventions, NHS and IAPT services typically presume no more than 3–6 hours of
input. The NICE guidelines advocate up to 10 hours of support for low-intensity interventions for OCD,
thereby positioning at least some of these treatments within the remit of higher-intensity services.
Summary of the evidence for low-intensity interventions for
obsessive–compulsive disorder
Despite NICE’s recommendations for low-intensity interventions for OCD, evidence of the clinical
effectiveness, cost-effectiveness and acceptability of these interventions is limited. Effective synthesis is
hampered by confusion over the scope of low-intensity interventions.
Lovell and Bee19 completed a systematic review of 13 studies (n = 492 participants) of CBT-based
treatments that used health or communication technology in adults with OCD, including self-help manuals
and cCBT alongside telephone and videoconferencing. Heterogeneity of populations, interventions and
outcomes across the studies prevented meta-analysis. Self-help manuals were assessed in five small,
uncontrolled, quasi-experimental studies and found moderate to large improvements in OCD symptoms;
however, the absence of controlled trials means that the generalisability of the findings is unclear.
cCBT was assessed in five studies, four of which were of BT Steps [now called OCFighter version 1.0
(CCBT Ltd, Birmingham, UK)]. The results revealed significant moderate to large effects on OCD symptoms
score in favour of BT Steps. However, all studies were undertaken by the developers of the software and
no independent analysis was available. The authors concluded that preliminary data support the idea that
technology holds promise in treatment for OCD. Nevertheless, definitive conclusions about the relative
efficacy of using health technologies as a replacement for therapist contact needed stronger evidence from
rigorous randomised controlled trials (RCTs).
Herbst et al.20 similarly examined telemental health applications for adults and children with OCD and
included studies delivered by computer, the internet, telephone or self-help literature either delivered alone
or supported by a health professional. No meta-analysis was completed and individual effect sizes ranged
from 0.46 to 2.5. Of the 24 studies (n = 839 participants) included in this review, seven used written
self-help materials (guided self-help), 11 were delivered by telephone, three were computer assisted,
one comprised an online self-help group and two used videoconferencing. The review suggested that
telemental applications may have promise but, once again, clinical and methodological heterogeneity,
and small sample sizes precluded definite conclusion.
A more recent review21 looked at the efficacy of all types of technology-delivered CBT for OCD versus
control conditions and in comparison with high-intensity CBT. Eight RCTs (n = 420 participants) were
included and results found that CBT delivered by technology was superior to the control intervention in
reducing OCD symptoms but not on comorbid depression. There were no differences in reductions in OCD
symptoms between CBT delivered by technology and therapist-delivered CBT. Similar to previous reviews,
this review concluded that further RCTs are warranted to examine the efficacy of technology-delivered CBT.
INTRODUCTION
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Guided self-help
Although NICE recommended the use of brief CBT (guided self-help) supported by a therapist, there is
only a very limited evidence base to support this. A limited number of small open/uncontrolled trials22–26
of self-help materials, with guidance from a therapist have demonstrated promising results. One RCT25
randomised 41 patients with OCD to a self-help book with two contacts with a therapist or to 15 sessions
of face-to-face therapist-delivered CBT including self-administered or therapist-administered ERP.
Patients in both treatment conditions showed statistically and clinically significant symptom reduction,
but therapist-delivered CBT was superior in OCD symptom and functional impairment reduction.
Since commencing OCTET, two RCTs have been published,27,28 neither of which used ERP (both RCTs
used different unsupported self-help interventions). The first27 focused on a self-help book based on
metacognitive training for OCD. Patients with OCD (n = 87) were randomised to either metacognitive
training for OCD or a waiting list control and results showed significant changes in OCD symptoms in the
intervention group post treatment.
The second RCT28 randomised 70 patients with OCD to either an unsupported self-help manual focusing
on meridian tapping (a body-oriented technique from the field of alternative medicine) or progressive
relaxation. The study did not lead to improvement in OCD symptoms.
Computerised cognitive–behavioural therapy
As a treatment option, cCBT is not recommended by NICE. A systematic review29 of cCBT for OCD found
only four studies, all using the software program OCFighter (previously known as BT Steps). The results
showed significantly better outcomes and less attrition for scheduled than for unscheduled telephone
support. The conclusion of the review found OCFighter to be as good as standard high-intensity CBT in
reducing time spent in rituals and obsessions, and in improving work and social functioning. Overall,
standard high-intensity CBT was more effective than OCFighter, but not for those who actually started the
intervention as opposed to those who failed to begin self-exposure therapy.
A key limitation of this work is that all OCFighter evaluations have been conducted by the commercial
company who developed the program. Furthermore, this program was originally delivered with an interactive
voice response and workbook. A more recent version, which has not yet been evaluated in a RCT, comprises
a web-based platform in conjunction with brief support via telephone, face-to-face or e-mail contact with a
mental health worker. A cost-effectiveness analysis has been completed30 with the original BT Steps program,
but this was not independent from the developers of the commercially produced package.
Since the beginning of our study a further RCT has been published with BT Steps.31 Eighty-seven
participants with OCD were randomised to cCBT with (1) no therapist support, (2) lay (non-therapist)
support or (3) support from an experienced CBT therapist. The results showed a positive change post
treatment compared with pretreatment, with no significant difference between the three treatment arms
in OCD symptoms or sessions completed. A number of internet-delivered CBT studies have been published
including open studies.32,33 Andersson et al.33 randomised 101 adults with OCD to either 10 weeks of
internet CBT or to an attention control condition, with online supportive therapy. Results found that both
interventions led to significant improvements in OCD symptoms, but internet CBT resulted in greater
improvements in OCD symptoms.
Summary
The provision of high-intensity CBT is ‘current best practice’ according to NICE OCD clinical guidelines.
Despite the introduction of IAPT, access to high-intensity CBT can still involve significant delay,
and the requirement to visit a therapist for treatments is poorly suited to the needs of some patients
(e.g. the housebound, those with caring responsibilities, those whose OCD makes it difficult to be with
people or to attend NHS settings, or those who live in rural locations).
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There is clearly a potential role for low-intensity interventions as part of a stepped-care model. However,
current evidence concerning low-intensity interventions (such as cCBT or guided self-help) is insufficient to
provide accurate estimates of clinical effectiveness and cost-effectiveness. No studies have compared
different low-intensity interventions (such as cCBT vs. guided self-help), nor do we know the numbers of
people who will not improve with low-intensity interventions and who will require more intensive CBT in
the stepped-care model.
The core question for patients, clinicians and policy-makers is ‘what is the role of low-intensity
interventions in relation to “usual care” (i.e. referral to a waiting list for high-intensity CBT)?’. Implicit in
the stepped-care model is the idea that giving patients on a waiting list for high-intensity CBT access to
low-intensity interventions, prior to high-intensity CBT, could potentially augment care by:
(a) improving patient outcomes either through more rapid improvement in clinical outcomes prior to
high-intensity CBT or by augmenting the effect of high-intensity CBT in the longer term
(b) reducing costs either by reducing the numbers of patients who need to access high-intensity CBT or
by reducing general health-care utilisation in the short and longer term.
The aims of the Obsessive–Compulsive Treatment Efficacy
randomised controlled Trial
The Obsessive–Compulsive Treatment Efficacy randomised controlled Trial emerged from a research
recommendation in the NICE OCD guidelines that specified the need to evaluate CBT treatment intensity
formats among adults with OCD.
In response to this recommendation, the National Institute for Health Research (NIHR)’s Health Technology
Assessment programme commissioned research on ‘self-managed therapy packages’ for OCD, with
specific reference to cCBT and guided self-help compared with treatment as usual. In this case, treatment
as usual was defined as being placed on a waiting list for high-intensity CBT.
The Obsessive–Compulsive Treatment Efficacy randomised controlled Trial was designed to address this
commissioned call. Our aims were to determine:
l the clinical effectiveness and cost-effectiveness of low-intensity interventions (guided self-help and
supported cCBT) versus a waiting list for high-intensity CBT in the management of OCD at 3 months
l the clinical effectiveness and cost-effectiveness of low-intensity interventions (guided self-help and
supported cCBT) plus high-intensity CBT versus a waiting list for high-intensity CBT plus high-intensity
CBT in the management of OCD at 12 months
l the acceptability of low-intensity interventions (guided self-help and supported cCBT) among patients
and professionals.
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Chapter 2 Trial design and methods
Study design
The Obsessive–Compulsive Treatment Efficacy randomised controlled Trial was a pragmatic, three-arm,
multicentre RCT and the primary outcome was OCD symptoms using the Yale–Brown Obsessive
Compulsive Scale – Observer Rated (Y-BOCS-OR) that aimed to determine:
l the clinical effectiveness and cost-effectiveness of low-intensity interventions (guided self-help and
supported cCBT) versus a waiting list for high-intensity CBT in the management of OCD at 3 months
l the clinical effectiveness and cost-effectiveness of low-intensity interventions (guided self-help and
supported cCBT) plus high-intensity CBT versus a waiting list plus high-intensity CBT in the
management of OCD at 12 months
l the acceptability of low-intensity interventions (guided self-help and supported cCBT) among patients
and professionals.
The trial protocol has been published.34 No major changes to the protocol were made after its publication.
The Obsessive–Compulsive Treatment Efficacy randomised controlled Trial involved two phases: an internal
pilot, moving seamlessly into the substantive trial. We describe the methods and outcomes of the internal
pilot, with a focus on the impact on the recruitment strategies used for the substantive trial. We then
describe the methods used for the substantive trial.
Internal pilot
An internal pilot study is defined by NIHR as:35
. . . a version of the main study that is run in miniature to test whether the components of the main
study can all work together. It is focused on the processes of the main study, for example to ensure
recruitment, retention, randomisation, treatment, and follow-up assessments all run smoothly.
The OCTET pilot study therefore resembled the substantive study in all respects, including an assessment of
the feasibility of the proposed primary outcome time point.
The internal pilot was conducted over 9 months and was designed to assess three questions:
1. Is it feasible to recruit the number of participants required to meet the planned sample size?
2. Do participants remain on a high-intensity CBT waiting list for a sufficient length of time (i.e. at least
3 months) to conduct an evaluation of the short-term clinical effectiveness and cost-effectiveness of
self-managed therapies, prior to access to high-intensity CBT?
3. Should the primary outcome point be 3 or 6 months? The commissioning call specified 6 months as the
primary assessment point but given the pressure of IAPT sites to minimise waiting lists we were unsure
if 6 months would be achievable.
Results of the internal pilot
In terms of question 1, the internal pilot proved that recruitment was feasible (with the addition of more
sites) and that the planned sample size could be achieved in principle. The pilot recruitment graph is
presented in Appendix 1.
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However, evaluation of questions 2 (time patients spent on the high-intensity CBT waiting list)
and 3 (timing of a 3- or 6-month outcome for the primary assessment point) demonstrated significant
challenges. As highlighted in the introduction, one of the key reasons for conducting OCTET was that
the need for psychological therapy services for OCD exceeds demand, meaning that patients often face
long waiting lists for high-intensity CBT treatment. Low-intensity interventions are designed to allow more
rapid access and better management of demand.
The OCTET recruitment method was to screen existing high-intensity CBT IAPT waiting lists for potentially
eligible patients where OCD was known or noted in the referral letter. Similar methods (large-scale
screening of existing lists of potentially eligible patients) have underpinned a number of our successful
large multicentre mental health trials [e.g. the Randomised Evaluation of the Effectiveness and
Acceptability of Computerised Therapy (REEACT trial),36 cost-effectiveness of collaborative care for
depression in UK primary care trial (CADET)37].
Extensive mapping of IAPT high-intensity CBT waiting lists at recruitment sites was conducted prior to
the trial commencing, which identified waiting lists of between 60 and 800 patients and between 40 and
100 OCD referrals per year. Therefore, it was predicted that we would be able to achieve and maintain the
required recruitment rate.
During the internal pilot, the Department of Health informed all IAPT sites in England that patients should
be offered more rapid access to treatment as part of the IAPT initiative. This had two major effects:
1. A proportion of participants randomised to a low-intensity intervention were offered their high-intensity
CBT appointment prior to commencing the intervention or before completing the low-intensity
intervention. One waiting list reduced from in excess of 700 patients to < 50 patients in 4 weeks.
2. A proportion of participants were ‘removed’ from the high-intensity CBT waiting list and offered access
to a form of low-intensity intervention. In many cases, these interventions were in line with current
good practice (including written material focusing on understanding and managing anxiety, supported
by a PWP), but were not OCD specific or recommended by the NICE OCD guidelines. However, having
been removed from the waiting list, such patients were lost to the OCTET recruitment procedure,
significantly reducing the numbers of potentially eligible patients who could be contacted.
These changes to the high-intensity CBT waiting list procedure had significant implications for OCTET.
In response, we made the following changes:
l As a proportion of participants were reaching the top of the CBT waiting list prior to 12 weeks, we
proposed to services that regardless of the length of waiting list, patients would be asked to wait at
least 12 weeks before high-intensity CBT was offered. This proposal was supported by the Health
Technology Assessment programme, the Data Monitoring and Ethics Committee (DMEC) and Trial
Steering Committee (TSC), and was approved by the National Research Ethics Service Committee
North West Lancaster. Despite this, only one site agreed to implement this change because of concerns
that such a strategy contradicted the requirements of the Department of Health.
l We initiated a new strategy in some sites, whereby all patients on waiting lists for high-intensity CBT
were mailed with an invite to OCTET rather than the original strategy that restricted mailing to patients
with an indication of OCD on NHS records. The rationale was that OCD is often underdiagnosed and in
consultation with clinical colleagues it transpired that many referrals from general practitioners (GPs)
did not indicate OCD on the referral letter. The trial consent procedures and inclusion criteria remained
the same. This strategy proved successful in increasing numbers, but was more time-consuming as a
number of people who self-reported OCD did not meet our trial inclusion criteria.
l We extended self-referral opportunities in two sites (as recruitment was low at these particular sites) by
placing adverts in local newspapers, on social media [e.g. local OCD group Facebook page (Facebook,
Inc., Menlo Park, CA, USA)], in GP surgeries, community centres, trust magazines and in other local
publications in one site. The trial consent procedures and inclusion criteria remained the same.
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l We engaged additional IAPT services within 10 NHS trusts in addition to our existing sites. Despite
increasing the number of potential participants, this raised logistical and resource challenges, as
additional recruitment and training of researchers and PWPs was required.
l Given the directive from the Department of Health regarding high-intensity CBT waiting lists, it was not
feasible to use the proposed 6-month follow-up as the primary outcome assessment point, and hence
it was agreed to retain the 3-month assessment as the primary outcome assessment point. Given that
removing the 6-month assessment would result in a variety of ethical issues and could potentially
reduce participant engagement at 12 months, it was decided that the 6-month assessment should
be retained.
Main trial methods
Ethics and governance
Ethics approval for the study was granted by National Research Ethics Service Committee North West –
Lancaster (reference number 11/NW/0276). Site-specific approvals were obtained from the relevant local
research governance offices covering the trusts involved in the trial. The trial was registered with the
International Standard Randomised Controlled Trial Number Register (ISRCTN73535163).
Low-intensity interventions
Experimental group: supported computerised cognitive–behavioural therapy
Supported cCBT was delivered using OCFighter, a commercially produced cCBT program for people with
OCD. OCFighter consists of a nine-step CBT approach (focused on ERP) to help people with OCD to
design, carry out and monitor their treatment and progress.
Participants randomised to OCFighter were given an access ID and password to log in to the system and
advised to use the program at least six times over a 12-week period. OCFighter was available to patients
for 12 months following activation.
Participants received six brief (10-minute) scheduled telephone calls from a PWP (total direct clinical input
60 minutes). The support offered consisted of a brief risk assessment, ensuring patients had been able to
access OCFighter, reviewing progress and solving any difficulties that were impeding progress.
Experimental group: guided self-help
The guided self-help consisted of a self-help book, Obsessive Compulsive Disorder: a Self-Help Book,
written by the chief investigator.38 The self-help book focused on information about OCD, maintenance
and provided guidance on how to implement the NICE-recommended treatment for OCD (i.e. CBT using
ERP). The self-help book was a refined and expanded version of a previous free-to-use self-help manual by
the trial team and a user and carer from an OCD self-help group.39 The self-help book was sent to the
participant immediately following randomisation.
Participants received weekly guidance from a PWP, with one initial session of up to 60 minutes (either face
to face or by telephone, dependent on patient preference) followed by up to 10 30-minute sessions over a
12-week period (total direct clinical input 6 hours).
The role of the PWP was to conduct a semistructured interview, to explain the structure and content of
the book and devise patient-centred goals. PWPs supported patients to use CBT (ERP) as described in the
self-help book, reviewed progress, pre-empted difficulties as they arose and engaged the participants in
collaborative problem-solving as required.
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Comparator group: waiting list for high-intensity cognitive–behavioural therapy
The comparator group for the short-term outcomes (3-month follow-up) was a waiting list for high-intensity
CBT. In the longer term (12-month follow-up), the comparator was a waiting list for high-intensity CBT plus
high-intensity CBT. High-intensity CBT is typically 8–20 face-to-face, 45- to 60-minute weekly sessions and
uses a combination of ERP and cognitive therapy.
Psychological wellbeing practitioner training and supervision
Psychological wellbeing practitioners were trained in both the guided self-help and supported cCBT
interventions. Training was delivered in all IAPT services in the 15 NHS sites. Top-up training was provided
to PWPs at sites where a large delay between training and participant recruitment occurred, and because
of the high turnover of PWPs the training was repeated at a number of sites.
The standardised training consisted of 3 days, and included 1 day explaining the nature, features,
treatment and NICE recommendations for the management of OCD. In addition, day 1 also explained
OCTET in terms of study design, rationale and trial procedures.
Day 2 focused on guided self-help and involved small- and large-group work and skills practice of ERP
with specific feedback using exemplar cases. Training was delivered by the chief investigator and two
coapplicants. cCBT training for OCFighter was delivered at the participating sites for 1 day by CCBT Ltd
(the commercial producers of OCFighter). The training was standardised, using the same trainers
(OCTET chief investigator, coapplicants and CCBT Ltd), materials and intervention manuals.
Training manuals for PWPs were developed by the trial team for guided self-help and by CCBT Ltd for the
supported cCBT arm. A reference manual for PWPs was also generated that included general information
about OCTET, recruitment, randomisation and allocation procedures, recording and storage of session
recordings and monitoring of allocated participants.
Psychological wellbeing practitioners delivering the interventions were provided with telephone supervision
on a 2-weekly basis for between 10 and 30 minutes (dependent on the number of patients to be
discussed). Supervision was delivered by OCTET applicants or CBT therapists within IAPT services.
All supervisors (two senior clinicians within a service and coapplicants) were required to attend the
3-day training).
Adherence and fidelity
To ensure the adherence to the guided self-help and supported cCBT interventions, and potentially
enhance the reliability and internal validity of the trial, a number of strategies were implemented during
trial development and completion.
Treatment adherence was examined by requesting PWPs complete contact sheets detailing dates of all
sessions attended, length of sessions and mode of contact (face to face, telephone or e-mail). CCBT Ltd
provided automated recordings of frequency and duration of supported cCBT use.
Fidelity was examined by asking PWPs to record all face-to-face and telephone sessions (with participant
consent), using a digital recorder and (when required) a telephone-recording device.
These recordings were used to examine fidelity to the low-intensity interventions. A rating scale was
developed based on the low-intensity intervention PWP manuals, which defined specific tasks to be carried
out in session 1 and in subsequent sessions for both supported cCBT and guided self-help. Criteria for the
fidelity scale were established via discussions within the OCTET team. The components extracted for fidelity
were rated as ‘implicit’, ‘explicit’ or ‘absent’, and an overall rating generated using a 5-point Likert scale
from ‘unacceptable’ to ‘excellent’. Fidelity was evaluated by a rater (a PWP independent of OCTET),
who was blind to the treatment outcome.
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Site recruitment
Mental health trusts across four UK centres in England (Manchester, York, East Anglia and Sheffield) were
involved in the trial. A dedicated site lead was allocated at each centre. Trusts were recruited throughout
the trial and further support was sought from the Mental Health Research Network (MHRN) to engage
with additional trusts.
Patient recruitment
Inclusion criteria
l Adults aged ≥ 18 years.
l On a waiting list for high-intensity CBT in either primary or secondary mental health-care settings.
l Met DSM-IV criteria for OCD, assessed using six OCD questions from the Mini-International
Neuropsychiatric Interview,40 module G.
l Scored ≥ 16 on the Yale–Brown Obsessive Compulsive Scale – Self-Report (Y-BOCS-SR), indicating a
moderate level of OCD. This is the cut-off score used in most trials. Previous studies suggest that only
a minority of people are referred for treatment or excluded from trials with a Y-BOCS score of < 16
(e.g. 2.3%,41 0%,42 14%25).
l Reported an ability to read English at a level of age ≥ 11 years.
Exclusion criteria
l Actively suicidal.
l Had organic brain disease.
l Currently experiencing psychosis.
l Had a diagnosis of alcohol or substance dependence using DSM-IV criteria (assessed using the
Mini-International Neuropsychiatric Interview,40 modules I and J).
l Currently receiving psychological treatment for OCD.
l Had literacy or language difficulties to an extent that would preclude them from reading written or
web-based materials.
Potential participants were identified using a variety of recruitment methods: waiting lists in primary and
secondary care in our clinical sites were screened by administrative and clinical staff; PWPs screening
patients entering services identified those who may be eligible; and self-referral options were used at one
site (i.e. via adverts in local newspapers, GP surgeries, on social media sites and community centres).
Individuals who were waiting for high-intensity CBT or responded to an advert were provided with a
participant information pack (including an invitation letter, patient information sheet and consent-to-contact
form) in the post or in person. Those who returned a completed consent-to-contact form initially took part
in a brief telephone eligibility screen to determine that they were aged > 18 years, not currently receiving a
psychological therapy for their OCD symptoms or experiencing severe and distressing psychotic symptoms.
Where participants met the initial eligibility screen they were offered a face-to-face eligibility appointment
(either at the clinical site or in their own home). During the interview, individuals had the opportunity to ask
any further questions prior to providing consent and completing the eligibility assessment.
Randomisation, concealment of allocation and blinding
Patients were randomised (in a ratio 1 : 1 : 1) into one of the three arms using a central randomisation
service, via a secure web-based system administered by the York Trials Unit (YTU).
Allocation involved minimisation on the following factors:
l OCD severity on the Y-BOCS-SR (16–23, moderate; 24+, severe/very severe)
l current antidepressant medication use (yes/no)
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l depression on the Patient Health Questionnaire-9 (PHQ-9) (< 10, mild depression; 10–14, moderate
depression; 15–19, moderate to severe depression; > 20, severe depression)
l duration of OCD (0–5 years; 6–10 years; > 10 years).
Researcher blinding
We attempted to blind outcome assessors to allocation; by ensuring that outcome assessments by
researchers were separate from days and locations in which treatment was delivered, asking OCTET
participants to refrain from revealing allocations during assessments and restricting researcher access to
the group allocation section of the trial database.
Blinding was monitored throughout the trial. Researchers were asked to complete an unblinding report
form at all follow-up time points, indicating if they had been unblinded and, if so, at what point during
the interview this occurred. Partial (treatment/no treatment) or full unblinding (trial arm) was recorded.
Researchers were also asked to complete an unblinding form if they became unblinded at any other point
during the trial (e.g. when arranging a follow-up interview with the participant).
Follow-up assessments
Follow-up assessments were conducted 3, 6 and 12 months following randomisation. Participants were
contacted approximately 1 month to 1 fortnight prior to the follow-up time point to arrange a suitable
time and location to meet (either at the clinical site or in their own home). To reduce the chance of the
researcher becoming unblinded, the Adult Service Use Schedule (AD-SUS) self-complete, Client Satisfaction
Questionnaire-8 (CSQ-8) and Pathway questionnaire were posted prior to the visit for return in a Freepost
envelope to the YTU. Participants were given a £5 shopping voucher to thank them for their time for each
follow-up they completed or partially completed.
Outcome assessments
As the primary outcome was the Y-BOCS-OR, the collection of data was face to face. However, we
acknowledged that achieving this with all follow-ups could prove difficult. Therefore, we developed a
highly structured standardised operating procedure (SOP) to assist researchers with participants who were
difficult to contact, to ensure retention rates were maximised. These procedures included contacting
participants using a scaling-down approach (i.e. if not willing/unable to attend face to face we offered
telephone assessment using Y-BOCS-SR and if this failed, to post the primary outcome with a Freepost
envelope for return to the YTU).
Measures
Primary outcome
The primary outcome was OCD symptoms as measured by the Y-BOCS-OR.43 The Y-BOCS-OR is an
interview-administered structured assessment that measures symptom severity in individuals with obsessive and
compulsive symptoms. It consists of two comprehensive symptom checklists, exploring current (over the past
week) and past symptoms, and a 10-item severity scale with obsession and compulsion subscales exploring
current symptoms. The severity scale is designed to identify the impairment experienced by individuals over
five clinical domains: time consumed, functional impairment, psychological distress, efforts to resist and
perceived sense of control. Responses are rated on a 5-point Likert scale from 0 (none) to 4 (extreme).
Responses to all items are added to generate subscale scores and a total Y-BOCS-OR score. Scores are
indicative of OCD severity over five severity categories: 0–7 (subclinical), 8–15 (mild), 16–23 (moderate),
24–31 (severe) and 32–40 (extreme).
The interview took, on average, 30–40 minutes to complete. Individuals conducting the interview required
prior training on OCD symptomatology and in how to rate respondents’ responses. The Y-BOCS-OR has
good psychometric properties.43,44
Secondary outcomes
Secondary outcomes are listed in Table 1, adapted with permission from Gellatly et al.34
TRIAL DESIGN AND METHODS
NIHR Journals Library www.journalslibrary.nihr.ac.uk
12
Yale–Brown Obsessive Compulsive Scale – Self-Report
The Y-BOCS-SR43 is a modified version of the Y-BOCS-OR scale for completion by individuals in the
absence of an interviewer. Identical questions from the Y-BOCS-OR 10-item severity scale are presented
along with responses for each for the individual to select.
As research has demonstrated a moderate relationship between the Y-BOCS-OR and Y-BOCS-SR in a
clinical sample of OCD patients,45 it was agreed at the inception of the trial that, where it was not possible
to complete the Y-BOCS-OR (primary outcome measure), the Y-BOCS-SR would be used as a proxy for the
primary outcome.
Short Form questionnaire-36 items
The Short Form questionnaire-36 items (SF-36)46 is a widely used generic measure of health-related quality
of life. It has eight dimensions of health: physical functioning; social functioning; physical role limitations;
emotional role limitations; energy; pain; mental health; and general health perceptions. Individuals provide
responses based on how they have felt over the previous week on Likert-type scales. Each question carries
equal weight, and is transformed into a 0–100 scale. Lower scores denote more disability. Two summary
scores are produced: the mental health component score and the physical health component score.
The scale has good psychometric properties.47
TABLE 1 Secondary outcome measures
Secondary outcome Measured using/by
Self-reported OCD symptoms Y-BOCS-SR
Self-reported health-related quality of life SF-36
Health-related quality of life EQ-5D-3L
Resource use AD-SUS
Generic mental health CORE-OM
Depression PHQ-9
Anxiety GAD-7
Functioning WSAS
Employment status IAPT employment status questions A13–14
Patient satisfaction CSQ-8
Patient progress through mental health services/proportion of
patients not improved or partially improved and requiring more
intensive CBT
Pathway questionnaire
Comorbiditiesa CIS-R
Attachmenta,b Relationship Styles Questionnaire
Perceived criticisma,b Perceived Criticism Scale
Expressed emotiona,b Family Emotional Involvement and Criticism Scale
CIS-R, Clinical Interview Schedule – Revised; CORE-OM, Clinical Outcomes in Routine Evaluation – Outcome Measure;
EQ-5D-3L, European Quality of Life-5 Dimensions-3 levels; GAD-7, Generalised Anxiety Disorder; SF-36, Short Form
questionnaire-36 items; WSAS, Work and Social Adjustment Scale.
a Collected at baseline only.
b Outcomes collected by a doctor of philosophy (PhD) student and not detailed in this report.
Adapted with permission from Gellatly J, Bower P, McMillan D, Roberts C, Byford S, Bee P, et al. Obsessive Compulsive
Treatment Efficacy Trial (OCTET) comparing the clinical and cost effectiveness of self-managed therapies: study protocol for
a randomised controlled trial. Trials 2014;15:278.34 © Gellatly et al.; licensee BioMed Central Ltd. 2014. This article is
published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution,
and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain
Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article,
unless otherwise stated.
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European Quality of Life-5 Dimensions-3 levels
The European Quality of Life-5 Dimensions-3 levels (EQ-5D-3L)48 is a self-complete instrument used to
measure health-related quality of life, providing health utility scores capable of generating quality-adjusted
life-years (QALYs). It consists of five questions addressing five dimensions of health: mobility; self-care;
ability to undertake usual activities; pain and discomfort; and anxiety and depression. Respondents report
difficulties in each area on three levels (none, some/moderate, extreme), generating individual health states
that can be converted into a weighted health index score, based on values derived from general population
samples.49 The measure has been extensively used and its psychometric properties are adequate.50
Adult Service Use Schedule
The AD-SUS was used to measure individual-level resource use over the period of the trial. The AD-SUS is
used to collect service use and related data, and has been successfully applied in a range of adult mental
health populations, including common mental disorders.51–53
The AD-SUS was adapted for OCD on the basis of clinical expertise and refined using feedback from a
stakeholder group of service users and carers to assess coverage, acceptability, ‘user friendliness’ and ease
of completion. The AD-SUS was completed in an interview with participants and recorded all-cause
hospital- and community-based health- and social-care services, use of psychotropic medication and
out-of-pocket expenses and savings. Use of psychological therapies (‘talking therapies’) was recorded
using a separate self-complete version of the AD-SUS to ensure that interviewers remained blinded to
randomisation allocation status.
Productivity losses were also recorded, using the absenteeism questions from the World Health
Organization’s Health and Work Performance Questionnaire (HPQ).54,55
Clinical Outcomes in Routine Evaluation – Outcome Measure
Clinical Outcomes in Routine Evaluation – Outcome Measure (CORE-OM)56 is a self-complete measure
designed to measure global distress. Thirty-four questions explore how individuals have been feeling over
the last week, using a 5-point scale ranging from ‘not at all’ to ‘most or all of the time’. Four dimensions
of global distress are addressed: subjective well-being; problems/symptoms; life functioning; and risk/harm.
Eight items are positively framed and scoring for these is reversed. Higher scores indicate higher levels of
distress. The CORE-OM has high internal and test–retest reliability, and demonstrates convergent validity
with other measures.57
Patient Health Questionnaire-9
The PHQ-958 is a 9-item self-report scale that facilitates the recognition and diagnosis of depression.
Scores range from 0 to 27, with a score of ≥ 10 considered to be a clinically significant level of depression.
The PHQ-9 has demonstrated good reliability and validity.59
Generalised Anxiety Disorder Scale-7
The Generalised Anxiety Disorder Scale-7 (GAD-7)60 is a 7-item self-report scale used to identify and
measure the severity of generalised anxiety disorder. Scores range from 0 to 21, with a cut-off score of
≥ 8 distinguishing between clinical and non-clinical populations. Good psychometric properties have
been reported.60
Work and Social Adjustment Scale
The Work and Social Adjustment Scale (WSAS)61 is a 5-item self-report measure that assesses functional
impairment. Scores range from 0 to 40. The scale assesses the impact on work, home, social and private
activities, and personal or family relationships. A score of > 20 provides indication of severe functional
impairment, whereas scores between 10 and 20 suggest less severe but significant functional impairment.
Scores of < 10 are considered subclinical. The scale is reported to display good reliability and validity.61
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Improving Access to Psychological Therapies employment status questions A13–14
This consists of two questions addressing the employment status of individuals and if statutory sick pay is
being received. This measure is used as part of the IAPT minimum data set.62
Pathway questionnaire
This is a self-complete measure developed specifically for use within OCTET to identify whether patients
had or had not stayed on the waiting list for high-intensity CBT.
Clinical Interview Schedule – Revised
The Clinical Interview Schedule – Revised (CIS-R)63 is a self-administered computerised assessment of
psychiatric disorder. The interview begins with general questions to establish an overall picture of health,
appetite and physical activity. The main body of the CIS-R contains 14 sections labelled A–N. Each section
scores a symptom, which may range in severity between 0 and 4. These symptoms are somatic symptoms,
fatigue, concentration and forgetfulness, sleep problems, irritability, worry about physical health,
depression, depressive ideas, worry, anxiety, phobias, panic, compulsions and obsessions.
The diagnostic output corresponds to the ICD-10 Classification of Mental and Behavioural Disorders64
diagnostic criteria for mild, moderate and severe depressive episodes. CIS-R has established reliability and
validity in primary care, occupational and community studies.63
Client Satisfaction Questionnaire-8
The CSQ-865 is a self-report scale that asks patients to assess their satisfaction with a service on a 4-point
Likert scale. Scores range from 8 to 32, with higher values indicative of higher satisfaction. The measure
has been tested with diverse client samples and demonstrates good retest reliability, internal consistency
and sensitivity to treatment.66
Table 2 provides detail about the time points at which each measure was completed.
Researcher training
Researchers and clinical study officers (CSOs) from the MHRN involved in the recruitment of participants
were provided with a 1-day training session covering trial procedures and completion of eligibility, baseline
and follow-up interviews. The trial manager provided training. A proportion of the day was spent
equipping individuals with the necessary skills to complete the Y-BOCS-OR. Inter-rater reliability among the
researchers/CSOs was employed to measure agreement between ratings for the Y-BOCS-OR. Top-up
training was provided throughout the trial.
Inter-rater reliability: Yale–Brown Obsessive Compulsive Scale – Observer Rated
All researchers and CSOs who undertook the 1-day training were trained on the purpose, content and
conduct of the Y-BOCS-OR. During the training, a practice recording of a Y-BOCS-OR interview (conducted by
an expert clinician) was played and ratings were collected and discussed in a group format. Researchers were
informed that if they were experiencing difficulties making a decision about the score to any of the questions,
they should allocate the higher of the two scores. All researchers had the opportunity to ask questions and
any queries were addressed. The aim was to investigate the inter-rater reliability between researchers/CSOs
and the expert rating of the practice sessions. Total scores for the measure were compared; a difference of
4 points between researcher/CSO ratings and expert ratings was tolerated. In addition, if differences in ratings
crossed diagnostic boundaries a reassessment may be required. Where the tolerance criterion was not met, a
discussion was held with the researcher/CSO and additional training and advice provided.
Following the training day an additional practice recording was provided and researchers/CSOs were asked
to return their rating to the trial manager within 2 weeks. Ratings were again compared with the expert
score. During the trial (6 months following commencement) researchers were asked to rate a third practice
tape. A ‘cues and prompts’ sheet was prepared to assist with the conduct of the Y-BOCS-OR.
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Sample size calculation
At each time point three pairwise comparisons were carried out between the three intervention options:
supported cCBT, guided self-help and a waiting list for high-intensity CBT. The study was therefore
powered using a 1.67% significance level.
The comparison of either supported cCBT or guided self-help is a partially nested design for which the
sample size calculation needs to consider the intracluster correlation coefficient (ICC) for therapist.
The comparison of supported cCBT with guided self-help is a crossed therapist design, as support for both
treatments was delivered by the same therapists. Sample size for crossed therapist design depends on the
ICC for therapist for treatment within therapist, which is smaller than the ICC for therapists. Formulae for
this calculation are given in Walwyn and Roberts.67 In the absence of estimates of the two ICCs required
for the two calculations, sensitivity of study power to larger values was considered in the calculation below.
Assuming a standard deviation (SD) for the primary outcome (Y-BOCS-OR) at 6 months of 7.3 units,
a correlation between baseline Y-BOCS-OR and 6-month Y-BOCS-OR of 0.43,41 a study with 366 service
users followed up to the primary end point has a power > 80% to detect a difference of 3 Y-BOCS points
for each comparison. We were unable to find evidence for a ‘clinically important difference’. A reduction
of 3 points was agreed based on clinical consensus with the study team. This calculation assumed
that supported cCBT and guided self-help were delivered by 24 therapists. It also assumes that the ICC
for therapists was 0.06 and an ICC for treatment within therapist was 0.015, which implies that the
correlation between the random effect for supported cCBT and guided self-help is 0.75. The design
effects, sometimes called the sample size inflation factor, were 1.1225 and 1.06125 for the partially
nested and crossed designs, respectively. We considered these values of the ICC to be plausible, but in the
event that the ICC for therapist was as large as 0.1 and the ICC for treatment within therapist was 0.05,
the power of the trial is still > 75% for all three comparisons.
TABLE 2 Measures collected and time point of data collection
Outcome measures
Time point
Eligibility Baseline 3 months 6 months 12 months
Primary outcome
Y-BOCS-OR ✗ ✗ ✗ ✗
Secondary outcomes
Y-BOCS-SR ✗ ✗ ✗ ✗ ✗
SF-36 ✗ ✗ ✗ ✗
CORE-OM ✗ ✗ ✗ ✗
PHQ-9 ✗ ✗ ✗ ✗
GAD-7 ✗ ✗ ✗ ✗
WSAS ✗ ✗ ✗ ✗
EQ-5D-3L ✗ ✗ ✗ ✗
IAPT employment status questions A13–14 ✗ ✗ ✗ ✗
CSQ-8 ✗ ✗
CBT uptake (Pathway questionnaire) ✗ ✗ ✗
AD-SUS – interview ✗ ✗ ✗ ✗
AD-SUS – self-complete ✗ ✗ ✗ ✗
CIS-R ✗
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Based on an 85% follow-up rate, the target sample size for the trial was set at 432 in the initial
application. Monitoring during the trial suggested that the follow-up rate to the primary end point
(3 months) was likely to be lower rather than the assumed 85%. Assuming a follow-up rate of 78%,
total sample size was increased to 472.
Analysis
Low-intensity intervention uptake
Patient engagement with the treatment process was summarised and reported descriptively. There is no
consensus for the level of uptake of low-intensity treatments that might define an appropriate ‘dose’.
Analysis of the primary outcome measure and secondary quantitative
outcome measures
Cleaning of outcome and baseline data was conducted without the treatment group allocations in view.
Summary statistics from these preliminary analyses were reviewed by the trial research team to identify
data errors.
Preliminary analyses compared the characteristics of subjects with and without complete data at follow-up
time points, by treatment group, using a logistic regression model. This was carried out for the primary
outcome at the three follow-up assessment points. This analysis was used to develop an understanding of the
missing data mechanism and to determine the appropriate methods for dealing with missing outcome data.
Statistical analyses of the primary outcome measure, Y-BOCS-OR, are based on a linear mixed model with
random effects for supported cCBT and guided self-help therapist using restricted maximum likelihood.
As therapist is crossed with treatment, separate random effects were included for each treatment enabling the
estimation of the intracluster correlation for supported cCBT and guided self-help. In addition to treatment,
the following fixed baseline or demographic covariates were included to improve statistical efficiency:
1. OCD duration (by categories 0–5, 5–10, > 10 years)
2. OCD severity (as measured by Y-BOCS-OR at baseline)
3. anxiety (as measured by GAD-7)
4. depression score (as measured by PHQ-9)
5. antidepressant drug use (yes/no)
6. sex.
A small number of baseline covariates were missing for those covariates not used in the minimisation.
To maximise the number of subjects included in the model, these values were imputed by single imputation
using other covariates in keeping with the method suggested by White and Thompson.68 Using this
procedure, statistical modelling can be carried out on all participants with outcome data. A logistic
regression model was used, fitted to CBT uptake, with treatment allocation, sex, duration of OCD,
baseline Y-BOCS-OR, GAD-7, PHQ-9 and antidepressant medication on entry into the trial as covariates.
The same analyses were carried out for quantitative secondary outcomes. These analyses assume that
subjects are missing at random.
Uptake of high-intensity cognitive–behavioural therapy
Uptake of high-intensity CBT was recorded at the 3-, 6- and 12-month follow-ups. A logistic regression
model was used to estimate the adjusted odds ratio (OR) for uptake (as a binary outcome of a patient
attending at least one CBT appointment), comparing the two low-intensity interventions separately with
a waiting list for high-intensity CBT. The models included treatment allocation, sex, duration of OCD,
baseline Y-BOCS-OR, GAD-7, PHQ-9 and antidepressant medication on entry into the trial as covariates.
Where presented, tables give the adjusted ORs with confidence intervals (CIs) and p-values and the
exponent of the model constant.
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Recovery and remission
Recently, expert consensus guidelines for defining treatment response and remission in OCD have been
published based on YBOC-OR.69 These are defined as ≥ 35% reduction on the Y-BOCS-OR for response
and Y-BOCS-OR score of ≤ 12 for remission. A logistic model was fitted to responses at 12 months
adjusting for sex, baseline GAD-7 and PHQ-9 scores, antidepressant medication use at randomisation
and duration of OCD. The analysis is additional to the statistical analysis plan as this was signed-off prior
to publication of the guidelines.
Moderator analyses
A subgroup analysis by severity specified in the trial protocol was conducted by adding a treatment severity
interaction term to the analysis of the primary outcome at the primary end point (3 months). In addition,
analysis of treatment effect moderation by both age and chronicity of OCD was carried out.
Two types of interactions between moderators and treatment can occur. If the moderator is just affecting
the magnitude of the treatment effect it is called a quantitative interaction. If the moderation causes a
reversal of the treatment effect it is called a qualitative interaction. Interactions of treatment with both
chronicity and severity were hypothesised to be quantitative, whereas interactions of treatment with age
were hypothesised to be qualitative (representing potential difficulties of older patients in engaging with
supported cCBT relative to guided self-help). Thus, a significant treatment effect would be required before
assessing treatment moderation via severity and chronicity of OCD.
The analyses were carried out by adding a treatment with moderator interaction terms to the primary
analysis model. For severity and chronicity, an overall test of the interaction was carried out. The hypothesis
related to age concerned only the low-intensity interventions, so the contrast between guided self-help
and supported cCBT was estimated.
Data were analysed using Stata version 13 (StataCorp LP, College Station, TX, USA).
Economic evaluation
Perspective
The primary perspective of the economic evaluation was the NHS/Personal Social Services perspective
preferred by NICE. Secondary analyses included all additional resources likely to be relevant to a societal
perspective in this population: productivity losses (as a result of time off work resulting from illness),
and out-of-pocket expenses and savings.
Data collection
An adapted version of the AD-SUS was used to measure individual-level resource use. The AD-SUS is used
to collect service use and related data, and has been successfully used in a range of adult mental health
populations.51–53 The AD-SUS was adapted for OCD, as described above (see Secondary outcomes), and used to
record all-cause hospital and community-based health- and social-care services, medication and out-of-pocket
expenses and savings. Information on medications used including drug, dose and duration were collected for
economic purposes only. Productivity losses were recorded using the World Health Organization’s HPQ.54,55
The AD-SUS and HPQ were administered by interview at baseline, and the 3-, 6- and 12-month follow-ups,
and covered the previous 6-month period at baseline interview and the time since last interview at each
follow-up point. Data on the number and duration of supported cCBT and guided self-help contacts were
recorded on a session-by-session basis by PWPs using an intervention proforma. Use of all other psychological
therapies, including high-intensity CBT, was collected and self-reported by participants in a separate
self-complete proforma kept separate from the AD-SUS in order to ensure that interviewers remained blinded
to randomisation allocation status. Participants completed the form alone and placed it in a sealed envelope
before handing it to the interviewers. Data on the number and duration of intervention contacts were recorded
on a session-by-session basis by PWPs using an intervention proforma.
TRIAL DESIGN AND METHODS
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Costs
All costs are reported in pounds sterling at 2013/14 prices. Discounting was not relevant, as the
follow-up did not exceed 12 months. Unit costs were applied to individual-level resource use data to
calculate total costs per participant and are detailed in Appendix 2. In summary, unit costs for most
hospital and primary care services were obtained from NHS Reference Costs,70 Unit Costs of Health and
Social Care71 and the British National Formulary for medications.72
Productivity losses because of OCD were calculated using the human capital approach by multiplying days
off work attributable to illness by the individual’s salary and not accounting for early retirement resulting
from illness.73 Lost productivity costs were capped at 5 days per week (maximum of 130 days for the
6-month period and 65 days for the 3-month period).
Intervention costs
Psychological wellbeing practitioner sessions were costed using published data on the cost of low-intensity
IAPT interventions,74 inflated to 2013/14 prices using the Hospital and Community Health Services Pay and
Prices Index.71 The approach is outlined in Appendix 3.
Training for PWPs to provide supported cCBT and guided self-help support was provided to all PWPs, and
associated costs were calculated as outlined in Appendix 4.
For the supported cCBT arm, the cost to the trial of the OCFighter program was £10,000. This was divided
by the 157 participants who were randomised to supported cCBT to give a cost per participant in this
group of £63.69. In the guided self-help arm, participants were provided with a self-help manual (£1.87
per manual for printing costs only, excluding development and design costs as these are sunk costs),
photocopied worksheets (£0.81 per set of photocopied sheets per participant) and a CD (£1.18 per CD,
one per participant), plus £1.68 postage charge. Thus, the total cost of guided self-help materials per
participant was £5.54.
Access to high-intensity CBT, for all groups, was recorded using the intervention proforma. Unit costs for
CBT are reported in Appendix 2.
Analysis
Data were analysed using Stata. Participants were analysed on an intention-to-treat basis (i.e. according to
the group to which they were randomised regardless of intervention compliance).
Costs and outcomes were compared at baseline, 3, 6 and 12 months and are presented as mean values
by arm with SDs. Mean differences and 95% CIs were obtained by non-parametric bootstrap regressions
(1000 repetitions) to account for the non-normal distribution commonly found in economic data, with
adjustment for clustering at the therapist level, using the ‘cluster’ option in Stata. To provide more relevant
treatment-effect estimates75 regressions to calculate mean differences in costs were repeated with the
further inclusion of covariates for the baseline value of the relevant variable (costs or EQ-5D-3L utility) plus
variables thought to influence costs and outcomes: antidepressant drug use; anxiety (GAD-7); depression
score (PHQ-9); sex; OCD duration (0–5, 5–10 and > 10 years); and Y-BOCS-OR score.
The primary analysis was a complete-case analysis (i.e. excluding those lost to follow-up or with missing
ADSUS and/or EQ-5D-3L data at a particular time point). To explore the potential impact of excluding
non-responders, we examined the sociodemographic and clinical characteristics of those included in
the analyses and those in the full sample. A secondary analysis was carried out with missing baseline,
3-month and 12-month total costs and outcomes imputed using the input imputation command in Stata
(version 11) and including the baseline variables described above.
Cost-effectiveness was explored in terms of QALYs calculated using the EQ-5D-3L measure of health-related
quality of life, assessed at baseline, 3, 6 and 12 months. Appropriate utility weights were attached to health
states76 and QALYs were calculated using the total area-under-the-curve approach with linear interpolation
between assessments.77
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Two sets of cost–utility analyses were conducted: one compared groups at 3 months and one compared
groups at 12 months (primary end point). Incremental cost-effectiveness ratios (ICERs) were calculated,
defined as the mean difference in cost between two groups divided by the mean difference in effect.
Uncertainty was explored using cost-effectiveness planes and cost-effectiveness acceptability curves
(CEACs) based on the net-benefit approach.78 Cost-effectiveness planes illustrate the uncertainty around
the estimates of costs and effects by plotting the bootstrapped cost and effects, with points in each
quadrant indicating a different implication for economic evaluation. CEACs are an alternative to CIs
around ICERs and show the probability that one intervention is cost-effective compared with the other,
for a range of values that a decision-maker would be willing to pay for an additional unit of an outcome.
A series of net benefits were calculated for each individual for a range of values for willingness to pay for a
QALY. After calculating net benefits for each participant for each value of willingness to pay, coefficients
of differences in net benefits between the trial arms were obtained through a series of bootstrapped linear
regressions (1000 repetitions) of group upon net benefit, which included the same covariates used for
comparisons of outcomes in the primary economic analyses. The resulting coefficients were then examined
to calculate the proportion of times that the intervention group had a greater net benefit than the control
group for each value of willingness to pay. These proportions were then plotted to generate CEACs for
all cost–outcome combinations.
This analysis takes a decision-making approach, ignoring statistical significance and focusing instead on the
probability of one intervention being cost-effective compared with another intervention, given the data
available. This is the recommended approach to economic evaluation, preferred over traditional reliance on
arbitrary decision rules regarding statistical significance, which are being increasingly criticised as irrelevant
in a decision-making context.79,80 Instead, it is argued that the decision to adopt one intervention over
another should be based on the expected cost-effectiveness of the intervention, or the probability of
making the correct decision.
Patient and professional acceptability: qualitative methods
Successful implementation of research into NHS practice requires that new interventions are accepted by
both patients and mental health professionals. Two qualitative acceptability studies were conducted.
We conducted post-intervention interviews with a subgroup of patients in both low-intensity arms of the
trial and with PWPs delivering the low-intensity interventions across clinical sites.
The methods and associated findings from these studies are presented in Chapter 5.
Trial administration
Trial monitoring
Independent committees
The TSC met twice per year, chaired by an academic GP. The TSC included an experienced PWP, a
consultant child and adolescent psychiatrist with a special interest in OCD, a service user with lived
experience of OCD, the chief investigator and the trial managers.
The DMEC was chaired by an academic GP, and included a mental health nurse with significant experience
of working with OCD and an independent statistician, with the trial statistician also in attendance.
The DMEC met once per year. Terms of reference for the TSC and DMEC committees were agreed at the
commencement of the study. Members of these committees are named in the Acknowledgements.
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Clinical trials unit
The YTU (UKCRC registration: 40) was responsible for facilitating the randomisation of participants,
establishing a study database, handling of safety reporting and the management of data for OCTET.
Data management included oversight of trial retention rates and monitoring of data entry and
completeness. Where required, additional procedures were generated to ensure that follow-up was
completed with all consenting participants and data entry was completed promptly.
The database established for use in OCTET was devised to facilitate study contacts, trial oversight and data
management. This included facilities to:
l record participant contact details
l record contact attempts and completed visits
l generate randomised allocation letters (for the participant and their GP)
l facilitate the allocation of PWPs to participants
l record documentation received at the YTU
l enable entry of collected data for compilation for the end analysis.
The database also provided an opportunity to run routine reports on recruitment and retention rates,
which facilitated the smooth administration of OCTET.
In addition, the YTU completed an independent quality control and verification process for the collected
data, by checking that a random 10% sample of data (across each time point, stratified by centre) did not
exceed a predefined error rate of 5%. This proportionate approach to data verification was deemed
appropriate because of the nature of this trial.81
The YTU was also available to provide trial management during periods of absence, thus ensuring
continued support throughout the trial for OCTET researchers and PWPs.
Audits
To ensure that all data collected during OCTET were complete and stored correctly, internal audits of all data
and documents collected at each research site were conducted. This included monitoring of the following:
l consent-to-contact forms
l consent forms
l baseline/follow-up booklets
l adverse event (AE) forms
l risk forms
l voucher receipts for follow-up interviews
l sending of booklets to the YTU.
An audit procedure guidance document was prepared by the trial managers that included a data checklist
for completion by each research team.
Trial-specific procedures
To standardise processes across all sites and to maximise data quality, trial-specific SOPs were generated
for all individuals involved in the trial covering all procedures and frequently asked questions.
Researcher trial-specific SOPs covered booking eligibility; baseline and follow-up interviews; recruitment
procedures; dealing with difficult to contact participants; retention procedures; conducting and reporting
risk assessments; AEs recording and reporting; managing participants; and own distress and blinding.
Checklists and letter templates were included to assist with all aspects of the trial and the trial procedure
document was updated and disseminated to all researchers as and when necessary throughout the trial.
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Risk assessment
A trial-specific SOP was implemented for reporting and managing suicidal risk. Question 9 on the PHQ-9
(Have you had thoughts that you would be better off dead or hurting yourself in some way?) was used
to identify potential suicide risk. If the patient indicated risk then a series of questions were asked to
determine level of risk including ‘thoughts only but no intent’, ‘thoughts with some intent but not
immediate’ and ‘thoughts with immediate intent’. Where risk was identified it was referred to a trial
coapplicant with clinical experience. Appropriate action was then taken usually involving informing both
the clinical site and the GP. All reported risk was documented on risk forms that were signed by the
research site lead.
Safety reporting and disclosure
To fulfil requirements for safety reporting and disclosure, a trial-specific procedure for detecting and
reporting AEs was implemented.
Initially in OCTET an AE was defined as any untoward medical occurrence in a participant that may or
may not have a causal relationship with the treatment. Events could then be classified as ‘serious’ or
‘non-serious’ as per The International Council for Harmonisation of Technical Requirements for
Pharmaceuticals for Human Use good clinical practice guidance.82
This resulted in a high level of AEs being reported that were unrelated to the condition or treatments of
interest. Following discussions with the OCTET DMEC, non-serious AE reporting was amended to include
events relating to (1) any mental health condition; (2) use of psychotropic medications; (3) dissatisfaction
with trial procedures; and (4) unplanned hospital visits for any medical condition. Serious AE reporting
remained unchanged.
Researchers and PWPs were requested to inform the trial manager at the YTU of any serious or non-serious
AEs using the OCTET AE reporting form. All serious AEs were independently reviewed by two clinicians
appointed by the YTU to ascribe relationship and expectedness. All serious and non-serious AEs were
summarised for discussion with the DMEC and TSC at each scheduled meeting.
Any serious AEs deemed to be related and unexpected were required to be reviewed by the DMEC prior
to subsequent reporting to the Research Ethics Committee and study sponsor within 7 days. No such
events were experienced during OCTET.
Patient and public involvement
Patient and public involvement was incorporated throughout all stages of OCTET, with links being made
during the early stages of the trial. The contributions made were extremely valuable, providing alternative
views and suggestions to those of the trial team and strengthening ideas.
From the outset, involvement derived from the chief executive of Anxiety UK (a national, user-led charity
run by sufferers and ex-sufferers of anxiety disorders), who was included as an applicant.
Members of an OCD self-help group agreed to be part of a consultation group at the inception of OCTET.
The aim of the OCD consultation group was to determine the ‘user-friendliness’ and ease of completion of
the guided self-help manual during the development stages. Comments provided during the focus group
were fed back to the OCTET team and various refinements to wording and presentation were made.
The consultation group also contributed to the adaptation of the AD-SUS for use with an OCD population.
Feedback was gathered in relation to the wording of questions, ease of completion and if additional
questions should be included, and appropriate amendments were made.
TRIAL DESIGN AND METHODS
NIHR Journals Library www.journalslibrary.nihr.ac.uk
22
In addition to the development and conduct of the research, service users were involved in the
undertaking and monitoring of the research. As detailed previously (see Trial administration), a service user
sat on the TSC and provided advice and guidance during the trial.
The patient acceptability study was supported by a service user, who attended bespoke qualitative
interview training delivered by assisted experienced members of the OCTET team, to assist with the
conduct of the interviews. Further details are provided in Chapter 5.
The trial team have additionally collaborated with a national service user-led OCD charity, OCD-UK,
to support the dissemination of the research findings.
A consultancy fee, based on INVOLVE guidelines,83 was paid to service users involved.
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Chapter 3 Results
In this chapter, we detail the results of OCTET.
Site recruitment
In our pilot phase we recruited five IAPT sites within five NHS trusts, each led by a coapplicant designated
as site lead. Following the dissolution of waiting lists, a further 10 sites were recruited either via the
existing site leads or through the MHRN (Table 3) to supplement recruitment activity.
Psychological wellbeing practitioners: recruitment
and characteristics
Recruitment
Psychological wellbeing practitioners were recruited from IAPT services within NHS trusts to deliver the trial
interventions. In total, 204 PWPs from 15 NHS trusts attended the 3-day OCTET training. The number of
PWPs trained from each trust ranged from 1 to 27, with an average of 13 per trust (see Table 3).
TABLE 3 Site and PWP recruitment
Trust Number of PWPs attending OCTET training, n (%)
Bradford District Care Trust 15 (7.4)
Camden & Islington NHS Foundation Trust 18 (8.8)
Cheshire & Wirral Partnership NHS Foundation Trust 20 (9.8)
Coventry & Warwickshire Partnership Trust 5 (2.5)
Lancashire Care NHS Foundation Trust 20 (9.8)
Manchester Mental Health and Social Care Trust 7 (3.4)
NHS City Health Care Partnership Trust 15 (7.4)
Norfolk and Suffolk Mental Health NHS Foundation Trust 27 (13.2)
Nottingham County Health Partnership 15 (7.4)
Pennine Care NHS Foundation Trust 6 (2.9)
Rotherham, Doncaster & South Humber (RDaSH) 8 (3.9)
Sheffield Health & Social Care Foundation Trust 21 (10.3)
South Staffordshire and Shropshire Healthcare NHS
Foundation Trust
17 (8.3)
South West Yorkshire Partnership NHS Foundation Trust 9 (4.4)
Worcestershire Health & Care NHS Trust 1 (0.5)
Total 204 (100.0)
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Psychological wellbeing practitioner characteristics
Of the 93 PWPs allocated OCTET patients, 68 returned a questionnaire detailing demographics,
qualifications, OCD training and previous experience (Table 4).
Most PWPs (87%) were female, aged between 24 and 61 years, with a mean age of 34 years. Their
highest educational qualification was a postgraduate certificate/diploma (81%) and the majority (66%)
were experienced in delivering psychological interventions with > 2 years in post.
As expected, most PWPs had experience of delivering guided self-help (94%), with a lower proportion
reporting experience of delivering supported cCBT (69%). The types of low-intensity interventions most
frequently delivered were behavioural activation (91%) and structured problem-solving (79%).
More than half of the PWPs had received some training in OCD as part of their IAPT training, but this had
largely focused on identification rather than treatment.
TABLE 4 Psychological wellbeing practitioner characteristics
Characteristic PWPs (N= 68)
Age (years)
Range 24–61
Mean (SD) 33.9 (10.8)
Sex (%)
Female 59 (87)
Male 9 (13)
Highest educational qualification, n (%)
Undergraduate degree 12 (18)
Postgraduate certificate 30 (44)
Higher education diploma 1 (1)
Postgraduate diploma 14 (21)
Master’s degree 9 (13)
PhD 1 (1)
Length of time in PWP role, n (%)
6 months to 1 year 6 (9)
1–2 years 17 (25)
2–5 years 45 (66)
Length of time in mental health, n (%)
Up to 1 year 1 (1)
1–5 years 34 (50)
5–10 years 25 (37)
10–20 years 8 (11.8)
Received OCD training as part of IAPT training, n (%)
Yes 37 (54)
No 31 (45)
PhD, doctor of philosophy.
RESULTS
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Patient recruitment
Patients were recruited from IAPT services within 14 NHS trusts between February 2011 and May 2014,
and all follow-up data collection was complete by May 2015. Participants were not recruited from one
NHS trust as a result of waiting list reductions.
Revised sample size
Our original sample was 432; however, because of concerns about meeting the proposed retention
rate (85%), we increased the target sample size to 472 (see Chapter 2, Sample size calculation).
Subsequently, there was a small overshoot of recruitment and randomisation to 475, but there were
also two post-randomisation exclusions because of a participant being aged < 18 years (n = 1, supported
cCBT) and issues relating to participant suicide risk (n = 1, waiting list). Both exclusions were ratified with
the DMEC, giving a trial sample of 473 participants. The Consolidated Standards of Reporting Trials
(CONSORT) diagram for OCTET is shown in Figure 1. Of the 473 patients recruited, 158 were randomised
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Trusts’ waiting lists searched
(n = 14)
Randomised
(n = 475)
Post-randomisation
exclusion,a n = 1
Returned consent to contact
(n = 779)
• Not contactable, n = 25
• Declined to participate, n = 96
Ineligible (n = 89)
• Accessing CBT, n = 40
• Other, n = 49
Ineligible (n = 94)
• Accessing CBT, n = 11
• Other, n = 83
Screening for eligibility; 
telephone interview
(n = 658)
Assessed for eligibility; baseline interview
(n = 569)
Allocated to 
guided self-help
(n = 158)
Allocated to waiting list
(n = 159)
Allocated to cCBT
(n = 158)
Post-randomisation
exclusion,a n = 1
FIGURE 1 The CONSORT flow chart illustrating recruitment participants into OCTET. a, Post-randomisation
exclusion required because of a participant aged < 18 years (n= 1, cCBT) and risk issues relating to increased risk
and not a change in supervisor decision (n= 1, waiting list). Source: Lovell et al.84 This is an open access article
distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use,
distribution, and reproduction in any medium, provided the original author and source are credited.
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to guided self-help, 157 to supported cCBT and 158 to a waiting list for high-intensity CBT. The number of
patients recruited by site is shown in Table 5.
Retention
Retention rates were 81% at 3 months, 75% at 6 months and 71% at 12 months (Figure 2). Retention
rates by group at 3 months were broadly similar: guided self-help was 82% (n = 130), supported cCBT
was 77% (n = 121); and a waiting list for high-intensity CBT was 84% (n = 133). At 12 months, retention
rates were: guided self-help at 72% (n = 114), supported cCBT at 67% (n = 105); and a waiting list for
high-intensity CBT at 73% (n = 115). Participants who withdrew from the study are reported in the
CONSORT flow chart (see Figure 2); more specific reasons for withdrawal are detailed in Appendix 5.
Patient baseline characteristics
Demographic characteristics
Baseline demographic characteristics are presented in Table 6 (variable counts are because of missing
data items).
Of the 473 patients recruited, 95% were white, 60% were female and the median age was 33 years.
Around three-quarters were employed, half were married or living with a partner, and 28% had been
educated to degree level or above.
Just over 50% of participants reported previous professional help with OCD and around half were
currently using antidepressant medication. Patients reported that the duration of their OCD was > 10 years
(55%), 5–10 years (12%) or < 5 years (33%).
The groups were largely comparable in terms of employment status and receipt of statutory sick pay.
Marginally fewer instances of long-term sickness/disability and being in receipt of associated benefits were
found in the waiting list for high-intensity CBT group than in the intervention groups (9.5%, waiting list
for high-intensity CBT; 14.0%, supported cCBT; 14.6%, guided self-help).
TABLE 5 Patient recruitment by site
Trust Number of patients recruited
Bradford District Care Trust 34
Camden & Islington NHS Foundation Trust 22
Cheshire & Wirral Partnership NHS Foundation Trust 62a
Coventry & Warwickshire Partnership Trust 26a
Lancashire Care NHS Foundation Trust 22
Manchester Mental Health and Social Care Trust 31
NHS City Health Care Partnership Trust 26
Norfolk and Suffolk Mental Health NHS Foundation Trust 87
Nottingham County Health Partnership 0
Pennine Care NHS Foundation Trust 28
Rotherham, Doncaster & South Humber 12
Sheffield Health & Social Care Foundation Trust 68
South Staffordshire and Shropshire Healthcare NHS Foundation Trust 18
South West Yorkshire Partnership NHS Foundation Trust 34
Worcestershire Health & Care NHS Trust 5
a Two post-randomisation exclusions.
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Allocated to guided self-help
(n = 158)
• Received guided self-help, 
   n = 104 (65%)
3-month follow-up
(n = 130) (82%)
• Withdrew from study, n = 8
• Lost to follow-up, n = 20
6-month follow-up
(n = 122) (77%)
• Withdrew from study, n = 16
• Lost to follow-up, n = 20
12-month follow-up
(n = 114) (72%)
• Withdrew from study, n = 20
• Lost to follow-up, n = 24
Allocated to cCBT
(n = 157)
Allocated to cCBT
(n = 157)
• Received cCBT, n = 125 (62%)
3-month follow-up
(n = 121) (77%)
• Withdrew from study, n = 12
• Lost to follow-up, n = 24
6-month follow-up
(n = 112) (71%)
• Withdrew from study, n = 22
• Lost to follow-up, n = 23
12-month follow-up
(n = 105) (67%)
• Withdrew from study, n = 26
• Lost to follow-up, n = 26
Allocated to waiting list
(n = 158)
Allocated to waiting list
(n = 158)
3-month follow-up
(n = 133) (84%)
• Withdrew from study, n = 7
• Lost to follow-up, n = 18
6-month follow-up
(n = 123) (78%)
• Withdrew from study, n = 16
• Lost to follow-up, n = 19
12-month follow-up
(n = 115) (73%)
• Withdrew from study, n = 20
• Lost to follow-up, n = 23
FIGURE 2 The CONSORT flow chart illustrating retention of participants in OCTET.
TABLE 6 Baseline comparison: sociodemographic variables
Characteristic
Intervention
Supported cCBT
(n= 157)
Guided self-help
(n= 158)
Waiting list
(n= 158)
Age (years), median (range) 32.0 (18–77) 32.8 (18–72) 33.3 (19–66)
Sex, n (%)
Male 66 (42.0) 57 (36.1) 65 (41.1)
Female 91 (58.0) 101 (63.9) 93 (58.9)
Ethnicity, n (%)
White 145 (92.4) 154 (97.5) 149 (94.3)
Non-white 12 (7.6) 4 (2.5) 8 (5.1)
Missing 0 (0) 0 (0) 1 (0.6)
Marital status, n (%)
Married/living with partner 84 (53.5) 81 (51.3) 85 (53.8)
Other 70 (44.6) 75 (47.4) 73 (46.2)
Missing 3 (1.9) 2 (1.3) 0 (0)
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Patients detailed their treatment preferences prior to randomisation. They were asked whether they
preferred to stay on the waiting list for high-intensity CBT, had no preference or preferred to receive a
low-intensity intervention. Of the total sample, 42% preferred allocation to the intervention groups,
47% had no preference and 11% preferred to stay on the waiting list for high-intensity CBT.
Patients who were allocated to a low-intensity intervention were also asked if they would prefer supported
cCBT or guided self-help. Preferences between the two low-intensity treatments were evenly balanced,
with 50% not having a preference (Table 7).
There were no striking differences in demographic characteristics at baseline.
Clinical characteristics
Baseline clinical characteristics are presented in Table 8 (variable counts are because of missing data).
The mean baseline Y-BOCS-OR score was approximately 25 at baseline (indicating severe OCD). The mean
PHQ-9 score was approximately 12 at baseline (indicative of mild to moderate depression), whereas GAD-7
scores were approximately 12.5 (indicating moderate anxiety).
TABLE 6 Baseline comparison: sociodemographic variables (continued )
Characteristic
Intervention
Supported cCBT
(n= 157)
Guided self-help
(n= 158)
Waiting list
(n= 158)
Employment status,a n (%)
Employed 86 (54.4) 95 (60.1) 97 (61.4)
Unemployed and seeking work 10 (6.3) 14 (8.9) 9 (5.7)
Student 17 (10.8) 19 (12.0) 17 (10.8)
Long-term sick/disabled receiving income support or
incapacity benefit
22 (14.0) 23 (14.6) 15 (9.5)
Homemaker, not actively seeking work 15 (9.6) 9 (5.7) 11 (7.0)
Not receiving benefits and not actively seeking work 1 (0.6) 0 (0) 1 (0.6)
Unpaid voluntary work and not actively seeking work 1 (0.6) 1 (0.6) 0 (0)
Retired 6 (3.8) 5 (3.2) 6 (3.8)
Missing 2 (1.3) 1 (0.6) 5 (3.2)
Receiving statutory sick pay, n (%)
Yes 8 (5.1) 8 (5.1) 11 (7.0)
No 144 (91.7) 146 (92.4) 138 (87.3)
Missing 5 (3.2) 4 (2.5) 9 (5.7)
Accessed previous OCD help, n (%)
Yes 76 (48.4) 86 (54.4) 72 (45.6)
No 80 (51.0) 71 (44.9) 85 (53.8)
Missing 1 (0.6) 1 (0.7) 1 (0.6)
Education, n (%)
Below degree level 107 (68.2) 110 (69.6) 112 (70.9)
Degree level or higher 45 (28.6) 43 (27.2) 40 (25.3)
Missing 5 (3.2) 5 (3.2) 6 (3.8)
a n and % for all groups do not sum (i.e. to sample size or 100%). This is as a result of some participants indicating more
than one employment status.
Source: Lovell et al.84 This is an open access article distributed under the terms of the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and
source are credited.
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TABLE 7 Baseline comparison: patient treatment preferences
Characteristic
Intervention, n (%)
Supported cCBT
(n= 157)
Guided self-help
(n= 158)
Waiting list
(n= 158)
Therapy preference
Wait for scheduled CBT 15 (9.6) 18 (11.4) 17 (10.8)
Limited or no preference 74 (47.1) 78 (49.4) 70 (44.3)
Low intensity 68 (43.3) 62 (39.2) 70 (44.3)
Missing 0 (0.0) 0 (0.0) 1 (0.6)
Low-intensity preference
Supported cCBT 32 (20.4) 30 (19.0) 47 (29.7)
No preference 83 (52.9) 83 (52.5) 68 (43.0)
Guided self-help 42 (26.7) 44 (27.9) 41 (26.0)
Missing 0 (0.0) 1 (0.6) 2 (1.3)
TABLE 8 Baseline comparison: clinical characteristics
Characteristic
Intervention
Supported cCBT
(n= 157)
Guided self-help
(n= 158)
Waiting list
(n= 158)
Current antidepressant medication, n (%)
Yes 82 (52) 81 (51) 80 (51)
No 75 (48) 77 (49) 78 (49)
OCD chronicity, n (%)
0–5 years 53 (34) 52 (33) 51 (32)
6–9 years 18 (11) 18 (11) 19 (12)
≥ 10 years 86 (55) 88 (56) 88 (56)
Y-BOCS-SR
Mean (SD) 24.34 (5.1) 24.18 (4.82) 24.20 (4.99)
Median 24 24 24
Min., max. 16, 36 16, 40 16, 38
Baseline characteristics
Comorbidity (primary diagnosis), n (%)
Mixed anxiety and depressive disorder 23 (15) 23 (15) 15 (10)
Mild depressive disorder 18 (11) 18 (11) 20 (13)
Moderate depressive disorder 28 (18) 24 (15) 26 (17)
Severe depressive disorder 7 (5) 13 (8) 12 (8)
Generalised anxiety disorder 18 (11) 27 (17) 18 (11)
Specific phobia 10 (6) 6 (4) 6 (4)
Social phobia 2 (1) 1 (1) 0 (0)
Agoraphobia 0 (0) 2 (1) 3 (2)
Panic disorder 2 (1) 0 (0) 5 (3)
continued
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TABLE 8 Baseline comparison: clinical characteristics (continued )
Characteristic
Intervention
Supported cCBT
(n= 157)
Guided self-help
(n= 158)
Waiting list
(n= 158)
Y-BOCS-ORa
Mean (SD) 25.03 (5.45) 25.01 (5.02) 25.34 (5.44)
Median 25 25 25
Min., max. 13, 38 14, 39 13, 38
Missing 0 0 0
PHQ-9
Mean (SD) 11.90 (6.27) 11.40 (6.56) 11.93 (6.29)
Median 12 11.5 12
Min., max. 0, 27 0, 26 0, 26
GAD-7
Mean (SD) 12.90 (5.33) 12.72 (5.56) 12.52 (5.52)
Median 13 14 13
Min; max 2, 21 1, 21 0, 21
Missing 2 4 4
CORE-OM
Mean (SD) 15.95 (6.27) 15.23 (6.67) 15.79 (6.63)
Median 16 16 16
Min., max. 5, 35 1, 34 1, 33
Missing 3 3 5
SF-36 – PCS
Mean (SD) 54.39 (11.29) 54.18 (9.57) 54.09 (10.56)
Median 57.36 56.01 57.14
Min., max. 18.04, 71.89 17.59, 70.35 22.21, 72.23
Missing 3 3 5
SF-36 – MCS
Mean (SD) 32.89 (9.87) 33.86 (11.05) 33.23 (11.71)
Median 32.66 34.33 33.17
Min., max. 11.88, 59.52 7.30, 58.55 10.64, 65.08
Missing 3 3 5
WSAS
Mean (SD) 14.78 (9.85) 15.05 (10.54) 14.74 (9.66)
Median 13 14 13
Min., max. 2, 21 1, 21 0, 21
Missing 2 4 4
Max., maximum; MCS, mental component score; min., minimum; PCS, physical component score.
a Incorporating YBOC-SR if YBOC-OR missing or incomplete.
Source: Lovell et al.84 This is an open access article distributed under the terms of the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and
source are credited.
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Just over half of the patients were currently taking antidepressant medication and 69% of patients had a
primary comorbid diagnosis, as derived from the CIS-R.
There were no striking differences in clinical characteristics at baseline.
Treatment delivery and fidelity
Allocation of patients to psychological wellbeing practitioners
Of the PWPs trained (n = 204), 93 (46%) were allocated an OCTET patient (Table 9). The number of PWPs
allocated patients per trust ranged from 0 to 14, a range of 0 to 100% of those trained within each trust.
PWPs were not allocated patients for various reasons: leaving the service, high clinical workload or insufficient
patients compared with the number of therapists in each site. In total, 315 patients were allocated to the
93 PWPs. The number of patients allocated to PWPs ranged from 1 to 18. Nearly half the PWPs (46%,
n = 42) were allocated patients in both supported cCBT and guided self-help; 33% (n = 30) were allocated
only guided self-help patients, and 20.9% (n = 19) were allocated only supported cCBT patients.
Uptake of interventions
As detailed in Chapter 2, PWPs completed a contact sheet for each allocated participant and recorded
session date, number and the length of the session. Of the 158 patients allocated to guided self-help,
155 (98%) contact sheets were received and of 157 patients allocated to supported cCBT, 154 (98%)
contact sheets were available.
Uptake and adherence to guided self-help
Of the 158 patients randomised to guided self-help, 103 (65%) received at least one session of support
from a PWP (Table 10). The mean number of guided self-help sessions provided was 4.11 (SD 4.29 sessions),
the average length of session 1 was 56.49 minutes (as per protocol: 60 minutes) and the average length of
sessions 2–11 was 30.79 minutes (as per protocol: 30 minutes). Nine patients were provided with more than
the 11 sessions detailed in the protocol, eight received one extra session (session 12) and one received
two extra sessions (sessions 12 and 13).
TABLE 9 Number of PWPs (and percentage) with at least one patient allocated to them, by NHS trust
Trust Number of PWPs (% of PWPs trained per trust)
Bradford District Care Trust 10 (66.7)
Camden & Islington NHS Foundation Trust 8 (44.4)
Cheshire & Wirral Partnership NHS Foundation Trust 12 (60.0)
Coventry & Warwickshire Partnership Trust 4 (80.0)
Lancashire Care NHS Foundation Trust 4 (20.0)
Manchester Mental Health and Social Care Trust 6 (85.7)
NHS City Health Care Partnership Trust 5 (33.3)
Norfolk and Suffolk Mental Health NHS Foundation Trust 11 (40.7)
Nottingham County Health Partnership 0 (0.0)
Pennine Care NHS Foundation Trust 4 (66.7)
Rotherham, Doncaster & South Humber (RDaSH) 3 (37.5)
Sheffield Health & Social Care Foundation Trust 15 (71.4)
South Staffordshire and Shropshire Healthcare NHS Foundation Trust 4 (23.5)
South West Yorkshire Partnership NHS Foundation Trust 6 (66.7)
Worcestershire Health & Care NHS Trust 1 (100.0)
Total 93 (45.6)
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The mode of delivery of sessions was face to face only (n = 50, 49%), telephone only (n = 26, 25%) or
mixed face to face/telephone (n = 23, 22%). For four patients the delivery mode was not recorded (4%).
Uptake and adherence to supported computerised
cognitive–behavioural therapy
Of the 157 patients randomised to supported cCBT, 93 (59%) received at least one session of PWP
support (Table 11). The mean number of supported cCBT sessions was 2.25 (SD 2.47) and the average
session length was 13.42 minutes. Of the nine steps available on OCFighter, the mean number of steps
completed was 3.64 (SD 3.19).
Delivery mode of sessions provided by PWPs to patients was telephone only (n = 90, 93%), mixed
telephone and face to face (n = 3, 3%) and mixed telephone and e-mail (n = 1, 1%). For three patients
delivery mode was not recorded.
TABLE 10 Guided self-help sessions attended
Total number of guided self-help
sessions attended N (%)
Percentage receiving at
least n sessions
0 55 (34.8) –
1 9 (5.7) 65.2
2 17 (10.8) 59.5
3 7 (4.4) 48.7
4 9 (5.7) 44.3
5 6 (3.8) 38.6
6 3 (1.9) 34.8
7 10 (6.3) 32.9
8 7 (4.4) 26.6
9 6 (3.8) 22.2
10 7 (4.4) 18.4
11 13 (8.2) 13.9
12 8 (5.1) 5.7
13 1 (0.6) 0.6
TABLE 11 Supported cCBT sessions attended
Number of supported cCBT
sessions attended N (%)
Percentage receiving at
least n sessions
0 64 (40.8) –
1 17 (10.8) 59.2
2 16 (10.2) 48.4
3 13 (8.3) 38.2
4 9 (5.7) 29.9
5 7 (4.5) 24.2
6 26 (16.6) 19.7
7 3 (1.9) 3.2
8 1 (0.6) 1.3
9 1 (0.6) 0.6
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Fidelity of delivery of guided self-help and supported computerised
cognitive–behavioural therapy
Psychological wellbeing practitioners were asked to record all face-to-face and telephone sessions using a
digital recorder and, when required, a telephone-recording device.
Owing to an ethics breach (a digital recorder was lost at one site), all recordings were stopped for 5 weeks.
Even with this lapse, adherence to recording was low, with only 169 (26%) of a possible 648 guided
self-help sessions recorded, and only 61 (17%) of a possible 350 supported cCBT sessions recorded.
All available session recordings were given a random number using an online random number generator
and the independent rater randomly selected 25% of the guided self-help and supported cCBT recordings.
The independent rater randomly selected 43 recordings from guided self-help sessions 1–12, and
17 recordings from supported cCBT sessions 1–6 to ensure an equal representation of each of the
different stages of the interventions.
Of the guided self-help sessions, nine (21%) were rated as average, 24 (56%) were rated as good and
10 (23%) were rated as excellent. Of the supported cCBT session recordings, 11 (65%) were rated as
good and six (35%) were rated as excellent.
The length of sessions on the digital audio files was examined to see if they were consistent with the
self-report data available, as recorded on the contact sheets. For guided self-help the mean duration of
session 1 (assessment) was 53 minutes (60 minutes was detailed in the PWP manual), the mean duration
of session 2 (treatment rationale) was 35 minutes (30 minutes recommended), the mean duration of
sessions 3–9 (setting weekly goals and support) was 26 minutes (30 minutes recommended) and the mean
duration for sessions 10–12 (relapse prevention/staying well) was 19 minutes (recommended 30 minutes).
The mean duration of sessions 1–6 for supported cCBT was 15 minutes (recommended 10 minutes).
In summary, PWP adherence was satisfactory, although the mean number of sessions for both guided
self-help and supported cCBT was substantially less than recommended. A small number of patients
receiving guided self-help had more sessions than in the protocol, although duration, as measured by
self-report and digital audio files, was within the recommended limits. No extra sessions were delivered in
the supported cCBT but both self-report and digital audio files revealed that the mean session length was
13 minutes, just over the recommended 10 minutes. Fidelity to the interventions was good, although
only a limited number of digital recordings were available.
Uptake of cognitive–behavioural therapy prior to primary outcome
assessment (3 months)
As designed, patients in OCTET were not expected to receive high-intensity CBT prior to the 3-month
outcome assessment. However, because of changes in service delivery outside the control of OCTET,
a number of patients started to receive high-intensity CBT prior to the 3-month assessment.
The Pathway questionnaire was used at each follow-up to collect data on high-intensity CBT uptake.
Owing to the nature of the delivery and completion of this questionnaire (left with the participant to
complete independently prior to postal return to the YTU), there were high levels of missing CBT uptake
data when compared with the number of visits completed at each time point (28% missing at 3 months,
29% at 6 months and 30% at 12 months).
In addition, the CBT uptake data, as reported by the participant, did not always correspond to other
patient-reported measures collecting treatment access data, nor did the data necessarily correspond to
information provided by the IAPT services. As a result, to ensure validity and accuracy of the CBT uptake
data, all sites were contacted to determine which participants had received a minimum of one session of
high-intensity CBT prior to each follow-up time point.
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In total, 67 (42%) of the patients allocated to the waiting list for high-intensity CBT group started full CBT
prior to the primary outcome assessment, compared with 21% in supported cCBT and 23% in guided
self-help (Table 12).
Patients in waiting list for high-intensity CBT group had a significantly higher uptake of high-intensity CBT
than supported cCBT (adjusted OR 0.36, 95% CI 0.19 to 0.68; p = 0.001) and guided self-help (adjusted
OR 0.43, 95% CI 0.22 to 0.84; p = 0.014). There were no differences between supported cCBT and
guided self-help (adjusted OR 0.84, 95% CI 0.47 to 1.51; p = 0.562). No other factors predicted uptake of
full CBT (Table 13).
TABLE 12 Cognitive–behavioural therapy uptake by group before 3-month assessment
Uptake
Intervention
Overall
(n= 473)
Supported cCBT
(n= 157)
Guided self-help
(n= 158)
Waiting list
(n= 158)
No, n (%) 123 (78.3) 119 (75.3) 92 (58.2) 334 (70.6)
Yes, n (%) 33 (21.0) 37 (23.4) 66 (41.8) 136 (28.8)
Missing, n (%) 1 (0.6) 2 (1.3) 0 (0.0) 3 (0.6)
TABLE 13 Logistic regression model of predictors of high-intensity CBT uptake before 3 months
Predictor Adjusted OR 95% CI p-value
Exposure group
cCBT vs. WL 0.36 0.19 to 0.68 0.001a
GSH vs. WL 0.43 0.22 to 0.84 0.014
cCBT vs. GSH 0.84 0.47 to 1.51 0.562
Baseline outcome measures
YBOC-OR 1.02 0.97 to 1.07 0.462
GAD-7 1.01 0.96 to 1.06 0.828
PHQ-9 0.99 0.95 to 1.04 0.789
Antidepressant medication
Yes 1.02 0.66 to 1.57 0.931
Duration of OCD (years)
6–9 1.12 0.55 to 2.27 0.756
≥ 10 0.89 0.55 to 1.42 0.606
Sex
Male 1.21 0.78 to 1.88 0.395
Exp (constant) 0.44 0.14 to 1.36 0.157
Exp, exponential function; GSH, guided self-help; WL, waiting list.
a Significance level is set at 1.67% to adjust for three pairwise comparisons.
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Short-term clinical outcomes: primary
Aim 1: the clinical effectiveness and cost-effectiveness of low-intensity
interventions (guided self-help and supported cCBT) versus waiting list for
high-intensity CBT in the management of OCD at 3 months
As noted earlier, the 3-month follow-up point was taken as the primary assessment point following the
internal pilot. As described in Chapter 1, Results of the internal pilot: (1) we retained the 6-month
follow-up point and report these data for completeness and (2) valid values of Y-BOCS-OR where obtained
for 346, 308 and 283 services users at 3, 6 and 12 months, respectively. Substitution of Y-BOCS-SR for
missing values increased the sample available for analysis to 383 at 3 months, 356 at 6 months and 332 at
12 months.
Analysis of the primary outcome (Y-BOCS-OR) (Table 14) showed that the benefit of supported cCBT over
waiting list for high-intensity CBT was less than 1 point on the Y-BOCS-OR (adjusted mean difference
–0.71, 95% CI –2.12 to 0.70; p = 0.325) at 3 months.
There was evidence of benefit of guided self-help over a waiting list for high-intensity CBT (adjusted mean
difference –1.91, 95% CI –3.27 to –0.55; p = 0.006) at 3 months. This was statistically significant at the
Bonferroni-corrected significance level (1.67%). This was < 3 points on the Y-BOCS-OR defined as a
‘clinically important difference’ in the sample size calculation, although the 95% CIs did include an effect
of this magnitude.
Comparison of guided self-help with supported cCBT showed a reduction of around 1 point on the
Y-BOCS-OR for guided self-help as compared with supported cCBT (adjusted mean difference 1.2, 95% CI
–0.22 to 2.61; p = 0.097) at 3 months.
Similar trends were observed for Y-BOCS-SR, although no significant differences between treatments were
observed at the 1.67% significance level used.
Short-term clinical outcomes: secondary
Analyses of the secondary outcomes at 3 months are shown in Table 15.
There were no statistically significant effects at 3 months on physical and mental functioning of the SF-36,
depression (PHQ-9) or distress (CORE-OM), but there was a statistically significant effect of supported cCBT
versus a waiting list for high-intensity CBT at 3 months on anxiety (GAD-7) (adjusted mean difference
–1.50, 95% CI –2.67 to –0.33; p = 0.012).
Patient satisfaction
Analysis of the satisfaction outcome (CSQ-8) showed no differences in the satisfaction of patients receiving
supported cCBT compared with those allocated to the waiting list for high-intensity CBT (adjusted mean
difference –0.31, 95% CI –2.07 to 1.45; p = 0.732) at 3 months (Table 16).
Analysis of the satisfaction outcome (CSQ-8) showed that patients receiving guided self-help were more
satisfied than those allocated to a waiting list for high-intensity CBT (adjusted mean difference 1.69,
95% CI –0.04 to 3.42; p = 0.055) at 3 months. The effect estimate did not reach statistical significance
according to the corrected significance level (1.67%).
Analysis of the satisfaction outcome (CSQ-8) showed that patients receiving supported cCBT were less
satisfied than those receiving guided self-help (adjusted mean difference –2.00, 95% CI –3.63 to –0.37;
p = 0.016) at 3 months. The effect estimate did reach statistical significance according to the corrected
significance level (1.67%).
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TABLE 14 The 3- and 6-month outcomes for the primary outcome measure (Y-BOCS-OR and Y-BOCS-SR)
Primary
outcome
measure and
time point
Intervention
Supported cCBT Guided self-help Waiting list Supported cCBT: waiting list Guided self-help: waiting list
Supported cCBT: guided
self-help
Mean SD n Mean SD n Mean SD n
Adjusted
mean
differencea 95% CI p-valueb
Adjusted
mean
differencea 95% CI p-valueb
Adjusted
mean
differencea 95% CI p-valueb
Y-BOCS-OR
Baseline 25.03 5.45 157 25.01 5.02 158 25.34 5.44 158
3 months 21.16 6.89 121 20.19 6.83 130 22.18 6.54 132 –0.71 –2.12 to
0.70
0.325 –1.91 –3.27 to
–0.55
0.006b 1.2 –0.22 to
2.61
0.097
6 months 18.96 7.26 112 18.7 7.7 122 20.29 7.27 122 –1.13 –2.84 to
0.58
0.195 –1.32 –3.00 to
0.35
0.121 0.19 –1.51 to
1.90
0.824
Y-BOCS-SR
Baseline 24.34 5.1 157 24.18 4.82 158 24.2 4.99 158
3 months 20.46 7.06 119 19.8 6.9 128 20.88 6.48 127 –0.43 –1.79 to
0.93
0.531 –1.31 –2.65 to
0.04
0.056 0.87 –0.49 to
2.23
0.209
6 months 18.6 7.47 110 18.29 7.78 119 19.34 7.24 118 –0.87 –2.52 to
0.78
0.3 –1.17 –2.87 to
0.53
0.178 0.3 –1.42 to
2.02
0.735
a Mean difference adjusted for Y-BOCS-OR, PHQ-9, GAD-7, antidepressant use, sex, OCD duration (0–5, 6–9 and ≥ 10 years). Statistical inference based on all subjects with outcome data.
b Significance level is set at 1.67% to adjust for three pairwise comparisons.
Source: Lovell et al.84 This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction
in any medium, provided the original author and source are credited.
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TABLE 15 The 3- and 6-month outcomes for the secondary outcome measures
Secondary
outcome
measure and
time point
Intervention
Supported cCBT Guided self-help Waiting list Supported cCBT: waiting list Guided self-help: waiting list
Supported cCBT: guided
self-help
Mean SD n Mean SD n Mean SD n
Adjusted
mean
differencea 95% CI p-valueb
Adjusted
mean
differencea 95% CI p-valueb
Adjusted
mean
differencea 95% CI p-valueb
SF-36 version 2 PCS
Baseline 54.4 11.3 154 54.2 9.6 155 54.1 10.6 153
3 months 53.6 10.8 104 53.5 10.0 117 53.9 10.0 123 0.14 –1.58 to
1.87
0.870 –0.38 –2.22 to
1.46
0.686 0.52 –1.51 to
2.56
0.614
6 months 53.4 10.8 91 53.9 10.0 107 51.8 10.7 107 0.64 –1.46 to
2.75
0.550 1.36 –0.43 to
3.15
0.140 –0.71 –2.74 to
1.31
0.490
SF-36 version 2 MCS
Baseline 32.9 9.9 154 33.9 11.1 155 33.2 11.7 153
3 months 37.0 11.7 104 36.3 12.1 117 35.6 11.5 123 1.48 –1.12 to
4.09
0.264 0.46 –1.82 to
2.73
0.694 1.03 –1.57 to
3.62
0.438
6 months 38.9 10.8 91 37.3 12.6 107 38.1 11.9 107 0.87 –1.90 to
3.63
0.540 –1.66 –4.36 to
1.04
0.230 2.53 –0.25 to
5.30
0.070
PHQ-9
Baseline 11.9 6.3 157 11.4 6.6 158 11.9 6.3 158
3 months 9.3 6.5 105 9.1 6.0 118 9.6 6.0 124 –0.48 –1.66 to
0.70
0.427 –0.34 –1.48 to
0.81
0.565 –0.14 –1.33 to
1.05
0.815
6 months 8.3 6.1 96 8.9 5.8 107 8.5 5.9 106 –0.09 –1.42 to
1.24
0.890 0.73 –0.53 to
1.99
0.260 –0.82 –2.10 to
0.46
0.210
continued
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TABLE 15 The 3- and 6-month outcomes for the secondary outcome measures (continued )
Secondary
outcome
measure and
time point
Intervention
Supported cCBT Guided self-help Waiting list Supported cCBT: waiting list Guided self-help: waiting list
Supported cCBT: guided
self-help
Mean SD n Mean SD n Mean SD n
Adjusted
mean
differencea 95% CI p-valueb
Adjusted
mean
differencea 95% CI p-valueb
Adjusted
mean
differencea 95% CI p-valueb
GAD-7
Baseline 12.9 5.3 155 12.7 5.6 154 12.5 5.5 154
3 months 9.9 5.9 104 10.6 5.7 115 11.2 5.8 124 –1.50 –2.67 to
–0.33
0.012b –0.77 –1.91 to
0.37)
0.186 –0.73 –1.97 to
0.50
0.245
6 months 9.4 5.9 94 9.4 5.6 107 9.4 5.9 107 –0.24 –1.63 to
1.15
0.730 0.15 –1.19 to
1.49
0.830 –0.39 –1.78 to
0.99
0.580
CORE-OM
Baseline 16.0 6.3 154 15.2 6.7 155 15.8 6.6 153
3 months 12.9 6.9 104 13.0 6.6 116 13.5 6.7 124 –0.38 –1.61 to
0.85
0.550 –0.20 –1.38 to
0.98
0.734 –0.17 –1.48 to
1.14
0.797
6 months 11.8 6.8 90 12.8 6.9 106 12.3 6.7 107 –0.16 –1.61 to
1.28
0.830 1.30 –0.13 to
2.74
0.080 –1.47 –2.93 to
–0.01
0.050
WSAS
Baseline 14.78 9.85 153 15.05 10.54 154 14.74 9.66 154
3 months 12.98 11.01 104 13.70 10.41 117 13.42 9.65 123 –0.55 –2.35 to
1.26
0.554 0.02 –1.17 to
1.75
0.985 –0.56 –2.38 to
1.25
0.544
6 months 12.46 11.09 94 13.11 10.53 106 12.48 9.83 107 –0.06 –2.24 to
2.12
0.956 0.60 –1.56 to
2.76
0.587 –0.66 –2.87 to
1.55
0.557
MCS, mental component score; PCS physical component score.
a Mean difference adjusted for Y-BOCS-OR, PHQ-9, GAD-7, antidepressant use, sex and OCD duration (0–5, 6–9 and ≥ 10 years). Statistical inference based on all subjects with
outcome data.
b Significance level is set at 1.67% to adjust for three pairwise comparisons.
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TABLE 16 The 3- and 6-month outcomes for the satisfaction outcomes (CSQ-8)
Satisfaction
outcome and
time point
Intervention
Supported
cCBT Guided self-help Waiting list Supported cCBT: waiting list Guided self-help: waiting list Supported cCBT: guided self-help
Mean SD n Mean SD n Mean SD n
Adjusted
mean
differencea 95% CI p-valueb
Adjusted
mean
differencea 95% CI p-valueb
Adjusted
mean
differencea 95% CI p-valueb
3 months 22.4 5.9 92 24.4 5.5 101 22.8 6.1 83 –0.31 –2.07 to
1.45
0.732 1.69 –0.04 to
3.42
0.055 –2.00 –3.63 to
–0.37
0.016b
6 months 23.8 5.8 81 24.3 6.3 82 24.6 5.8 77 –0.87 –2.77 to
1.03
0.371 –0.31 –2.23 to
1.61
0.751 –0.56 –2.44 to
1.32
0.561
a Mean difference adjusted for Y-BOCS-OR, PHQ-9, GAD-7, antidepressant use, sex and OCD duration (0–5 years, 5–10 years and > 10 years). Statistical inference based on all subjects
with outcome data.
b Significance level is set at 1.67% to adjust for three pairwise comparisons.
Source: Lovell et al.84 This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction
in any medium, provided the original author and source are credited.
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Longer-term clinical outcomes: primary
Aim 2: the clinical effectiveness and cost-effectiveness of low-intensity
interventions (guided self-help and supported cCBT) plus high-intensity CBT
versus waiting list for high-intensity CBT plus high-intensity CBT in the
management of OCD at 12 months
Analysis of the primary outcome (Y-BOCS-OR) showed that the benefit of supported cCBT over a waiting
list for high-intensity CBT was around 1.5 points (adjusted mean difference –1.37, 95% CI –3.59 to 0.84;
p = 0.224) at 12 months (Table 17).
Analysis of the primary outcome (Y-BOCS-OR) showed that the benefit of guided self-help over waiting list
for high-intensity CBT was around 2.5 points (adjusted mean difference –2.37, 95% CI –4.37 to –0.38;
p = 0.02) at 12 months, although the effect estimate did not reach statistical significance according to the
Bonferroni-corrected significance level (1.67%).
The benefit of guided self-help over supported cCBT was 1 point on the Y-BOCS-OR, but this was not
statistically significant (adjusted mean difference –1.00, 95% CI –1.19 to 3.19; p = 0.37).
Longer-term clinical outcomes: secondary
Analyses of the secondary outcomes at 12 months are also shown in Table 17.
There were no statistically significant effects at 12 months on physical and mental functioning (SF-36),
depression (PHQ-9), distress (CORE-OM) or anxiety (GAD-7).
Intracluster correlation coefficients caused by therapist variation and
design effects
Sample size calculation and statistical analysis allowed for ICC for therapist variation. Estimates of the ICC
are given in Table 18 for the primary outcome and quantitative secondary outcome measures. These were
calculated from the variance components of the linear mixed-model analyses. The estimation procedure
(restricted maximum likelihood) constrains estimates of the random-effects variance to be positive. Twenty
of the 52 estimates had a magnitude < 0.001. Estimates of the ICC were highly variable with a maximum
of 0.225 for SF-36 mental functioning.
When designing the trial we assumed that the interventions would be delivered by 24 therapists, each with
an average caseload of six supported cCBT and six guided self-help patients. The number of therapists was
somewhat larger (see Table 9) making the study power less sensitive to larger values of the ICC.
The observed design effect can be calculated as the ratio of the variance of the treatment effect estimate
when cluster is accounted for in a random-effects model to the same variance in an ordinary least squares
model that takes no account of clustering. As there are three treatment comparisons there are three
design effects for each end point. For the primary outcome measure, the largest value of the three design
effects was 1.035 at 3 months when supported cCBT was compared with a waiting list. At 6 months,
design effects were 1 as the ICC was negligible (< 0.001). At 12 months, the largest design effect was
1.129, again when supported cCBT was compared with a waiting list. The design effects of the sample
size calculation (see Chapter 2, Sample size calculation) were 1.123 for the comparison of supported
cCBT or guided self-help with a waiting list and 1.061 when supported cCBT was compared with guided
self-help. The design effect of the study was similar to that hypothesised in the trial protocol.
A 98.33% CI corresponds to a 1.67% significance level that we have used for hypothesis testing. For the
comparison of cCBT against a waiting list, the 98.33% CI is –4.07 to 1.33, and for guided self-help against
a waiting list it is –4.81 to 0.06. Given that the upper limits are small, we can conclude that both active
interventions are non-inferior to waiting list.
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TABLE 17 The 12-month outcomes for the primary and secondary clinical measures
Outcome
measure and
time point
Intervention
Supported cCBT Guided self- help Waiting list Supported cCBT: waiting list Guided self-help: waiting list
Supported cCBT: guided
self-help
Mean SD n Mean SD n Mean SD n
Adjusted
mean
differencea 95% CI p-valueb
Adjusted
mean
differencea 95% CI p-valueb
Adjusted
mean
differencea 95% CI p-valueb
Y-BOCS-OR
Baseline 25.03 5.45 157 25.01 5.02 158 25.34 5.44 158
12 months 16.14 8.69 105 15.19 8.35 113 17.93 8.07 114 –1.37 –3.59 to
0.84
0.224 –2.37 –4.37 to
–0.38
0.020 1.00 –1.19 to
3.19
0.371
Y-BOCS-SR
Baseline 24.34 5.1 157 24.18 4.82 158 24.2 4.99 158
12 months 15.61 8.7 101 15.72 8.11 109 17.38 8.24 107 –1.45 –3.67 to
0.76
0.198 –1.52 –3.54 to
0.49
0.137 0.07 –2.01 to
2.16
0.946
SF-36 version 2 PCS
Baseline 54.4 11.3 154 54.2 9.6 155 54.1 10.6 153
12 months 54.7 9.7 84 53.4 10.0 97 53.1 10.9 98 0.69 –1.20 to
2.57)
0.474 –0.37 –2.18 to
1.43
0.685 1.06 –0.82 to
2.94
0.269
SF-36 version 2 MCS
Baseline 32.9 9.9 154 33.9 11.1 155 33.2 11.7 153
12 months 43.0 11.6 84 40.7 12.7 97 40.0 11.4 98 2.29 –0.94 to
5.51
0.165 0.13 –2.79 to
3.05
0.932 2.16 –1.11 to
5.43
0.195
PHQ-9
Baseline 11.9 6.3 157 11.4 6.6 158 11.9 6.3 158
12 months 6.4 5.9 86 7.1 5.9 99 7.7 6.1 98 –1.35 –2.96 to
0.25
0.098 –0.41 –1.78 to
0.96
0.557 –0.94 –2.50 to
0.62
0.236
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TABLE 17 The 12-month outcomes for the primary and secondary clinical measures (continued )
Outcome
measure and
time point
Intervention
Supported cCBT Guided self- help Waiting list Supported cCBT: waiting list Guided self-help: waiting list
Supported cCBT: guided
self-help
Mean SD n Mean SD n Mean SD n
Adjusted
mean
differencea 95% CI p-valueb
Adjusted
mean
differencea 95% CI p-valueb
Adjusted
mean
differencea 95% CI p-valueb
GAD-7
Baseline 12.9 5.3 155 12.7 5.6 154 12.5 5.5 154
12 months 7.8 6.0 84 8.0 5.8 100 9.0 6.0 98 –1.04 –2.64 to
0.55
0.199 –0.89 –2.43 to
0.64
0.253 –0.15 –1.70 to
1.40
0.849
CORE-OM
Baseline 16.0 6.3 154 15.2 6.7 155 15.8 6.6 153
12 months 9.7 7.1 82 10.7 7.4 97 11.3 7.4 98 –0.81 –2.65 to
1.02
0.385 –0.16 –1.92 to
1.60
0.857 –0.65 –2.47 to
1.16
0.482
WSAS
Baseline 14.78 9.85 153 15.05 10.54 154 14.74 9.66 154
12 Months 10.65 10.34 84 11.94 11.11 99 12.37 10.69 98 –0.39 –3.16 to
2.38
0.782 –0.31 –2.67 to
2.06
0.798 –0.08 –2.82 to
2.65
0.952
MCS, mental component score; PCS physical component score.
a Mean difference adjusted for Y-BOCS-OR, PHQ-9, GAD-7, antidepressant use, sex and OCD duration (0–5, 6–9 and ≥ 10 years). Statistical inference based on all subjects with
outcome data.
b Significance level is set at 1.67% to adjust for three pairwise comparisons.
Source: Lovell et al.84 This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction
in any medium, provided the original author and source are credited.
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Longer-term employment status
At 12 months, employment levels had increased in the waiting list for high-intensity CBT and guided
self-help groups (Table 19), compared with the 6-month follow-up.
Unemployment levels had also decreased compared with baseline, except in the supported cCBT group,
in which levels had increased since both the baseline and 6-month follow-up time points.
Receipt of statutory sick pay also reduced over the course of follow-up. The guided self-help group
reported greater levels of sick pay receipt than the supported cCBT and waiting list for high-intensity CBT
groups. Levels of receipt of sick pay gradually reduced during the trial. In the guided self-help group,
sick pay initially increased but by the 12-month time point had fallen compared with baseline.
TABLE 18 Intracluster correlation coefficients for therapist for each intervention
Outcome measure
Time point
3 months 6 months 12 months
Supported
cCBT
Guided
self-help
Supported
cCBT
Guided
self-help
Supported
cCBT
Guided
self-help
Y-BOCS-OR 0.027 < 0.001 < 0.001 < 0.001 0.109 0.001
Y-BOCS-SR 0.003 0.009 < 0.001 0.078 0.098 0.004
SF-36 version 2 PCS 0.182 0.178 0.164 0.004 0.011 0.002
SF-36 version 2 MCS 0.225 < 0.001 0.018 0.048 0.090 0.007
PHQ-9 < 0.001 < 0.001 0.019 < 0.001 0.160 0.011
GAD-7 0.028 0.030 < 0.001 < 0.001 0.151 0.082
WSAS < 0.001 < 0.001 < 0.001 < 0.001 0.158 0.012
CORE-OM 0.026 0.003 < 0.001 < 0.001 < 0.001 < 0.001
CSQ-8 < 0.001 < 0.001 0.041 0.097 – –
MCS, mental component score; PCS physical component score.
TABLE 19 Comparison of IAPT employment status at follow-up
Employment status
Intervention, n (%)
Supported cCBT
(n= 98)
Guided self-help
(n= 109)
Waiting list
(n= 109)
Employed 45 (45.9) 63 (57.8) 58 (53.2)
Unemployed and seeking work 8 (8.2) 3 (2.8) 5 (4.6)
Student 6 (6.1) 11 (10.1) 7 (6.4)
Long-term sick/disabled receiving income support or
incapacity benefit
8 (8.2) 16 (14.7) 14 (12.8)
Homemaker: not actively seeking work 10 (10.2) 5 (4.6) 7 (6.4)
Not receiving benefits and not actively seeking work 0 (0) 1 (0.9) 1 (0.9)
Unpaid voluntary work and not actively seeking work 3 (3.1) 0 (0) 2 (1.8)
Retired 5 (5.1) 4 (3.7) 6 (5.5)
n and % for all groups do not sum correctly (i.e. to sample size or 100%). This is as a result of this being a participant
self-completed measure with some participants indicating more than one employment status.
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Recovery and remission
We used the recently published international expert consensus guidelines for defining treatment response
and remission in OCD.69
l Responders are defined as those who achieved a ≥ 35% reduction on the Y-BOCS-OR.
l Remitters are defined as those with a Y-BOCS-OR score of ≤ 12.
Logistic regression models were fitted to responses at 12 months adjusting for sex, baseline GAD-7 and
PHQ-9 scores, antidepressant medication use at randomisation and duration of OCD.
Consistent with the statistical analysis plan for other outcome measures, we conducted an additional
analysis of differences in rates of response. At 12 months, response to treatment was higher in the
supported cCBT and guided self-help groups than in the waiting list for high-intensity CBT group, but
neither analysis reached statistical significance (supported cCBT adjusted OR 1.76, 95% CI 0.99 to 3.15;
p = 0.055; guided self-help adjusted OR 1.79, 95% CI 0.94 to 3.40; p = 0.077) (Table 20).
Longer-term cognitive–behavioural therapy uptake
In total, 136 (86%) of the patients allocated to the waiting list for high-intensity CBT started CBT by the
end of the trial, compared with 98 (62%) in supported cCBT and 90 (57%) in guided self-help (Table 21).
A logistic regression model was fitted to uptake of high-intensity CBT at 6 and 12 months adjusting for
sex, baseline GAD-7 and PHQ-9 scores, antidepressant medication use at randomisation and duration of
OCD (Table 22).
At 12 months the adjusted OR was significantly lower in supported cCBT than in the waiting list for
high-intensity CBT group (adjusted OR 0.34, 95% CI 0.15 to 0.79; p = 0.011). For guided self-help, the
adjusted OR of starting high-intensity treatment as compared with the waiting list for high-intensity CBT
group was also significantly lower (adjusted OR 0.27, 95% CI 0.12 to 0.60; p = 0.001).
As noted in Chapter 1, Summary, there was a number of potential hypotheses concerning the longer-term
outcomes of patients in OCTET, and the pattern of findings with respect to clinical outcomes, high-intensity
CBT uptake and overall costs.
TABLE 20 Recovery and remission rates at 3, 6 and 12 months
Response and
remission rates
Intervention
TotalSupported cCBT Guided self-help Waiting list
Frequency % n Frequency % n Frequency % n Frequency % n
Response
3 months 20 16.5 121 28 21.9 128 17 12.9 132 65 17.1 381
6 months 39 34.8 112 45 37.2 121 30 24.6 122 114 32.1 355
12 months 55 52.4 105 59 52.2 113 44 38.6 114 158 47.6 332
Remission
3 months 15 12.4 121 11 8.6 128 14 10.6 132 40 10.5 381
6 months 22 19.6 112 30 24.8 121 19 15.6 122 71 20.0 355
12 months 38 36.2 105 48 42.5 113 31 27.2 114 117 35.2 332
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TABLE 21 Descriptive data on CBT uptake at 6 and 12 months
Uptake of CBT
Intervention, n (%)
Overall, n (%)
(n= 473)
Supported cCBT
(n= 157)
Guided self-help
(n= 158)
Waiting list
(n= 158)
6 months
No 68 (43.3) 72 (45.6) 38 (24.1) 178 (37.6)
Yes 76 (48.4) 69 (43.7) 113 (71.5) 258 (54.6)
Missing 13 (8.3) 17 (10.8) 7 (4.4) 37 (7.8)
12 months
No 44 (28.0) 50 (31.7) 17 (10.8) 111 (23.5)
Yes 98 (62.4) 90 (56.9) 136 (86.1) 324 (68.5)
Missing 15 (9.6) 18 (11.4) 5 (3.2) 38 (8.0)
TABLE 22 Logistic regression model for CBT uptake at 6 and 12 monthsa
Uptake predictor Adjusted OR 95% CI p-value
6 months
Exposure group
cCBT vs. WL 0.42 0.24 to 0.73 0.002b
GSH vs. WL 0.48 0.22 to 1.03 0.06
cCBT vs. GSH 0.87 0.42 to 1.84 0.718
Baseline outcome measures
Y-BOCS-OR 1.02 0.97 to 1.06 0.514
GAD-7 0.99 0.94 to 1.04 0.591
PHQ-9 1.02 0.98 to 1.07 0.271
Antidepressant medication
Yes 0.71 0.46 to 1.09 0.117
Duration of OCD (years)
6–9 1.26 0.60 to 2.64 0.552
≥ 10 0.89 0.55 to 1.42 0.619
Sex
Male 1.12 0.73 to 1.73 0.606
Exp (constant) 2.14 0.67 to 6.82 0.201
12 months
Exposure group
cCBT vs. WL 0.34 0.15 to 0.79 0.011b
GSH vs. WL 0.27 0.12 to 0.60 0.001b
cCBT vs. GSH 1.27 0.53 to 3.00 0.59
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The broad pattern of similar clinical outcomes, and significantly lower uptake of higher intensity CBT in the
low-intensity treatments arms, is potentially a positive outcome for low-intensity interventions. However, it
is important to explore whether or not patients who received low-intensity interventions and did not go on
to access higher-intensity CBT demonstrated poor outcomes. We therefore present descriptive statistics
comparing the use of low-intensity interventions among patients who did and did not access high-intensity
CBT, and the clinical outcomes of those groups.
Table 23 shows the number of supported cCBT and guided self-help support sessions received by patients
that did or did not go on to receive high-intensity CBT by 12 months.
In Table 24, we present descriptive data on the mean scores of patients in the low-intensity arms according
to their pattern of high-intensity CBT use.
Such a comparison does not have the benefits afforded by randomisation, but the data do not suggest
that those who accessed only low-intensity treatments demonstrated markedly different outcomes than
those who accessed both low- and high-intensity interventions.
Sensitivity and subgroup analyses
The trial protocol specified that a moderator analysis of severity would be conducted by adding a
treatment severity interaction term to the analysis model of the primary outcome (YBOC-OR) at the primary
end point (3 months), with severity measured by YBOC-OR at baseline. In addition, analysis of treatment
effect moderation by both age and chronicity of OCD (< 5 or ≥ 5 years) was proposed and included in the
statistical analysis plan.
The interactions of treatment with both chronicity and severity were hypothesised to be quantitative,
whereas interactions of treatment with age were hypothesised to be qualitative, representing potential
difficulties of older patients in engaging with supported cCBT relative to guided self-help. Thus, a
significant treatment effect would be required before assessing treatment moderation via severity and
chronicity of OCD. This was found and so all three analyses were carried out.
TABLE 22 Logistic regression model for CBT uptake at 6 and 12 monthsa (continued )
Uptake predictor Adjusted OR 95% CI p-value
Baseline outcome measures
Y-BOCS-OR 1.03 0.97 to 1.08 0.36
GAD-7 1.03 0.97 to 1.08 0.341
PHQ-9 0.99 0.94 to 1.04 0.73
Antidepressant medication
Yes 1.02 0.63 to 1.67 0.933
Duration of OCD (years)
6–9 2.66 1.03 to 6.89 0.043
≥ 10 0.99 0.59 to 1.67 0.968
Sex
Male 1.25 0.76 to 2.03 0.395
Exp (constant) 2.86 0.76 to 10.81 0.121
Exp, exponential function; GSH, guided self-help; WL, waiting list.
a Note that results are taken from a logistic regression model and any effect should be interpreted as an OR.
b The Bonferroni-corrected significance level is 1.67%, for three pairwise comparisons.
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TABLE 23 Number of supported cCBT and guided self-help sessions by uptake of high-intensity CBT at 12 months
Low-intensity intervention High-intensity CBT received?
Number of sessions
Number of
patientsMean SD Median Min. Max.
Supported cCBT No 3.33 2.55 2.5 0 8 30
Yes 3.95 2.44 4 0 9 65
Guided self-help No 5.41 4.63 5 0 12 41
Yes 5.1 3.96 4.5 0 13 70
Max., maximum; min., minimum.
TABLE 24 Yale–Brown Obsessive Compulsive Scale – Observer Rated summaries by CBT uptake at 12 months
Y-BOCS-OR
(proxy included) Allocation CBT received?
Number of sessions
Number of
patientsMean SD Median Min. Max.
Baseline cCBT No 24.05 5.66 22.5 16 36 44
Yes 25.16 5.25 25.5 13 38 98
GSH No 24.7 5.21 25 14 35 50
Yes 25.43 4.71 25 14 39 90
WL No 23.82 4.65 23 15 33 17
Yes 25.59 5.59 26 13 38 136
3 months cCBT No 19.42 7.6 20 6 35 33
Yes 21.63 6.62 23 7 36 83
GSH No 20.19 7.5 20.5 1 31 42
Yes 20.59 6.26 20 0 36 79
WL No 22.13 6.08 22 11 31 15
Yes 22.17 6.66 23 7 36 114
6 months cCBT No 18.34 7.29 19 5 33 29
Yes 19.00 7.36 19.5 0 36 78
GSH No 18.51 8.26 19 0 32 41
Yes 18.96 7.58 19 1 35 75
WL No 21.67 6.36 21.5 12 33 12
Yes 20.11 7.41 21 0 35 107
12 months cCBT No 16.81 8.71 15 1 31 31
Yes 15.67 8.69 15 0 37 72
GSH No 16.37 8.45 18 0 36 38
Yes 14.59 8.29 13 0 36 75
WL No 20.07 7.01 21 10 32 14
Yes 17.59 8.23 17 0 35 99
GSH, guided self-help; max., maximum; min., minimum; WL, waiting list.
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When an interaction of treatment with YBOC-OR at baseline was added to the model there was no evidence
of an effect (p = 0.44; degrees of freedom 2). When an interaction between chronicity and treatment was
added there was again no evidence of an effect (p = 0.37; degrees of freedom 2). When the interaction
between treatment (supported cCBT vs. guided self-help) and age was fitted, the interaction with age was in
the hypothesised direction with YBOC-OR scores increasing for supported cCBT relative to guided self-help
in older patients, but this result was small and not statistically significant (0.027, 95% CI –0.084 to 0.138;
p = 0.63). Note that this represents a 1.35-point increase in YBOC-OR scores for supported cCBT compared
with guided self-help across the approximate 50-year age range observed in the OCTET cohort.
Unblinding
As described in Chapter 2, we collated data on unblinding. Information was collected regarding the
point at which unblinding occurred and if the outcome was partial (treatment/no treatment) or full
(trial arm) unblinding. Data were available for 278 3-month interviews, 255 6-month interviews and
264 12-month interviews. Unblinding was reported to have occurred in 30%, 22% and 26% of the 3-,
6- and 12-month interviews, respectively.
Where unblinding occurred, the majority of follow-up visits were conducted by another researcher at the
site to limit the introduction of any bias to the outcome assessment.
Adverse events
During the trial, 13 serious AEs were reported. Of these, 10 were related to unplanned hospitalisation,
one event related to significant disability and two events related to a potential risk to life (self-harm and
suicidality). Twelve events were deemed to be unrelated to the trial treatment. One event was deemed to
be possibly related – OCD and another comorbidity resulting in the participant leaving permanent
employment. Eight events were deemed to be unexpected, whereas five were deemed to be expected.
No events were deemed to be suspected, unexpected serious AEs.
During the trial, 173 non-serious AEs were reported. A total of 111 events were reported detailing any
untoward medical occurrence experienced by the participant. Following changes to the AE reporting
procedure (see Chapter 2), reporting became more targeted to the condition of interest. This resulted in a
further 62 events being reported, of which 32 related to a change in mental health status, four related
to dissatisfaction in trial procedures, 12 related to a change in psychotropic medication use and
14 related to unplanned hospital visits (not involving emergency inpatient admission).
RESULTS
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Chapter 4 Economic evaluation: results
Response rates
The response rates for the AD-SUS, the EQ-5D-3L and the PWP intervention data are summarised in Table 25.
One hundred per cent of data were available for intervention provision in all three arms, and > 60% of
AD-SUS data and 50% of EQ-5D-3L data were available for the total sample at all four time points. AD-SUS
and EQ-5D-3L data availability were similar across the groups at each follow-up, but were generally lower in
the supported cCBT group.
Table 26 summarises the percentage of participants with all intervention, AD-SUS and EQ-5D-3L data at
the 3-month and 12-month analysis points. Just over 70% of participants (334/473) had both baseline and
3-month cost and outcome data, allowing them to be included in complete-case economic analyses at the
3-month analysis point. Slightly fewer than 50% of participants (231/473) had all cost and outcome data
at baseline and all follow-up points, and could thus be included in complete-case economic analyses at the
12-month analysis point.
Table 27 compares the baseline characteristics of the full sample with those participants with all economic
data for the 3- and 12-month economic analyses. The samples with enough data to be included in
complete-case economic analyses were very similar to the full sample in terms of sex, ethnicity, age,
number of years with OCD, Y-BOCS-SR and EQ-5D-3L score and costs.
TABLE 25 Response rates for economic data
Data response rates
Intervention, n (%)
Total, n (%)
(n= 473)
Supported cCBT
(n= 157)
Guided self-help
(n= 158)
Waiting list
(n= 158)
PWP intervention
Baseline 157 (100) 158 (100) 158 (100) 473 (100)
3 months 157 (100) 158 (100) 158 (100) 473 (100)
6 months 157 (100) 158 (100) 158 (100) 473 (100)
12 months 157 (100) 158 (100) 158 (100) 473 (100)
AD-SUS
Baseline 156 (99.4) 156 (98.7) 155 (98.1) 467 (98.7)
3 months 118 (75.2) 130 (82.3) 129 (81.7) 377 (79.7)
6 months 102 (65.0) 115 (72.8) 117 (74.1) 334 (70.6)
12 months 88 (56.1) 100 (63.3) 100 (63.3) 288 (60.9)
EQ-5D-3L
Baseline 155 (98.7) 155 (98.1) 154 (97.5) 464 (98.1)
3 months 104 (66.2) 117 (74.1) 124 (78.5) 345 (72.9)
6 months 94 (59.9) 105 (66.5) 106 (67.1) 305 (64.5)
12 months 84 (53.5) 100 (63.3) 99 (62.7) 283 (59.8)
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Resource use
Resource use by group is reported in Tables 28–30, for the 6 months prior to baseline, the 3-month period
from baseline to first follow-up and the 12-month period from baseline to last follow-up. Individual point
resource use in the 3–6 and 6–12 month periods are presented in Appendix 6. Hospital inpatient services
varied and mostly involved admission to general wards. Hospital outpatient services used also varied and
no one type of service was predominant. Outpatient mental health contacts were low.
Cognitive–behavioural therapy was the most commonly reported psychological therapy, with a much smaller
number reporting the use of counselling and other psychotherapies. The pattern of access to psychological
therapies, primarily CBT, is similar to the CBT data from clinical records reported in Chapter 3, with a larger
proportion of the waiting list group accessing psychological therapies between baseline and the 3-month
follow-up (51%) than either the supported cCBT group (29%) or the guided self-help group (31%), and
between baseline and 12 months (94% compared with 81% for supported cCBT and 76% for the guided
self-help group).
Use of other resources appears similar for all randomisation arms across all time points. Services most
commonly used at baseline and over the follow-up period included contacts with GPs at the GP surgery or by
telephone, contacts with GP practice nurses, outpatient attendances, accident and emergency attendances,
use of psychological therapies and psychotropic medication. There was no obvious pattern to the differences
between the three groups, with service use being similar between groups at each time point.
TABLE 26 Participants with all economic data at 3 and 12 months
Analysis point
Intervention, n (%)
Total, n (%)
(n= 473)
Supported cCBT
(n= 157)
Guided self-help
(n= 158)
Waiting list
(n= 158)
All data 3 months 104 (66) 113 (72) 117 (74) 334 (71)
All data 12 months 71 (45) 76 (48) 84 (53) 231 (49)
TABLE 27 Baseline characteristics of the full sample and those with full economic data
Characteristics
Full sample
(n= 473)
Full data for 3-month
analyses (n= 334)
Full data for 12-month
analyses (n= 231)
Sex, n (%)
Male 188 (39.8) 137 (41.0) 100 (43.3)
Female 285 (60.3) 197 (59.0) 131 (56.7)
Ethnicity, n (%)
White British 431 (91.3) 305 (91.6) 215 (93.1)
Other 41 (8.7) 28 (8.4) 16 (6.9)
Age (years), mean (SD) 35.86 (12.4) 36.22 (12.7) 37.76 (13.3)
Years with OCD, mean (SD) 13.93 (12.2) 13.74 (12.4) 15.03 (12.9)
Y-BOCS-SR, mean (SD) 24.24 (5.0) 24.24 (4.9) 24.20 (4.8)
EQ-5D-3L utility, mean (SD) 0.67 (0.27) 0.67 (0.27) 0.66 (0.27)
Costs (£), mean (SD) 625 (1149) 604 (1125) 641 (1182)
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TABLE 28 Resource use over the 6 months prior to baseline
Resource Unit
Intervention
Supported cCBT
(n= 156)
Guided self-help
(n= 156) Waiting list (n= 155)
n (%) of
users
Mean (SD)
of those
using
n (%) of
users
Mean (SD)
of those
using
n (%) of
users
Mean (SD)
of those
using
Hospital
Inpatient Nights 7 (4.5) 5.17 (8.0) 9 (5.8) 2.58 (1.3) 12 (7.7) 3.20 (3.4)
Outpatient Attendances 42 (26.9) 2.50 (1.7) 45 (28.9) 2.64 (3.6) 48 (30.8) 3.68 (7.8)
A&E Attendances 19 (12.2) 1.16 (0.4) 23 (14.7) 1.13 (0.3) 28 (18.1) 1.96 (4.0)
Community
GP at surgery Contacts 149 (95.5) 3.77 (3.1) 142 (91.0) 4.60 (4.2) 144 (92.9) 4.33 (4.1)
GP at home Contacts 2 (1.3) 3.00 (2.8) 0 (0.0) 0.00 (0.00) 3 (1.9) 1.33 (0.6)
GP by telephone Contacts 20 (12.8) 2.85 (4.2) 24 (15.4) 2.58 (3.0) 33 (21.3) 3.27 (4.1)
Practice nurse Contacts 39 (25.0) 1.95 (1.3) 63 (40.4) 1.92 (1.6) 49 (31.6) 1.82 (1.4)
District nurse Contacts 6 (3.9) 5.83 (7.3) 6 (3.9) 2.17 (1.9) 9 (5.8) 3.78 (2.9)
NHS walk-in clinic Contacts 9 (5.8) 1.22 (0.7) 9 (5.8) 1.33 (0.7) 13 (8.4) 1.46 (0.9)
Community
psychiatric nurse
Contacts 7 (4.5) 5.29 (9.2) 2 (1.3) 1.00 (–) 9 (5.8) 1.67 (1.7)
Psychiatrist in
community
Contacts 6 (3.9) 1.67 (0.82) 8 (5.1) 3.00 (2.33) 9 (5.8) 1.33 (0.71)
Occupational
therapist
Contacts 6 (3.9) 2.17 (1.94) 5 (3.2) 2.80 (2.49) 6 (3.9) 1.83 (1.17)
Marriage counselling Contacts 1 (0.6) 1.00 (–) 0 (0.0) 0.00 (0.00) 2 (1.3) 3.00 (2.83)
Social worker Contacts 1 (0.6) 12.00 (–) 4 (2.6) 6.25 (6.7) 3 (1.9) 5.67 (4.5)
Advice service Contacts 4 (2.6) 3.50 (3.1) 13 (8.3) 1.92 (1.1) 13 (8.4) 4.00 (5.8)
Helpline Contacts 0 (0.0) 0.00 (0.0) 7 (4.5) 2.29 (1.6) 10 (6.4) 1.30 (0.5)
Day centre/drop-in Contacts 0 (0.0) 0.00 (0.0) 1 (0.6) 25.00 (–) 1 (0.7) 3.00 (–)
Complementary
therapy
Contacts 8 (5.1) 3.13 (2.7) 8 (5.1) 4.75 (6.4) 3 (1.9) 5.00 (1.00)
Other psychological
therapies
Contacts 39 (25.0) 5.37 (6.7) 38 (24.4) 5.61 (4.5) 43 (27.7) 6.27 (4.5)
Psychotropic medication Yes/no 81 (51.9) – 84 (53.9) – 79 (51.0) –
Time off work Days 21 (13.5) 24.3 (36.7) 25 (16.0) 21.0 (30.0) 29 (18.7) 20.7 (30.8)
A&E, accident and emergency.
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TABLE 29 Resource use between baseline and 3-month follow-up
Resource Unit
Intervention
Supported cCBT
(n= 105)
Guided self-help
(n= 118) Waiting list (n= 121)
n (%) of
users
Mean (SD)
of those
using
n (%) of
users
Mean (SD)
of those
using
n (%) of
users
Mean (SD)
of those
using
Hospital
Inpatient Nights 3 (2.9) 7.33 (11.0) 3 (2.5) 1.00 (0.00) 3 (2.5) 1.00 (0.00)
Outpatient Attendances 24 (22.9) 1.96 (1.4) 27 (22.9) 2.07 (1.5) 28 (23.1) 3.14 (4.8)
A&E Attendances 5 (4.8) 1.00 (0.00) 6 (5.1) 1.17 (0.4) 11 (9.1) 1.09 (0.30)
Community
GP at surgery Contacts 67 (63.8) 2.43 (1.9) 79 (67.0) 2.35 (1.5) 78 (64.5) 2.73 (2.6)
GP by telephone Contacts 7 (6.7) 1.57 (1.5) 12 (10.2) 1.75 (0.8) 17 (14.1) 2.00 (1.27)
GP at home Contacts 0 (0.0) 0.00 (0.0) 0 (0.0) 0.00 (0.00) 0 (0.0) 0.00 (0.00)
Practice nurse Contacts 22 (21.0) 1.23 (0.4) 20 (17.0) 1.60 (0.8) 16 (13.2) 1.69 (1.5)
District nurse Contacts 5 (4.8) 1.40 (0.6) 8 (6.8) 1.13 (0.4) 2 (1.7) 3.50 (3.5)
NHS walk-in clinic Contacts 2 (1.9) 1.00 (0.00) 6 (5.1) 1.33 (0.8) 3 (2.5) 1.00 (0.00)
Community
psychiatric nurse
Contacts 1 (1.0) 1.00 (–) 1 (0.9) 1.00 (–) 2 (1.7) 2.50 (2.1)
Psychiatrist in
community
Contacts 1 (1.0) 2.00 (–) 2 (1.7) 1.00 (0.00) 3 (2.5) 1.33 (0.6)
Occupational
therapist
Contacts 4 (3.8) 1.75 (1.0) 3 (2.5) 4.67 (3.5) 1 (0.8) 6.00 (–)
Marriage counselling Contacts 1 (1.0) 5.00 (–) 1 (0.9) 8.00 (–) 2 (1.7) 3.00 (2.8)
Social worker Contacts 0 (0.0) 0.00 (0.00) 3 (2.5) 1.67 (0.6) 1 (0.8) 3.00 (–)
Advice service Contacts 3 (2.9) 1.67 (0.58) 5 (4.2) 1.80 (1.8) 5 (4.1) 6.20 (10.6)
Helpline Contacts 0 (0.0) 0.00 (0.00) 0 (0.0) 0.00 (0.0) 5 (4.1) 1.40 (0.6)
Day centre/drop-in Contacts 0 (0.0) 0.00 (0.00) 1 (0.9) 24.00 (–) 1 (0.8) 8.00 (–)
Complementary
therapy
Contacts 2 (1.9) 3.00 (2.83) 2 (1.7) 2.00 (1.4) 2 (1.7) 5.50 (3.5)
Other psychological
therapies
Contacts 30 (28.6) 5.14 (4.13) 37 (31.4) 5.52 (2.9) 62 (51.2) 4.71 (3.8)
Psychotropic medication Yes/no 48 (45.7) – 54 (45.8) – 48 (39.7) –
Time off work Days 5 (4.8) 15.1 (25.4) 5 (4.2) 18.0 (26.7) 6 (5.0) 20.2 (21.3)
A&E, accident and emergency.
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The percentage of participants taking time off work because of their OCD was relatively low at all time
points and was highest in the 6 months before trial entry (14% in supported cCBT group, 16% in the guided
self-help group and 19% in the CBT group). Over the follow-up periods, the proportion of participants
reporting time off work in all groups was approximately 5% from baseline to 3-month follow-up and
approximately 10% from baseline to 12-month follow-up. For those who reported time off work because of
OCD, mean days off work were similar at baseline (mean days 24, 21 and 21, respectively) and 3-month
follow-up (mean days 15, 18 and 20, respectively) but were substantially higher in the waiting list group for
the full 12-month follow-up period (mean 52 days compared with 11 days for supported cCBT and 23 days
for guided self-help).
TABLE 30 Resource use between baseline and 12-month follow-up
Resource Unit
Intervention
Supported cCBT
(n= 88)
Guided self-help
(n= 100) Waiting list (n= 100)
n (%) of
users
Mean (SD)
of those
using
n (%) of
users
Mean (SD)
of those
using
n (%) of
users
Mean (SD)
of those
using
Hospital
Inpatient Nights 7 (8.0) 3.9 (7.1) 6 (6.0) 2.3 (2.0) 9 (9.0) 2.8 (2.9)
Outpatient Attendances 27 (30.7) 4.4 (5.1) 36 (36.0) 3.8 (3.6) 42 (42.0) 4.9 (5.5)
A&E Attendances 10 (11.4) 1.4 (0.7) 20 (20.0) 1.3 (0.6) 24 (24.0) 1.5 (0.7)
Community
GP at surgery Contacts 74 (84.1) 5.7 (4.3) 90 (90.0) 6.3 (3.8) 89 (89.0) 7.5 (10.1)
GP at home Contacts 1 (1.1) 2.00 (–) 1 (1.0) 1.00 (–) 0 (0.0) 0.0 (0.0)
GP by telephone Contacts 13 (14.8) 1.5 (1.1) 19 (19.0) 2.2 (1.4) 24 (24.0) 3.0 (2.5)
Practice nurse Contacts 31 (35.2) 2.2 (1.6) 43 (43.0) 2.9 (5.2) 34 (34.0) 2.9 (3.6)
District nurse Contacts 6 (6.8) 2.5 (2.74) 9 (9.0) 3.00 (4.2) 10 (10.0) 2.3 (1.6)
NHS walk-in clinic Contacts 5 (5.7) 1.2 (0.5) 11 (11.0) 1.4 (0.7) 11 (11.0) 1.6 (0.9)
Community
psychiatric nurse
Contacts 3 (3.4) 9.3 (14.4) 3 (3.0) 2.7 (1.5) 4 (4.0) 4.3 (5.9)
Psychiatrist in
community
Contacts 4 (4.6) 2.3 (1.3) 4 (4.0) 2.3 (1.0) 9 (9.0) 3.3 (5.6)
Occupational
therapist
Contacts 4 (4.6) 1.8 (1.0) 4 (4.0) 4.3 (3.0) 3 (3.0) 3.0 (2.0)
Marriage counselling Contacts 0 (0.0) 0.00 (0.00) 1 (1.0) 1.00 (–) 2 (2.0) 3.0 (2.8)
Social worker Contacts 2 (2.3) 3.5 (3.5) 2 (2.0) 4.5 (5.0) 3 (3.0) 4.0 (1.0)
Advice service Contacts 5 (5.7) 3.8 (3.5) 8 (8.0) 3.6 (3.6) 9 (9.0) 8.9 (15.4)
Helpline Contacts 0 (0.0) 0.0 (0.0) 3 (3.0) 1.3 (0.6) 5 (5.0) 4.4 (7.1)
Day centre/drop-in Contacts 0 (0.0) 0.0 (0.0) 4 (4.0) 13.0 (12.2) 1 (1.0) 15.0 (–)
Complementary
therapy
Contacts 7 (8.0) 4.3 (7.4) 3 (3.0) 7.0 (2.7) 6 (6.0) 3.8 (2.5)
Other psychological
therapies
Contact 71 (80.7) 11.2 (8.2) 76 (76.0) 10.1 (6.4) 94 (94.0) 11.4 (6.5)
Psychotropic medication Yes/no 52 (59.1) – 61 (61.0) – 49 (49.0) –
Time off work Days 9 (10.2) 10.8 (7.6) 10 (10.0) 23.2 (37.7) 12 (12.0) 52.0 (64.4)
A&E, accident and emergency.
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Out-of-pocket expenses and savings were variable and some items were difficult for participants to value.
As a result, some out-of-pocket items had to be excluded from the analysis, so the cost and savings
calculations are, therefore, underestimated.
Participants attributed over 800 individual out-of-pocket expenses or savings to their OCD over the four
time points. By far the most commonly reported items of expense were cleaning materials including
(but not limited to) antibacterial gel, antibacterial wipes, hand wash, soap, toiletries, bleach and other
household cleaners. Other items were highly variable, but examples included extra petrol for additional
journeys required to complete checking, throwing away food as a result of contamination concerns and
spending sprees to improve mood. Cost savings reported were mostly because of avoidance of, or inability
to do, certain things, such as socialising or participating in leisure activities (e.g. attending the gym, eating
out or going on holiday) or being very careful with money (e.g. avoiding spending money, careful control
of finances, heating and electricity).
Tables 31 and 32 describe the number and proportion of participants who reported out-of-pocket
expenses and savings at each time point by randomisation allocation. Out-of-pocket expenses were far
more commonly reported than out-of-pocket savings. On the whole, the percentage of people reporting
out-of-pocket expenses reduced over time in all three groups and a slightly lower percentage of the
supported cCBT group reported such expenses, compared with guided self-help and the waiting list for
high-intensity CBT groups. Out-of-pocket savings were reported so rarely that no conclusions can
be drawn.
TABLE 31 Out-of-pocket expenses
Time point
Intervention
Supported cCBT Guided self-help Waiting list
Number of
participants
reporting (n/N) Percentage
Number of
participants
reporting (n/N) Percentage
Number of
participants
reporting (n/N) Percentage
Baseline 57/156 36.5 62/156 39.7 62/155 40.0
3 months 31/105 29.5 39/118 33.1 42/121 34.7
6 months 21/95 22.1 31/107 29.0 35/108 32.4
12 months 20/88 22.7 33/100 33.0 28/100 28.0
TABLE 32 Out-of-pocket savings
Time point
Intervention
Supported cCBT Guided self-help Waiting list
Number of
participants
reporting (n/N) Percentage
Number of
participants
reporting (n/N) Percentage
Number of
participants
reporting (n/N) Percentage
Baseline 0/156 0 0/156 0 3/155 1.9
3 months 0/105 0 1/118 0.9 2/121 1.7
6 months 3/95 3.2 1/107 0.9 2/108 1.9
12 months 2/88 2.3 0/100 0 1/100 1.0
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Costs
Supported computerised cognitive–behavioural therapy and guided self-help
Table 33 provides details of resources and costs in the two low-intensity interventions. The mean cost of
guided self-help (£383) was over twice that of supported cCBT (£155) as a result of the greater number
and length of the PWP contacts.
Health- and social-care services
Cost components over the three follow-up periods (from baseline to 3 months, between 3 and 6 months
and between 6 and 12 months) are summarised in Table 34 and cost comparisons between groups are
presented in Table 35.
TABLE 33 Cost of supported cCBT and guided self-help
Cost component
Intervention, mean (SD)
Supported cCBT Guided self-help
Number of sessions attended 2.3 (2.5) 4.11 (4.3)
Total session minutes 30.2 (38.6) 142.9 (146.1)
Cost of materials (£) 63.7 (0) 5.5 (0)
Cost of training (£) 18.8 (20.7) 34.5 (35.9)
Cost of PWP contacts (£) 72.4 (92.6) 343.0 (350.7)
Total cost (£) 154.9 (111.1) 383.0 (385.0)
TABLE 34 Cost components over the three time periods
Cost component
Intervention
Supported cCBT Guided self-help Waiting list
Valid n Mean (SD), £ Valid n Mean (SD), £ Valid n Mean (SD), £
Intervention 157 155 (111) 158 383 (385) 158 0 (0)
Baseline to 3 months
Health- and social-care services 118 366 (366) 130 315 (402) 129 400 (501)
Employment losses 118 87 (799) 130 103 (763) 129 53 (346)
Out-of-pocket expenses 118 138 (1104) 130 71 (168) 129 113 (339)
Out-of-pocket savings 118 0 (0) 130 0 (2) 129 –3 (24)
Between 3 and 6 months
Health- and social-care costs 102 407 (556) 115 368 (521) 117 529 (626)
Employment losses 102 100 (813) 115 25 (212) 117 28 (151)
Out-of-pocket expenses 102 44 (173) 115 48 (119) 117 98 (249)
Out-of-pocket savings 102 –3 (19) 115 –1 (12) 117 –9 (67)
Between 6 and 12 months
Health- and social-care costs 88 663 (934) 100 546 (546) 100 792 (828)
Employment losses 88 10 (86) 100 64 (455) 100 199 (1875)
Out-of-pocket expenses 88 131 (372) 100 128 (295) 100 200 (493)
Out-of-pocket savings 88 –62 (555) 100 0 (0) 100 –13 (130)
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Health- and social-care services (the largest cost component in each arm) were lowest in the guided
self-help group and highest in the waiting list for high-intensity CBT group over all three time periods.
At the adjusted p-value threshold of 0.0167, only the intervention costs were significantly different between
the groups, with the intervention costs in the supported cCBT group (unadjusted mean difference £155,
95% CI £134 to £175; p < 0.001; adjusted mean difference £158, 95% CI £137 to £180; p < 0.001) and
the guided self-help group (unadjusted mean difference £383, 95% CI £316 to £449; p < 0.001; adjusted
mean difference £383, 95% CI £313 to £450; p < 0.001) being higher in the adjusted and unadjusted
TABLE 35 Comparison of cost components over the three time periods
Cost
component
Intervention comparison, £ (95% CI; p-value)
Supported cCBT vs. waiting
list
Guided self-help vs. waiting
list
Supported cCBT vs. guided
self-help
Unadjusted
mean
differencea
Adjusted
mean
differenceb
Unadjusted
mean
differencea
Adjusted
mean
differenceb
Unadjusted
mean
differencea
Adjusted
mean
differenceb
Intervention
costs
155 (134 to
175; < 0.001)c
158 (137 to
180; < 0.001)c
383 (316 to
449; < 0.001)c
383 (313 to
450; < 0.001)c
–228 (–299 to
–157; < 0.001)c
–223 (–298 to
149; < 0.001)c
Baseline to 3 months
Health- and
social-care costs
–34 (–310 to
242; 0.808)
–25 (–276 to
227; 0.848)
–85 (–198 to
28; 0.140)
–76 (–184 to
32; 0.167)
51 (–200 to
301; 0.691)
51 (–184 to
287; 0.669)
Employment
losses
33 (–129 to
196; 0.686)
39 (–117 to
196; 0.622)
49 (–95 to
194; 0.505)
–16 (–95 to
62; 0.686)
–16 (–221 to
190; 0.881)
56 (–99 to
210; 0.480)
Out-of-pocket
expenses
25 (–194 to
243; 0.825)
28 (–191 to
247; 0.801)
–42 (–108 to
25; 0.220)
–35 (–101 to
31; 0.298)
66 (–146 to
279; 0.540)
63 (–146 to
272; 0.554)
Out-of-pocket
savings
3 (–1 to
7; 0.217)
0 (–1 to
1; 0.948)
2 (–2 to
6; 0.259)
0 (–2 to
1; 0.704)
0 (0 to
1; 0.311)
0 (0 to
1; 0.325)
Between 3 and 6 months
Health- and
social-care costs
–122 (–273 to
30; 0.115)
–102 (–262 to
59; 0.213)
–160 (–308 to
–13; 0.034)
–130 (–291 to
32; 0.116)
39 (–96 to
173; 0.572)
28 (–95 to
150; 0.656)
Employment
losses
72 (–91 to
235; 0.387)
71 (–88 to
230; 0.382)
–3 (–51 to 45;
0.909)
–13 (–71 to
44; 0.655)
75 (–91 to
241; 0.378)
84 (–75 to
243; 0.299)
Out-of-pocket
expenses
–53 (–110 to
3; 0.062)
–47 (–105 to
12; 0.116)
–50 (–101 to
2; 0.060)
–40 (–88 to
8; 0.103)
–4 (–43 to
35; 0.847)
–7 (–47 to
33; 0.731)
Out-of-pocket
savings
6 (–7 to
19; 0.373)
6 (–9 to
20; 0.451)
8 (–5 to
20; 0.218)
8 (–6 to
21; 0.267)
–2 (–7 to
2; 0.372)
–2 (–7 to
3; 0.406)
Between 6 and 12 months
Health- and
social-care costs
–129 (–390 to
132; 0.333)
–108 (–356 to
140; 0.394)
–246 (–443 to
–48; 0.015)c
–216 (–413 to
–18; 0.033)
117 (–101 to
335; 0.293)
108 (–96 to
311; 0.300)
Employment
losses
–189 (–567 to
189; 0.327)
–213 (–621 to
196; 0.307)
–135 (–526 to
257; 0.501)
–191 (–580 to
198; 0.336)
–54 (–150 to
41; 0.266)
–22 (–103 to
60; 0.599)
Out-of-pocket
expenses
–69 (–199 to
61; 0.296)
–59 (–179 to
62; 0.339)
–72 (–190 to
45; 0.226)
–54 (–166 to
57; 0.342)
3 (–88 to 94;
0.947)
–5 (–88 to 79;
0.915)
Out-of-pocket
savings
–49 (–176 to
77; 0.447)
–44 (–167 to
80; 0.489)
13 (–12 to
38; 0.316)
17 (–22 to
55; 0.400)
–62 (–185 to
61; 0.324)
–60 (–179 to
58; 0.320)
a Adjusted by PWP only.
b Adjusted by PWP, sex and baseline cost, utility, use of antidepressants, duration of OCD, PHQ-9 score, GAD-7 score and
Y-BOCS-OR score.
c p< 0.0167.
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analyses, and with the cCBT group having lower intervention costs than the guided self-help group
(unadjusted mean difference –£228, 95% CI –£299 to –£157; p < 0.001; adjusted mean difference –£223,
95% CI –£298 to –£149; p < 0.001).
Productivity losses and out-of-pocket expenses and savings
Productivity losses were highest in the guided self-help group between baseline and 3 months, in the
supported cCBT group between 3 and 6 months and in the waiting list for high-intensity CBT group
between 6 and 12 months, but there were no significant differences between either supported cCBT or
guided self-help compared with the waiting list for high-intensity CBT over any of the time periods.
Out-of-pocket expenses also varied greatly between groups and over the three time periods, but there
were no significant differences. Out-of-pockets savings were minimal over all time periods in all arms
(see Tables 34 and 35).
Table 36 reports total health- and social-care costs and total societal costs (including productivity losses
and out-of-pocket expenses and savings) for the two economic analysis periods: baseline to 3 months and
baseline to 12 months.
Table 37 details the results of the statistical comparisons between the two self-help interventions and
between the waiting list for high-intensity CBT group and the supported cCBT and guided self-help groups.
Over the baseline to 3-month period, guided self-help was the most expensive group and the waiting list
for high-intensity CBT group was the least expensive at the 0.0167 p-value threshold. The guided self-help
group was significantly more expensive in unadjusted and adjusted analyses at 3 months than the waiting
list for high-intensity CBT group in terms of both health- and social-care costs and societal costs, but no
other significant differences were detected.
Over the full baseline to 12-month period (primary end point), differences between the groups had
disappeared for health- and social-care costs, which were almost identical between the three groups.
In terms of societal costs, guided self-help was the cheapest group and the waiting list for high-intensity
CBT group the most expensive, although these differences were not significant. Tables 38 and 39 report
the same results but with missing data imputed, and show very similar results with no changes in terms of
statistical significance.
TABLE 36 Total costs between baseline and 3 months and between baseline and 12 months: complete case
Costs
Intervention
Supported cCBT Guided self-help Waiting list
Valid n
Mean cost,
£ (SD) Valid n
Mean cost,
£ (SD) Valid n
Mean cost,
£ (SD)
Baseline to 3 months
Health- and social-care costsa 118 529 (1521) 130 756 (557) 129 400 (501)
Societal costsb 118 754 (2435) 130 930 (1059) 129 564 (774)
Baseline to 12 months
Health- and social-care costsa 88 1691 (2353) 100 1696 (1155) 100 1714 (1288)
Societal costsb 88 2207 (3664) 100 2141 (1786) 100 2400 (2636)
a Includes health- and social-care and intervention costs.
b Includes health- and social-care and intervention costs, productivity losses and out-of-pocket expenses and savings.
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Outcomes
Table 40 reports the EQ-5D-3L results at baseline, and at 3, 6 and 12 months, plus QALYs at the two
analysis points – between baseline and 3 months and between baseline and 12 months – for the complete
case sample and the full sample with missing data imputed.
TABLE 37 Comparison of total costs between baseline and 3 months and between baseline and 12 months:
complete case
Cost
component
Intervention comparison, £ (95% CI; p-value)
Supported cCBT vs. waiting
list
Guided self-help vs. waiting
list
Supported cCBT vs. guided
self-help
Unadjusted
mean
differencea
Adjusted
mean
differenceb
Unadjusted
mean
differencea
Adjusted
mean
differenceb
Unadjusted
mean
differencea
Adjusted
mean
differenceb
Baseline to 3 months
Health- and
social-care
costsc
129 (–157 to
415; 0.375)
138 (–123 to
399; 0.300)
356 (207 to
505; < 0.001)d
364 (220 to
507; < 0.001)d
–227 (–508 to
54; 0.113)
–226 (–492 to
41; 0.097)
Societal costse 190 (–266 to
646; 0.413)
202 (–201 to
605; 0.327)
366 (112 to
620; 0.005)d
310 (123 to
498; 0.001)d
–176 (–637 to
285; 0.454)
–109 (–523 to
305; 0.606)
Baseline to 12 months
Health- and
social-care
costsc
–24 (–697 to
649; 0.945)
–9 (–602 to
583; 0.976)
–18 (–384 to
347; 0.921)
24 (–334 to
381; 0.896)
–5 (–591 to
581; 0.986)
–33 (–540 to
475; 0.899)
Societal costse –193 (–1242 to
856; 0.719)
–159 (–1066
to 748; 0.731)
–259 (–935 to
416; 0.452)
–355 (–951 to
242; 0.244)
66 (–843 to
976; 0.886)
196 (–555 to
946; 0.610)
a Adjusted by PWP only.
b Adjusted by PWP, sex and baseline cost, utility, use of antidepressants, duration of OCD, PHQ-9 score, GAD-7 score and
Y-BOCS-OR score.
c Includes health- and social-care and intervention costs.
d p< 0.0167.
e Includes health- and social-care and intervention costs, productivity losses and out-of-pocket expenses and savings.
TABLE 38 Total costs between baseline and 3 months and between baseline and 12 months: imputed missing data
Costs
Intervention
Supported cCBT Guided self-help Waiting list
Valid n
Mean cost,
£ (SD) Valid n
Mean cost,
£ (SD) Valid n
Mean cost,
£ (SD)
Baseline to 3 months
Health- and social-care costsa 157 535 (1321) 158 721 (518) 158 443 (472)
Societal costsb 157 739 (2115) 158 894 (973) 158 608 (721)
Baseline to 12 months
Health- and social-care costsa 157 1665 (1798) 158 1676 (976) 158 1737 (1143)
Societal costsb 157 2174 (2823) 158 2154 (1534) 158 2352 (2216)
a Includes health- and social-care and intervention costs.
b Includes health- and social-care and intervention costs, productivity losses and out-of-pocket expenses and savings.
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TABLE 39 Comparison of total costs between baseline and 3 months and between baseline and 12 months:
imputed missing data
Cost
component
Intervention comparison, £ (95% CI; p-value)
Supported cCBT vs. waiting
list
Guided self-help vs. waiting
list
Supported cCBT vs. guided
self-help
Unadjusted
mean
differencea
Adjusted
mean
differenceb
Unadjusted
mean
differencea
Adjusted
mean
differenceb
Unadjusted
mean
differencea
Adjusted
mean
differenceb
Baseline to 3 months
Health- and
social-care costsc
92 (–130 to
314; 0.418)
115 (–99 to
328; 0.293)
278 (153 to
402; < 0.001)d
297 (182 to
411; < 0.001)d
–186 (–395 to
24; 0.082)
–182 (–389 to
24; 0.084)
Societal costse 132 (–222 to
485; 0.465)
161 (–478 to
469; 0.305)
286 (74 to
499; 0.008)d
307 (118 to
495; 0.001)d
–155 (–520 to
210; 0.406)
–145 (–472 to
181; 0.383)
Baseline to 12 months
Health- and
social-care costsc
–71 (–471 to
328; 0.727)
–18 (–372 to
336; 0.920)
–60 (–330 to
209; 0.660)
24 (–205 to
253; 0.836)
–11 (–336 to
314; 0.947)
–42 (–346 to
261; 0.785)
Societal costse –178 (–796 to
440; 0.573)
–119 (–636 to
399; 0.654)
–198 (–665 to
269; 0.407)
–119 (–525 to
288; 0.567)
20 (–489 to
529; 0.939)
0 (–434 to
435; 0.999)
a Adjusted by PWP only.
b Adjusted by PWP, sex and baseline cost, utility, use of antidepressants, duration of OCD, PHQ-9 score, GAD-7 score and
Y-BOCS-OR score.
c Includes health- and social-care and intervention costs.
d p< 0.0167.
e Includes health- and social-care and intervention costs, productivity losses and out-of-pocket expenses and savings.
TABLE 40 European Quality of Life-5 Dimensions-3 levels results at baseline, 3, 6 and 12 months
Time point
Intervention
Supported cCBT Guided self-help Waiting list
Valid n Mean (SD) Valid n Mean (SD) Valid n Mean (SD)
Baseline
EQ-5D-3L utility 155 0.67 (0.29) 155 0.68 (0.26) 154 0.68 (0.26)
3 months
EQ-5D-3L utility 104 0.69 (0.31) 117 0.73 (0.24) 124 0.67 (0.28)
QALYs 104 0.17 (0.07) 115 0.18 (0.05) 123 0.17 (0.06)
QALYs imputed 157 0.17 (0.07) 158 0.17 (0.05) 158 0.17 (0.06)
6 months
EQ-5D-3L utility 94 0.71 (0.29) 105 0.72 (0.25) 106 0.71 (0.25)
12 months
EQ-5D-3L utility 84 0.79 (0.27) 100 0.73 (0.26) 99 0.70 (0.31)
QALYs 71 0.72 (0.27) 81 0.71 (0.22) 86 0.70 (0.23)
QALYs imputed 157 0.72 (0.24) 158 0.72 (0.11) 158 0.71 (0.21)
Source: Lovell et al.84 This is an open access article distributed under the terms of the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and
source are credited.
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Table 41 details the results of the statistical comparisons between the groups. In terms of the observed
data, EQ-5D-3L scores were very similar between the groups at all time points. There were no statistically
significant differences between the groups at the 0.0167 p-value threshold. Analyses using imputation for
missing data were very similar.
Cost-effectiveness analyses
Incremental cost-effectiveness ratios
Table 42 presents the ICERs for all three pairwise comparisons at 3 and 12 months. Results are reported
for both the health- and social-care perspective, and the societal perspective.
At 3 months, cost-effectiveness ratios for both supported cCBT and guided self-help compared with
waiting list for high-intensity CBT are greater than £30,000 per QALY for both the health- and social-care
perspective and the societal perspective. At 12 months (primary end point), however, ratios for supported
cCBT compared with the waiting list for high-intensity CBT are negative for both perspectives, indicating,
on average, that the supported cCBT group is both cheaper and more effective than waiting list for
high-intensity CBT.
TABLE 41 Comparisons of outcomes at 3, 6 and 12 months
Outcome
measure
and time
point
Intervention comparison, £ (95% CI; p-value)a
Supported cCBT vs. waiting list Guided self-help vs. waiting list
Supported cCBT vs. guided
self-help
Unadjusted
mean
differenceb
Adjusted mean
differencec
Unadjusted
mean
differenceb
Adjusted mean
differencec
Unadjusted
mean
differenceb
Adjusted mean
differencec
3 months
EQ-5D-3L
utility
0.0223 (–0.0538
to 0.0984; 0.556)
0.0333 (–0.0229
to 0.0895; 0.246)
0.0573 (–0.0095
to 0.1241; 0.566)
0.0525 (0.0018
to 0.1032; 0.042)
–0.0350 (–0.1008
to 0.0308; 0.297)
–0.0192 (–0.0729
to 0.0354; 0.491)
QALYs 0.0004 (–0.0159
to 0.0166; 0.965)
0.0042 (–0.0029
to 0.0112; 0.246)
0.0069 (–0.0076
to 0.0214; 0.348)
0.0066 (0.0002
to 0.0129; 0.042)
–0.0066 (–0.0202
to 0.0071; 0.347)
–0.0024 (–0.0092
to 0.0044; 0.491)
QALYs
imputed
0.0014 (–0.0127
to 0.0154; 0.850)
0.0034 (–0.0019
to 0.0086; 0.206)
0.0056 (–0.0070
to 0.0182; 0.385)
0.0051 (–0.0000
to 0.0101; 0.049)
–0.0042 (–0.0159
to 0.0074; 0.478)
–0.0017 (–0.0066
to 0.0032; 0.500)
6 months
EQ-5D-3L
utility
0.0077 (–0.0682
to 0.0838; 0.841)
0.0015 (–0.0600
to 0.0631; 0.961)
0.0165 (–0.0537
to 0.0867; 0.645)
0.0071 (–0.0523
to 0.0664; 0.815)
–0.0087 (–0.0845
to 0.0671; 0.822)
–0.0055 (–0.0688
to 0.0577; 0.864)
12 months
EQ-5D-3L
utility
0.0890 (0.0010
to 0.1771; 0.047)
0.0741 (0.0029
to 0.1452; 0.041)
0.0299 (–0.0512
to 0.1111; 0.469)
0.0255 (–0.0405
to 0.0915; 0.449)
0.0591 (–0.0231
to 0.1413; 0.159)
0.0485 (–0.0223
to 0.1194; 0.179)
QALYs 0.0202 (–0.0550
to 0.0955; 0.599)
0.0151 (–0.0347
to 0.0649; 0.553)
0.0100 (–0.0589
to 0.0890; 0.776)
0.0061 (–0.0419
to 0.0541; 0.804)
0.0102 (–0.0656
to 0.0859; 0.792)
0.0090 (–0.0463
to 0.0643; 0.750)
QALYs
imputed
0.0032 (–0.0476
to 0.0541; 0.900)
0.0075 (–0.0185
to 0.0335; 0.570)
0.0079 (–0.0376
to 0.0534; 0.733)
0.0037 (–0.0223
to 0.0298; 0.779)
–0.0047 (–0.0500
to 0.0407; 0.840)
0.0038 (–0.0229
to 0.0305; 0.781)
a p< 0.0167.
b Adjusted by PWP only.
c Adjusted by PWP, sex and baseline utility, use of antidepressants, sex, duration of OCD, PHQ-9 score, GAD-7 score and
Y-BOCS-OR score.
Source: Lovell et al.84 This is an open access article distributed under the terms of the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and
source are credited.
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Ratios for guided self-help compared with the waiting list for high-intensity CBT are negative from the
societal perspective (on average guided self-help is cheaper and more effective than the waiting list for
high-intensity CBT) and approximately £4000 per QALY from the health- and social-care perspective
(on average guided self-help is more expensive but also more effective), which is below the NICE
willingness-to-pay threshold level of £20,000–30,000 or less. However, as ICERs are based on point
estimates, we must examine the cost-effectiveness planes and CEACs to account for the variability and
uncertainty around these estimates.
Supported computerised cognitive–behavioural therapy versus the waiting
list for high-intensity cognitive–behavioural therapy
Figures 3–6 show the bootstrapped replications for cost and effect pairs on the cost-effectiveness plane
for supported cCBT versus a waiting list for high-intensity CBT at 3 and 12 months (health- and social-care
perspective and societal perspective). At 3 months, a greater proportion of scatter points lie to the right
of the vertical axis where the bootstrap replications represent points where cCBT is more effective than
the waiting list. In addition, a greater proportion of scatter points lie above the horizontal axis where the
bootstrap replications represent supported cCBT having higher costs than the waiting list. This is the same
from both perspectives and generates a trade-off scenario – there are better outcomes but for a greater cost.
TABLE 42 Incremental cost-effectiveness ratios
Perspective
Intervention comparison, £ (incremental cost per QALY)
Supported cCBT vs.
waiting list
Guided self-help vs.
waiting list
Supported cCBT vs.
guided self-help
3 months
Health and social care 138/0.0042 (32,857) 364/0.0066 (55,152) –226/–0.0024 (94,167)
Societal 202/0.0042 (48,095) 310/0.0066 (46,970) –109/–0.0024 (45,417)
12 months
Health and social care –9/0.0151 (–596) 24/0.0061 (3934) –5/0.0090 (–556)
Societal –159/0.0151 (–10,530) –355/0.0061 (–58,197) 196/0.0090 (21,778)
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FIGURE 3 Cost-effectiveness plane for supported cCBT vs. the waiting list for high-intensity CBT at 3 months from
the health- and social-care perspective.
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Figure 7 shows the CEACs for supported cCBT versus the waiting list for high-intensity CBT at 3 months
from both perspectives. The probability of supported cCBT being cost-effective compared with the waiting
list at the NICE willingness-to-pay level of £20,000–30,000 is around 40–50% from the NHS/Personal
Social Services perspective and 25–35% from the societal perspective.
At 12 months, from both perspectives, a greater proportion of scatter points lie to the right of the vertical
axis, where the bootstrap replications represent supported cCBT being more effective than the waiting list,
while a slightly greater proportion of scatter points fall below the horizontal axis where the bootstrap
replications represent cCBT being less costly than the waiting list.
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FIGURE 4 Cost-effectiveness plane for supported cCBT vs. the waiting list for high-intensity CBT at 3 months from
the societal perspective.
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FIGURE 5 Cost-effectiveness plane for supported cCBT vs. the waiting list for high-intensity CBT at 12 months from
the health- and social-care perspective.
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Figure 8 shows the CEACs for supported cCBT versus the waiting list at 12 months (primary end point)
from both perspectives. The probability of supported cCBT being cost-effective compared with the waiting
list at the NICE willingness-to-pay level of £20,000–30,000 is around 70% from both perspectives.
Guided self-help versus the waiting list for high-intensity
cognitive–behavioural therapy
Figures 9–12 show the bootstrapped replications for cost and effect pairs on the cost-effectiveness plane for
guided self-help versus the waiting list for high-intensity CBT at 3 and 12 months (health- and social-care
perspective and societal perspective). At 3 months, the majority of the scatter points lie to the right
of the vertical axis, where the bootstrap replications represent guided self-help being more effective than
the waiting list, and the majority of the scatter points lie above the horizontal axis where the bootstrap
replications represent guided self-help having higher costs from both perspectives, indicating a trade-off.
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FIGURE 6 Cost-effectiveness plane for supported cCBT vs. the waiting list for high-intensity CBT at 12 months from
the societal perspective.
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FIGURE 7 Cost-effectiveness acceptability curves for supported cCBT vs. the waiting list for high-intensity CBT at
3 months from the health- and social-care perspective and societal perspective.
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FIGURE 8 Cost-effectiveness acceptability curves for supported cCBT vs. the waiting list for high-intensity CBT at
12 months from the health- and social-care perspective and societal perspective.
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FIGURE 9 Cost-effectiveness plane for guided self-help vs. the waiting list for high-intensity CBT at 3 months for
the health- and social-care perspective.
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FIGURE 10 Cost-effectiveness plane for guided self-help vs. the waiting list for high-intensity CBT at 3 months for
the societal perspective.
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The guided self-help versus the waiting list for high-intensity CBT CEACs in Figure 13 indicate that
the probability of guided self-help being cost-effective compared with the waiting list at the NICE
willingness-to-pay level of £20,000–30,000 is 0–5% from the health- and social-care perspective and
5–10% from the societal perspective.
At 12 months (primary end point), from a health- and social-care perspective, slightly more of the scatter points
lie to the right of the vertical axis where the bootstrap replications represent guided self-help being more
effective than the waiting list. In addition, slightly more of the scatter points lie below the horizontal axis, where
the bootstrap replications represent guided self-help having lower costs than the waiting list. From a societal
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FIGURE 11 Cost-effectiveness plane for guided self-help vs. the waiting list for high-intensity CBT at 12 months
from the health- and social-care perspective.
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FIGURE 12 Cost-effectiveness plane for guided self-help vs. the waiting list for high–intensity CBT at 12 months
from the societal perspective.
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perspective, more of the scatter points lie to the right of the vertical axis, where the bootstrap replications
represent guided self-help being more effective than the waiting list, while the majority of the scatter points lie
below the horizontal axis, where the bootstrap replications represent guided self-help having lower costs.
This is reflected in the guided self-help versus the waiting list CEACs in Figure 14, which show that
the probability of guided self-help being cost-effective compared with the waiting list group at
£20,000–30,000 per QALY is around 60% from the health- and social-care perspective and below
80% from the societal perspective.
Supported computerised cognitive–behavioural therapy versus guided
self-help
Figures 15–18 show the bootstrapped replications for cost and effect pairs on the cost-effectiveness plane
for supported cCBT versus guided self-help at 3 and 12 months, and from the health- and social-care
perspective and societal perspective.
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FIGURE 13 Cost-effectiveness acceptability curves for guided self-help vs. the waiting list for high-intensity CBT at
3 months from the health- and social-care perspective and societal perspective.
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FIGURE 14 Cost-effectiveness acceptability curves for guided self-help vs. the waiting list for high-intensity CBT at
12 months from the health- and social-care perspective and societal perspective.
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At 3 months, for both the health- and social-care perspective and societal perspective, more bootstrap
replications lie below the horizontal axis, where the replications represent supported cCBT being less costly
than guided self-help. In addition, more replications lie to the left of the vertical axis indicating lower
effectiveness of supported cCBT indicating a trade-off scenario.
The supported cCBT versus guided self-help CEACs in Figure 19 indicate that supported cCBT has an 80%
probability of being cost-effective compared with guided self-help at the NICE willingness-to-pay levels of
£20,000–£30,000 from the health- and social-care perspective, and over a 60% probability from the
societal perspective.
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FIGURE 15 Cost-effectiveness plane for supported cCBT vs. guided self-help at 3 months from the health- and
social-care perspective.
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FIGURE 16 Cost-effectiveness plane for supported cCBT vs. guided self-help at 3 months from the societal
perspective.
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At 12 months (primary end point), from both the health- and social-care perspective and the societal
perspective, slightly more replications lie to the right of the vertical axis, indicating that the effectiveness of
supported cCBT is higher than that of guided self-help. From a health- and social-care perspective, slightly
more bootstrap replications lie below the horizontal axis, where the replications represent supported cCBT
being less costly than guided self-help. In addition, from a societal perspective, slightly more replications lie
above the horizontal axis, where the bootstraps indicate supported cCBT being more costly.
The supported cCBT versus guided self-help CEACs in Figure 20 suggest that the probability of supported
cCBT being cost-effective compared with guided self-help is around 65% from the health- and social-care
perspective and around 50% from the societal perspective.
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FIGURE 17 Cost-effectiveness plane for supported cCBT vs. guided self-help at 12 months from the health- and
social-care perspective.
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FIGURE 18 Cost-effectiveness plane for supported cCBT vs. guided self-help at 12 months from the societal
perspective.
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Supported computerised cognitive–behavioural therapy versus guided
self-help versus the waiting list for high-intensity cognitive–behavioural therapy
The three interventions were compared head to head in a three-way comparison at 12 months (the primary
end point). The CEAC in Figure 21 shows that the probability of supported cCBT being cost-effective at the
NICE willingness-to-pay level of £20,000–30,000 is between 40% and 50% from the NHS/Personal Social
Services perspective, compared with between 30% and 40% for guided self-help and around 20% for the
waiting list for high-intensity CBT. The CEAC in Figure 22 shows that the probability of supported cCBT
being cost-effective at the NICE willingness-to-pay threshold of £20,000–30,000 is between 35% and 40%,
compared with 50–55% for guided self-help and around 10% for the waiting list for high-intensity CBT.
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FIGURE 19 Cost-effectiveness acceptability curves for supported cCBT vs. guided self-help at 3 months from the
health- and social-care perspective and societal perspective.
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FIGURE 20 Cost-effectiveness acceptability curves for supported cCBT vs. guided self-help at 12 months from the
health- and social-care perspective and societal perspective.
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FIGURE 21 Cost-effectiveness acceptability curves for supported cCBT vs. guided self-help vs. the waiting list for
high-intensity CBT at 12 months from the health- and social-care perspective.
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FIGURE 22 Cost-effectiveness acceptability curves for supported cCBT vs. guided self-help vs. the waiting list for
high-intensity CBT at 12 months from the societal perspective.
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Chapter 5 Acceptability of guided self-help and
supported computerised cognitive–behavioural
therapy
Nested qualitative research is increasingly popular in RCTs to explore the acceptability of trialinterventions from the perspectives of those delivering and receiving a treatment. Findings from
qualitative research form an important part of a trial’s evaluation and can aid the understanding of
quantitative findings.
Two qualitative studies were conducted as part of OCTET: the first explored the acceptability of supported
cCBT and guided self-help from the perspective of trial participants, and the second explored the feasibility
and acceptability of delivering these two interventions from the perspective of the PWPs. This chapter
reports the findings of these two qualitative studies.
Quantitative data relating to trial participants’ baseline treatment preferences and treatment satisfaction
(as measured using the CSQ-8) at 3- and 6-month follow-up are presented in Chapter 3.
Study 1: acceptability of guided self-help and supported
computerised cognitive–behavioural therapy to
trial participants
The aim of this study was to explore the acceptability of supported cCBT and guided self-help from the
perspective of trial participants. Quantitative data demonstrated a 66% and 61% uptake of guided
self-help and supported cCBT, respectively (defined as participants receiving one or more sessions of their
trial allocated treatment). The overall mean number of sessions was 4.87 (SD 4.21 sessions) for guided
self-help and 3.73 (SD 2.49 sessions) for supported cCBT. Although informative, these quantitative data
are unable to elucidate important process factors. Therefore, an in-depth qualitative study was nested
within OCTET.
Methods
Sampling and participant recruitment
Sampling was purposive, and only those allocated to an intervention arm were invited for interview.
We deployed maximum variation sampling techniques to ensure a range of ages and geographical
locations (trial sites) and a relatively even split between sexes and intervention groups. Data collection and
analysis occurred in parallel and sampling continued until data saturation was achieved.
Between September 2012 and January 2014 invitation letters, consent-to-contact forms and study
information sheets were posted to 125 participants who had consented at trial baseline to subsequent
contact from the research team regarding additional research opportunities. To be eligible for inclusion in
our qualitative study, participants had to have been allocated to one of the two trial intervention arms
(guided self-help or supported cCBT) and had to have reached or passed the anticipated date for intervention
completion (i.e. ≥ 12 weeks post randomisation). Following the return of the consent-to-contact forms,
participants were contacted by telephone to arrange a suitable time and place for the interview. Written
consent was obtained at the time of a face-to-face interview or in writing prior to telephone interviews.
Participation was voluntary and no reimbursement was offered for taking part.
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Data collection
Interviews were conducted face to face or over the telephone, depending on participant preference.
A semistructured interview schedule was developed from prior knowledge of the research area and via
discussion between the clinical and academic research team members and service users with OCD.
The schedule was structured to focus researcher attention while simultaneously enabling participants to raise
salient issues (Table 43). To ease participants into the interview process and reduce anxiety, the opening section
of the interview schedule covered general questions about OCD symptoms and their daily impact. Subsequent
sections use open-ended questions to explore preferences and expectations of the trial interventions and
their subsequent treatment experiences. Additional questions relating to potential influences on intervention
uptake and engagement were included to accommodate the research questions of a Doctor of Philosophy
(PhD) student.
The majority of the interviews (31 out of 36) were conducted by a female PhD student trained in qualitative
methods, the remaining five interviews were conducted by a service user researcher trained by the research
team. An interviewer manual was developed to guide both through the interview process; this manual
included information relating to health and safety requirements, ethical conduct, informed consent, research
governance procedures, transcription services, data management and support in dealing with challenges
prior to, throughout, and following, the interviews. The research aims and interview schedule were regularly
revisited and discussed between interviewers to ensure consistency between their interviews.
Data analysis
Interviews were audio-recorded and transcribed verbatim with written participant consent. Data collection
and analysis occurred in parallel to allow early analysis to inform the focus and analysis of later interviews.
Interview data were subjected to a thematic analysis,85 using the constant comparison method.86 In line
with current gold standard recommendations, data were analysed without prior knowledge of trial effects.
Transcripts were read and reread independently by three researchers (an OCTET team member, a research
student and an independent student supervisor) all with qualitative expertise. Data coding was led by the
research student who met the other researchers periodically to discuss their interpretations and establish
an NVivo-hosted (version 10; QSR International, Warrington, UK) coding manual. As the constant
comparison of new data occurred, and the researchers’ understandings of the themes under consideration
developed, the coding manual was amended and reshaped to enable the introduction of new codes
and/or the deletion of redundant, similar or otherwise compromised codes.
Coding was subsequently discussed with a service user representative to ensure that the analysis remained
grounded in the original data and to ensure that any perceived omissions or ambiguities were resolved.
TABLE 43 Interview topics explored with trial participants
Topic Subtopic
OCD l Illness presentation
l Illness impact
l Management support
Treatment preferences and expectations l OCD treatment requirements
l Trial-specific treatment preferences
l Trial-specific treatment expectations
l Treatment outcome expectations
Trial treatment experiences l Trial treatment allocation
l Patterns of use
l Expectation vs. experience
l Likes and dislikes
l Suggestions for improvement
l Remaining treatment needs
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Results
Sample characteristics
A total of 315 of the 473 trial participants were allocated to a treatment arm, 125 were offered an
acceptability interview and 44 returned a consent-to-contact form, expressing an interest in taking part.
Eight participants (18%) who returned consent-to-contact forms did not complete an interview; three had
competing commitments or time constraints, one failed to provide written consent and, despite repeated
attempts, four could not be reached by a researcher.
Thirty-six individuals (11% of participants randomised to a trial treatment) participated in an interview.
Eighteen had been randomised to supported cCBT and 18 to guided self-help. All interviews took place
between October 2012 and January 2014, and between 4 and 13 months post randomisation. Interviews
ranged in length from 27 to 129 minutes; 47% were conducted face to face in the participants’ homes or
a university setting, and 53% were completed by telephone.
As per our study protocol, all participants were contacted after the anticipated date of trial treatment
completion; however, because of unplanned delays in therapist allocation and bookings, two (6%) were
still undergoing their trial-allocated treatments at the time of their interview. Half of the sample (50%) had
reached the top of the waiting list for high-intensity CBT and were currently receiving, or had recently
completed, high-intensity CBT.
Representativeness of the sample
Baseline characteristics for the 36 participants providing qualitative interview data are presented in Table 44.
Data for the 473 OCTET participants are provided for comparative purposes.
Participant views
Findings are laid out to reflect the aim of this study [i.e. to report on the acceptability of two low-intensity
interventions (supported cCBT and guided self-help) to adult trial participants with OCD].
Participants highlighted six characteristics of ‘good’ therapy, against which the acceptability of the trial
interventions was judged. Individual narratives highlighted, to a greater or lesser extent, the need for
psychological treatments that were:
1. accessible (capable of overcoming or accommodating traditional barriers to care)
2. enabling (able to reduce the fear, embarrassment or burden of OCD disclosure)
3. applicable (providing the type or components of therapy valued by service users)
4. relevant (tailored to individual symptoms and experiences)
5. responsive (capable of acknowledging and reacting to users’ real-time needs)
6. motivating (providing the incentive to attend or engage with treatment).
These characteristics provide an empirical structure through which to examine the acceptability of guided
self-help and supported cCBT. Participants are assigned a number rather than a name or pseudonym
within the text. Sex (male or female) and intervention allocation (guided self-help or supported cCBT)
are provided.
Accessibility
At the time of study, NICE guidelines recommended low-intensity interventions for mild to moderate OCD,
delivered within a stepped-care model designed to address a gap between psychological therapy demand
and supply.
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For participants in the current study, treatment accessibility was perceived to be a key advantage of
low-intensity interventions, albeit in slightly different terms to that implied by the stepped-care model.
Concepts of access, defined in terms of reduced waiting times for psychological treatment, were strikingly
absent from service user narratives. Instead, their focus was on the operational flexibility of the service that
they received, with high emphasis placed on the capacity of low-intensity interventions to overcome many
user-centred barriers to care.
Perceived flexibility stemmed from two distinct, yet complementary, features of the low-intensity
interventions evaluated in the trial: (1) the provision of an omnipresent health technology (i.e. the self-help
manual or supported cCBT program); and (2) the delivery of brief PWP support, capable of being delivered
remotely as well as face to face. Unbounded access to a health technology was advocated as a major
strength of both supported cCBT and guided self-help, enabling participants to engage with professionally
endorsed therapy materials at a time and place convenient to them. The provision of telephone support
TABLE 44 Characteristics of study participants
Characteristic
Sample
Acceptability (n= 36) Overall trial (n= 473)
Age (years)
Range 20.7–64.5 18.0–77.6
Mean (SD) 42.7, 13.4 35.9, 12.4
Sex, n (%)
Female 21 (58) 285 (60)
Male 15 (42) 188 (40)
Treatment preference, n (%)
Wait for scheduled CBT 1 (3) 50 (10.6)
No preference 16 (44) 222 (46.9)
Try a self-help intervention 19 (53) 200 (42.3)
Missing 0 (0) 1 (0.2)
Self-management preference, n (%)
Try supported cCBT 11 (30) 109 (23.0)
No preference 14 (39) 234 (49.5)
Try guided self-help 11 (30) 127 (26.9)
Missing 0 (0) 3 (0.6)
Y-BOCS-OR score at baseline, mean (SD)
cCBT arm 25.06 (6.47) 25.03 (5.45)
Guided self-help arm 24.11 (5.57) 25.03 (5.02)
Y-BOCS-OR score at 3 months, mean (SD)
cCBT arm 20.71 (6.47) 20.92 (7.09)
Guided self-help arm 17.59 (10.08) 20.92 (6.9)
Number of support sessions received, mean (SD)
cCBT arm 4.42 (3.00) 3.73 (2.49)
Guided self-help arm 5.94 (4.15) 4.87 (4.21)
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maximised this flexibility, facilitating access to PWP guidance and overcoming multiple geographical and
practical barriers to care:
If you have a psychologist you have to make time to go. They give you specific days you’ve got to be
there. If you’ve got a book or you’re doing it on the computer you can do it yourself when you want
to do it, when you feel like doing it, not when the appointment’s due or something like that. It’s a
more casual approach isn’t it?
P1446, male, supported cCBT
When you have a very little daughter, it’s quite hard, which means I usually read the booklet at night
when she is sleeping. And I tried to do the sort of work after she was in bed. And more, I tried at the
weekend, because obviously during weekdays, my husband is working. At the weekend he’s at home,
this means . . . I can do it at the weekend.
P1276, female, guided self-help
Flexibility in the timing and delivery of scheduled PWP support emerged as a critical factor influencing the
acceptability of low-intensity interventions, particularly within the guided self-help arm, in which trial and
service delivery protocols permitted practitioners to provide this support either remotely or face to face.
For some participants, face-to-face provision challenged the notion of accessible care, reintroducing
treatment barriers and diluting the advantages of a portable health technology:
[The PWP support] was going to be in [site]; the appointment day, from what I can remember, I was
working that day, so I had to cancel it.
P1334, female, guided self-help
The place I got offered, it was too far . . . when we found finally, a place that is not far away, and easy
travel for me, there wasn’t an appointment in that centre that was suitable for both of us. Plus, the
problem was, I have a daughter . . . I don’t mind, she is a very good girl, and all the time I’m talking to
someone she’s usually drawing, but they didn’t let children in the building. The phone . . . this for me,
was easier. I don’t need to go out, still I got the one to one attention . . . I can’t say it would work for
everyone, but personally for me, it was really suitable.
P1276, female, guided self-help
Enablement
Help-seeking for OCD is often delayed, in part because of egodystonic symptoms and a low level of public
awareness about the condition. Within the current study, stigma and embarrassment emerged as two key
factors influencing participants’ OCD disclosures. Trial participants recognised that low-intensity service
models had potential to negate the need for face-to-face contact and that, by doing so, were capable of
preserving anonymity in care:
So, I thought, well, OK, that’s something I can do at home, I can do it in the privacy of my own home,
because going, actually going to a counsellor, in the first place, I think, is quite daunting, that you’re
expected to sit there and talk to somebody, you know, so, yes, so I plumped for the computer one.
P1006, female, supported cCBT
I do. I think on the phone’s quite good because you’re not here in the room are you, so you’re not
seeing the reactions on the face, I’m not seeing your reactions if I tell you something bad that you’ve
sort of looked disgusted at me or interpret anything, and I don’t know who you are either, and you’re
miles away, so . . .
P1213, male, guided self-help
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Anonymity and privacy were two features of treatment that, although important to most service users,
were a specific priority for individuals experiencing intrusive thoughts of a sexual or a violent nature.
Within the context of OCTET, ‘privacy’ was a construct that applied to both the characteristics of the
environment in which treatment was received (often a participant’s own home) and the health technology
platforms with which people interacted. A secure cCBT interface conveyed a sense of confidentiality that
was unavailable in the guided self-help arm, which when combined with a lack of face-to-face contact,
provided a novel opportunity to disclose important yet sensitive information:
Because it was passworded as well it became private and I knew that nobody would be looking at it.
I mean I don’t know if that’s true. I don’t know if you can even see what I’ve done, but I think I felt
like it was mine and mine only . . . There are some questions on there that I’ve answered really
honestly, but I don’t think I would’ve answered them to a person and some of them I struggled
answering with [the researcher]. I think from that you’d probably get a better result because it’s
private . . . you’re not telling anyone anything really; you’re just doing it with yourself so you can be
more honest.
P1198, female, supported cCBT
Competing participant narratives revealed somewhat divided opinions regarding the therapeutic benefits
of non-face-to-face care. Although some participants clearly benefited from the privacy that low-intensity
interventions conferred, others argued that face-to-face contact was essential to overcome the shame
associated with OCD disclosure and ensure that an appropriate level of therapeutic progress was
maintained. Such views were evident across both the supported cCBT and guided self-help modalities.
Often informed by direct personal experience of face-to-face therapies, they hinted at a possible
disjuncture between users’ initial preferences for treatment and subsequent service satisfaction:
Originally . . . I would rather have had something where I could just do it myself . . . but I’ve changed
my mind now that I’ve started therapy sessions . . . I personally found that more helpful. Like I said
originally I’d have probably said ‘Oh no I just want to deal with it myself’, but having started the
therapy sessions, especially with the person I’ve just started with now, it’s like quite a bit of a weight
off your mind as well when you can talk to somebody.
P1027, female, supported cCBT
Face to face, they’re asking you for answers and if you’re not giving the right answers, she’ll explain
why, or saying you’re going off on a tangent and then pulls you back in and then you have to face
what you’re saying and sometimes you don’t . . . I think you do hide from it, you do hide from what
you want to say.
P1282, male, guided self-help
Applicability
The process of psychological therapy is typically conceptualised in terms of two key domains: specific and
common (or non-specific) factors. Specific factors refer to the elements, principles or techniques that are
clearly delineated by proponents of that therapy as the active causes of change. Common factors refer to
elements that are present across multiple therapeutic models or are not specified in the theoretical or
practical delineation of the therapy in question.
In the context of the interventions evaluated in OCTET, the specific factors comprised CBT principles
delivered predominantly through an internet (cCBT) or bibliographic (self-help manual) platform. Common
factors included the elements and characteristics of the interpersonal relationships forged between users
and practitioners. Participants were able to distinguish clearly between these two intervention components,
with conflicting discourse reflecting personal differences in the value and significance attributed to them.
For most participants, the interpersonal components of treatment remained a central feature of mental
health care. Among these individuals, guided self-help attracted proportionally more support than
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supported cCBT, primarily because of its enhanced level of PWP input. Although the specific factors
underpinning the two interventions remained similar, supported cCBT was more likely to be perceived
as a suboptimal intervention, because of its inherent lack of richness in feedback and interaction.
I quite liked the fact that I had a face-to-face appointment once a week, I got on really, really, well
with my therapist, [name]; she was lovely, and I think that was probably the bigger help to me than
the book actually.
P1047, female, guided self-help
Really isolation, loneliness, cold, not very friendly, you know, it might be saying all these things to you
but at the end of the day you’re talking to a machine you’re not talking to a human being, and things
like that so, the reactions, the gestures, the smiles, and all the rest of it, and things like that, you can’t
get that.
P1149, male, supported cCBT
In a small number of cases, neither of the two trial interventions was felt to provide adequate therapeutic
support. Guided self-help was criticised, albeit infrequently, for time-bounded protocols that were
perceived to limit a shared dialogue and negatively impact on the therapeutic alliance:
I’m not saying the guided self-help is not a good thing, I’m just saying I think talking is a better way
really, you know, for somebody who has problems . . . I wouldn’t say she didn’t have the insight but I
think she was working to the trial . . . she was working to trial guidelines . . . she had a set time to do
it in. And so I thought it wasn’t, you know, a one on one situation, if you like, it was just me giving
my opinion really . . . rather than a one on one, you know.
P1443, male, guided self-help
Comparatively few participants identified the acquisition of specific CBT techniques as the only driver of
therapy engagement. At most, the prioritisation of self-management strategies appeared to diminish rather
than negate the need for professional input, giving rise to two separate yet essential components of
intervention delivery:
So yeah, I mean, the techniques are not going to work without the therapist, because you’re doing
them for . . . well, you’re not doing it for the therapist, but you don’t want to let the therapist, you’ve
got to be doing what he says. But equally, it’s the techniques as well, isn’t it, those are the techniques
that make you understand it more, and enable you. So to me, the techniques win, but the therapist is
equally, you know, as important, just slightly the techniques are more.
P1188, male, supported cCBT
With the vast majority of participants emphasising a need for practitioner contact, choice in the delivery
mode of the PWP sessions became vital. Different communication methods provoked different responses
in different individuals, leading to an additional layer of complexity in participants’ appraisals of
intervention acceptability. Although criticisms of remote service provision were by no means universal,
a key observation emerged – service user views of supported cCBT and guided self-help were both
occasionally challenged by the practical difficulties encountered in non-face-to-face support and/or the
socioemotional responses that these more innovative models engendered:
The only thing I didn’t like much, and this isn’t obviously your fault because it’s pragmatics, but, doing
it over the phone was a little awkward somehow. It reminded me of a call centre. Not at all that the
therapist had a call centre manner, it was just the act of being on the phone rather than being face to
face, it just made it a tad more difficult, but not impossible.
P1083, male, guided self-help
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Relevance
Obsessive–compulsive disorder is an often chronic mental health disorder comprising multiple symptoms
and subtypes. Participants’ existing knowledge of OCD and condition management emerged as a
significant influence on engagement with trial interventions. Many participants perceived the content of
the resources to be too superficial, and/or restricted in scope, with potential relevance only to those with
little therapy experience or knowledge of their condition:
I mean, there’s much more information out there than there was when I was young, you know,
much more than even 10 years ago, that you can find out things on your own really on the internet
and whatever. So really, maybe if that was somebody, like, newly diagnosed, it would be really good
but I think I’m so, sort of, like an old hand with it that, you know, it probably didn’t have as much
effect on me.
P1185, female, guided self-help
To this end, participants relied heavily on PWP support to adapt and personalise therapy materials,
the success of which ultimately depended on the amount of professional contact available and individual
practitioner expertise. For the most part, the availability of greater practitioner input into the guided
self-help arm increased its capacity to deliver individualised care. On one occasion, however, a decision
was reached to discontinue therapy because of the perceived irrelevance of the guided self-help material.
Whether or not this decision was driven by the practitioner’s strict interpretation of trial protocols or
reflected an underlying prejudice or lack of confidence in adapting therapy materials to a particular
symptom profile was unclear:
. . . she [the PWP] said, you know, maybe you want to have a look through the booklet and see what
you think. And I think because she was wondering whether it would actually be suitable for me . . .
because it was something which was based on obsessive thoughts, and my issues were more about
obsessive . . . about compulsive actions. I think she was, sort of, saying well, do you want to have a
look through this and see if it applies to you, and having a little bit of a think about it, you know,
it’s not really . . . I can’t use that tool to stop myself doing my OCD symptoms. And I think she said,
you know, you should really only get assigned to this if you were more obsessive thoughts based.
P1364, female, guided self-help
User dissatisfaction with the supplied therapy materials was most evident in the supported cCBT arm,
where the relatively fixed content of the internet program generated perceptions of a less tailored and,
by implication, more superficial intervention model. Restricted contact between cCBT users and PWPs was
perceived to exacerbate the weakness inherent in the computerised program, reducing its application to
different disorder subtypes and lessening its potential reach:
I suppose it was probably the worst actual, you know, out of all of them. Because it had to be . . . the
worst thing about it, you go to see an individual therapist, he analyses you and then he comes up with
his strengths, but because that program has to be for everybody with OCD, it was too generic, it was
too . . . and there’s no other way you can do it . . . it was too kind of [I] couldn’t hone down on it.
P1188, male, supported cCBT
Responsiveness
Intervention responsiveness is a concept that aligns with, but remains separate from, intervention
relevancy. Whereas relevancy refers to the applicability of original therapeutic content, responsiveness
refers to the provision of subsequent opportunities for clarification and information exchange.
Common expectations among participants were that low-intensity interventions, by virtue of their reliance
on portable health technologies, would enhance the flexibility of OCD treatment and empower service
users to progress through therapy at a self-determined rate. Yet, within the supported cCBT arm,
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technological and therapeutic design constraints slowed participants’ progression through the sessions,
reducing the utility of the internet program and negating one of its principal benefits:
I mean I didn’t know how the computer program was going to be, but I find the time I have had to do it
I’m going with it and then it stops and it says you’ve got to wait 24 hours. I thought oh, it’s a real bugger
because I want to carry on. But we’ll get to . . . I mean I know that’s what they’re replicating. But it would
be better I think if it was more flexible, otherwise you may as well go and see someone face to face.
P1198, female, supported cCBT
Rather than mediating practitioner contact, computerised therapies are designed to replace professional
input; cCBT support was permitted within OCTET, but was constrained in both time and scope.
More so than guided self-help, supported cCBT was perceived to lack the depth of contact necessary
to facilitate a user’s understanding or respond dynamically to changing concerns:
No, I thought it would be good to have a one to one as well, because if you’re on the internet, you’re
not conversing, you can’t ask questions can you? So, in the one to one, it was very handy because you
could ask questions about this, and ask questions about that. He was setting me exercises, I know
I do them on the computer program as well, but . . . If you’ve got any problems, you can’t ask the
computer can you really?
P1008, male, supported cCBT
Motivation
Few participants had been exposed to low-intensity therapies for OCD prior to OCTET, although many had
informally engaged in self-help by reading books, participating in internet forums and researching their
condition on the web. Those consenting to interview regarded OCD as a chronic condition and very few
expected a ‘cure’. Nevertheless, most seemed content to trial a new intervention, in the hope that it would
alleviate the symptoms and burden of OCD via an enhanced capacity for self-management:
Yeah, definitely, I mean, I’ve lived with it (OCD) for years, and I know that it’s got to be . . . I need help
to move on to try and . . . and any help that is offered, or any help that is available, I’d be prepared to
take that.
P1207, male, supported cCBT
Maintaining the motivation to remain in treatment was more challenging. Central to participant discourse
was the recognition that external support systems were critical to treatment progress, with proactive,
repetitive and scheduled contact providing a much-needed impetus for intervention engagement:
Yeah, I think it was once a month. I can’t remember. That’s it. Mrs X I think they call her. They sort
of encourage you to carry on I think. That’s what you miss, encouragement, when you’re doing it on
your own on the computer or whether you’ve been left, you miss the encouragement and the
support, and you feel lost.
P1446, male, supported cCBT
I think somebody phoning, that was helpful . . . You can always turn a computer off; you can’t turn
something like that off!
P1158, female, guided self-help
Differences in the levels of PWP support permitted under the guided self-help and supported cCBT
protocols emerged as a key influence on therapy continuation, and thus, by implication, on intervention
acceptability. Less clear were participants’ views regarding the source of support that was required.
For some, non-clinical contact, provided as part of the trial was sufficient to ensure ongoing treatment
participation. Although small in number, these occurrences occurred across both guided self-help and
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supported cCBT arms, raising the possibility that the mere instigation of monitoring may ultimately be
more important than the provision of clinical expertise:
I would think, well, I’ll do that, I’ll do it. And it was constantly trying to put it off. Whereas with you
coming out, you know, coming in and doing the interviews and what have you, it was a lot better,
because you know that you are there. So I am doing the questionnaires and what have you, and it’s
carrying on with the treatment. I wouldn’t . . . if it had carried on with the computer, I don’t think
I’d have . . . well, I know I couldn’t have carried on with it.
P1207, male, supported cCBT
Yeah, I’m really pleased, and thank you for ringing and speaking to me. I know it’s a long time on the
phone, but it’s really helpful. I mean that’s the thing, speaking to you again, it reinforces my desire as
it is to want to do something about it. So although you’ve not really given me any treatment as such,
it is in a way treatment for me because it’s making me just more aware, keeping me aware of what’s
going on around me and addressing it. So it’s good, so thank you.
P1198, female, supported cCBT
Summary of findings
Qualitative research was nested in the intervention arms of OCTET to explore participants’ views of two
low-intensity interventions for OCD. Group consensus suggested that the provision of low-intensity
psychological interventions may confer substantial benefits in terms of increasing the perceived accessibility
of psychological treatments for this population. Both guided self-help and supported cCBT were professed
to increase perceived service flexibility, overcome intervention access barriers and sustain, where desired,
a sense of anonymity or privacy in care.
Both guided self-help and supported cCBT are based on CBT principles. Integral to both interventions is
the concept of problem-solving, through which participants were encouraged to work in a time-limited
process towards specific, agreed goals. Much of the rise in the popularity of low-intensity interventions has
been attributed to their ability to convey these empirically grounded techniques (CBT) with limited therapist
resource. Paradoxically, however, the findings of our current study suggest that a minimum amount of
therapeutic contact may be necessary to optimise the acceptability of these interventions.
Intervention acceptability emerged as a complex construct that extended beyond a basic concept of
accessible care. Key differences in the two interventions were observed in terms of their capacity to provide
the type or components of therapy most valued by service users, the ability to tailor therapy to individual
symptoms and experiences, their capability to respond dynamically to participant need and to sustain
participant motivation for therapy engagement. Although not guaranteed, greater amounts of practitioner
contact appeared to increase the likelihood that these requirements would be met, and thus that the
intervention would be positively appraised by study participants. With the two low-intensity interventions
differing in the amount of professional support available, guided self-help benefited from greater PWP
support and personalisation and thus was more likely to be the subject of positive feedback.
As with any study determining the acceptability of a new health intervention, variation in patient
preferences and values will be observed. For a minority of individuals in the current study, access to
evidence-based techniques was a priority and was in itself sufficient to confer treatment satisfaction.
cCBT, with proportionally less practitioner support, thus still attracted a level of positive participant
feedback, albeit less frequently and among the most self-efficacious participants.
Increasingly, innovations in treatment delivery are being proposed by health-care providers to maximise
the availability, accessibility and cost-effectiveness of mental health care. Differences in the underlying
treatment experiences of different individuals raises the question of whether the acceptability of
low-intensity interventions is determined more by the features of the delivery model itself or the
ACCEPTABILITY OF GUIDED SELF-HELP AND SUPPORTED COMPUTERISED COGNITIVE–BEHAVIOURAL THERAPY
NIHR Journals Library www.journalslibrary.nihr.ac.uk
82
characteristics and underlying treatment preferences of the patients being referred. The current study
identified six different characteristics of ‘good’ therapy, against which the acceptability of the trial
interventions was judged. Future generations of low-intensity treatments for OCD, whether computerised
or manual based, should seek to encompass and optimise features to maximise therapeutic uptake and
population reach. Greater recognition of each of these characteristics and of their potential loss in current
incarnations of low-intensity interventions would ultimately enable service users to achieve their desire for
personalised treatment with a more rapid, anonymised and less stigmatising pathway to care.
Strengths and limitations of qualitative study 1
Qualitative exploration of the views of trial participants provides critical insight into the experiences of
low-intensity intervention users. However, it is nonetheless subject to many limitations inherent in
qualitative research, particularly with respect to generalisability. Nesting a qualitative study within a trial
inevitably raises the possibility of selection bias. All interviewees had consented to participate in a
randomised trial of low-intensity interventions for OCD and thus may be argued to display a level of
openness towards low-intensity interventions atypical of a broader service population. OCTET recruited
participants from waiting lists for high-intensity CBT and it is, therefore, possible that satisfaction with the
trial interventions was elevated because of the difficulties participants were experiencing in accessing
usual care. Conversely, it may also be argued that participants’ existing treatment expectations could
negatively bias attitudes towards alternative and less-intensive forms of care. OCTET offered low-intensity
interventions as a precursor, rather than a replacement, to high-intensity CBT. This design reflected the
ethos of the NICE-recommended stepped-care models for adults with OCD. Within stepped-care models,
low-intensity interventions are advocated as front-line treatments for mild impairments, with the option of
‘stepping up’ to higher-intensity care if initial intervention is ineffective. Hence, our nested trial design
offered an opportunity to explore important tensions between users’ treatment priorities and preferences,
and the economic and political drivers behind the routine integration of low-intensity interventions into
mental health care.
By employing a purposive sampling approach, we ensured maximum variation in the ages and
geographical locations of study participants. Heterogeneity in ethnicity was more limited. Our sample was
predominantly white British, reflecting an underlying bias in our trial population. Had it been possible to
include the views of individuals from different ethnic backgrounds, this may have contributed substantially
to informing culturally relevant and sensitive care.
The majority of the interviews were conducted by a single researcher, who had also conducted trial
follow-up visits for the purposes of quantifying intervention outcomes. Although this may have hindered
as much as facilitated participants’ willingness to discuss their treatment experiences, the broad array of
views expressed in relation to supported cCBT and guided self-help go some way to negating this concern.
Independent data coding, undertaken by three academic researchers in collaboration with a service user
representative, raises confidence in the rigour of our analysis. The views of those allocated to a waiting list
for high-intensity CBT were not explored qualitatively; as such, data were unable to illuminate treatment
experiences. They may, however, have offered an objective insight into the treatment expectations and
preferences of a clinical sample, not affected by recall bias or the post hoc reconstruction of events.
Baseline treatment preferences were measured quantitatively in the trial to redress this knowledge gap.
Study 2: acceptability of guided self-help and supported
computerised cognitive–behavioural therapy to
health professionals
The aim of this study was to explore the acceptability of supported cCBT and guided self-help from the
perspective of those delivering treatment, the PWPs.
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Methods
Sampling and psychological wellbeing practitioner recruitment
Sampling for this study was purposive; invitations were sent to all PWPs who had delivered one or both of
the trial interventions to at least one participant. Invites were not sent to one site at which recruitment had
not commenced because of a lack of waiting lists and to one other site because of research governance
delays. The final sample size was determined by the limits of the population and the numbers of PWPs
consenting to take part.
Between October 2013 and March 2014, all eligible PWPs (n = 71) were e-mailed a personal invitation
letter, information sheet and consent-to-contact form. Upon receipt of a completed consent-to-contact
form, the OCTET trial manager made contact with the PWP to address any outstanding queries and
arrange a convenient interview date. Participation in the study was voluntary and no reimbursement was
offered for taking part. Verbal, recorded consent was taken prior to each interview.
Data collection
All interviews were conducted over the telephone. A semistructured interview schedule was developed from
prior knowledge of the research area, via discussion between clinical and academic members of the trial
team in conjunction with a PWP working at one of the trial sites. A preliminary interview schedule was
piloted with an independent PWP employed by the NHS but not taking part in OCTET. Minor amendments
to question length and flow were made on the basis of their feedback. The final interview schedule explored:
l PWPs’ personal views of the low-intensity treatments they delivered (guided self-help and/or
supported cCBT)
l perceived influences on patient engagement and outcomes
l any issues or challenges that PWPs experienced while delivering the intervention
l potential barriers, and facilitators, to implementing guided self-help and supported cCBT in
routine practice
l PWPs’ views on their involvement in the trial as a whole.
All interviews were conducted by a qualified PWP, employed as a member of the trial team to deliver
treatments as part of OCTET. Qualitative interview training, covering obtaining consent, conducting
interviews and qualitative data analysis was provided by two experienced qualitative researchers, both of
whom were part of the OCTET team. Interviews ranged in length between 18 and 125 minutes; all were
completed by telephone.
Data analysis
Interviews were audio-recorded and transcribed verbatim. Anonymised transcripts were imported and
managed in NVivo qualitative data analysis software.
Transcripts were read and reread independently by four researchers comprising the trial manager, an OCTET
research team member and two PWPs, one of whom conducted interviews and delivered treatment as
part of the trial. Qualitative analysis training was provided to the PWPs prior to the study commencing.
The in-depth training comprised general aspects of collecting and analysing qualitative data, incorporating
practical exercises on the different phases of thematic analysis.
Data coding was led by the trial manager, who met the other researchers periodically to discuss their
interpretations and establish a shared coding manual. Interview data were subjected to a thematic
analysis,85 using the constant comparison method.86 Although traditionally associated with the generation
of theory, the constant comparison method can be used in other forms of qualitative analysis. The method
ensures that all data are systematically compared with all other data available in a data set.87 As the
constant comparison of new data occurred and the researchers’ understandings of the themes under
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consideration developed, the coding manual was amended and reshaped to enable the introduction of
new codes and/or the deletion of redundant, similar or otherwise compromised codes. In line with current
gold standard recommendations, data were analysed without prior knowledge of trial effects.
Results
Sample characteristics
A total of 20 PWPs responded to the initial invitation, all of whom subsequently participated in an
interview. Table 45 provides details of the PWPs who took part. Data for the PWPs who had been
allocated a patient and returned a PWP demographic questionnaire are provided for comparative purposes.
Representativeness of the sample
Practitioners involved in the qualitative study represented 11 of the 14 sites recruiting patients to OCTET.
The mean number of patients treated per practitioner was four. The sample had a similar sex and age
distribution to the overall sample of practitioners participating in OCTET. The vast majority of the
acceptability sample (75%) had been in post for > 2 years. Compared with the overall sample delivering
trial interventions, a smaller proportion of practitioners in the acceptability study had received OCD-specific
training prior to starting OCTET (45% vs. 54%).
TABLE 45 Characteristics of PWPs
Characteristic
Sample
Acceptability (n= 20) Trial (n= 68)
Age (years)
Range 24–59 24–61
Mean (SD) 34.1 (9.49) 33.9 (10.8)
Sex, n (%)
Female 18 (90) 59 (87)
Male 2 (10) 9 (13)
Highest educational qualification, n (%)
Undergraduate degree 7 (35) 12 (18)
Postgraduate certificate 8 (40) 30 (44)
Postgraduate diploma 3 (15) 14 (21)
Master’s degree 2 (10) 9 (13)
PhD 0 1 (2)
Length of time in PWP role, n (%)
6 months to 1 year 1 (5) 6 (9)
1–2 years 4 (20) 17 (25)
2–5 years 15 (75) 44 (65)
Received OCD training as part of IAPT training, n (%)
Yes 9 (45) 37 (54)
No 11 (56) 31 (46)
Reproduced from Gellatly et al.88 This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made.
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Practitioner views
From the perspective of PWPs, the acceptability of low-intensity psychological interventions for OCD was
based upon their perceived fit with:
1. patient lifestyle
2. patient need
3. existing service delivery protocols
4. intervention objectives and purpose
5. practitioner
6. practitioner role.
These six issues emerged directly from the data and take into account matters that are both patient
centred and professionally relevant. They thus provide a professionally centred platform through which to
examine the relative strengths and weaknesses of guided self-help and supported cCBT. Participants are
assigned a number rather than a name or pseudonym within the text. Sex (male or female) and length of
professional experience (≤ 1, ≤ 2 or ≤ 5 years) are provided.
Fit with patient lifestyle
Increasingly, low-intensity psychological interventions are being advocated to maximise the availability
and accessibility of effective mental health care. Among PWPs in the current study, the provision of any
intervention that enhanced access to services was considered a major advantage for people living
with OCD.
Reminiscent of the underlying philosophy of the stepped-care model, practitioners who had been exposed
to the OCTET intervention conceived substantial benefit in moving towards a sequential service delivery
model that offered lower-intensity interventions as a first-line treatment:
I think particularly with the client I was speaking with and seeing the benefits of that I think that it’s
made me feel quite hopeful about the intervention being used at step 2 and the usefulness of a brief
intervention rather than the person being on a longer waiting list to be seen at step 3. They could get
a lot of benefits from the interventions available at step 2.
167, female, > 2 years
Many of the PWPs who were interviewed acknowledged the need not only to increase treatment
accessibility on a population level but also to enhance patient access at an individual level. Akin to service
user views of the low-intensity interventions, PWPs were consistent in emphasising the flexibility of the
treatments they provided and their capacity to overcome different user-centred barriers to care. Across
the PWP sample, advantages were conceived both in terms of the opportunity to provide patients with a
readily accessible health technology (the guided self-help manual or supported cCBT program) and the
choice of accessing brief support remotely as well as face to face:
We did a mixture [of phone and face-to-face sessions] because she had child-care issues because it
wasn’t every session and it was intermittent, by alternating between phone sessions and face-to-face
it actually worked quite well, because she wasn’t under the pressure of having to try and get to the
sessions, it meant I knew where she was at . . . She liked the flexibility of having some telephone and
face-to-face sessions as well, it created less stress for her because she didn’t want to miss any sessions,
and knowing that the phone calls were there kept her on track.
53, female, 2–5 years
Although enhanced access was advocated as a strength of both supported cCBT and guided self-help,
PWP discourse revealed some unique advantages to cCBT that could not be gained so easily from other
delivery methods. In seeking to provide effective therapeutic intervention independently of practitioner
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support, supported cCBT appeared to hold more promise as a flexible and accessible intervention
unconstrained by service norms:
. . . the thing is, that when you’ve got your sessions with somebody, you know, if they don’t remember
what you’ve said, and they didn’t take any notes . . . they might look back at their guided self-help
book and think, now [the PWP] said something, and that really triggered in my mind, now what was it?
They might not remember it, but if they had access to OCFighter . . . they could replay it! And I just
think, then, that’s . . . and they can replay it 24/7 as long as they’ve got access to the internet.
127, female, > 2 years
Fit with patient need
Obsessive–compulsive disorder is a diagnosable mental health disorder associated with reduced quality of
life and substantial impairment of role, specifically work, social, home and family/relationship functioning.5
Reflecting on their beliefs at the start of the trial, many PWPs acknowledged OCD as a complex
condition with symptoms that were often ‘ingrained’ and requiring ‘deep-level work’. Initial expectations
revealed a level of scepticism towards low-intensity interventions for OCD, a perception that practitioners
themselves recognised was fuelled by a lack of prior exposure to such treatments and/or professional
cynicism regarding their underpinning evidence base. Negative attitudes towards low-intensity psychological
interventions for OCD were, for the most part, transient and once PWPs had undergone training and
experiential learning via OCTET, more positive views emerged:
. . . once [guided self-help] is up and running, people have got a really good knowledge of what they
need to do, it’s just continuing to implement it and managing with the challenges that are faced as a
result of implementing it. But, I think it’s very, very clear and very easy to deliver, and I think that’s
what was really good about it, and very fitting to a person’s problem as well, because the compulsions
often take over their day, their time. And actually, it’s an intervention that allows a person to gain
back some time, and some of their life in terms of engaging in other things as well.
09, female, 1–2 years [reproduced from Gellatly et al.88 This article is distributed under the terms
of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/
licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium,
provided you give appropriate credit to the original author(s) and the source, provide a link to the
Creative Commons license, and indicate if changes were made]
Some key implementation issues nonetheless remained. PWPs retained the view that OCD is a complex
mental health disorder, characterised by an exceptionally heterogeneous symptom profile. PWPs therefore
stressed the importance of tailoring any psychological intervention, whether high or low intensity, to
service user preference and need.
I’d always adapt, and then try and pace it and deal with whatever the patient presents. So it’s prescriptive
but flexible. It’s down to you as the therapist to meet the needs of the patient. [The interventions]
gave us the steps and so on, so I’d got a clear plan on how to do it and deal with it [OCD], and then it
sometimes is that flexibility, when to go back and repeat the early steps and motivate the patient and bits
and pieces. So it’s prescriptive, but on the other hand you are using your own knowledge and experience
to adapt to the patient’s needs.
158, male, 2–5 years [reproduced from Gellatly et al.88 This article is distributed under the terms
of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/
licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium,
provided you give appropriate credit to the original author(s) and the source, provide a link to the
Creative Commons license, and indicate if changes were made]
Notably, however, practitioner concepts of treatment personalisation rarely prioritised changes to therapy
content over changes to treatment delivery protocols and access routes. Being able to offer different
interventions that varied in presentational style and therapeutic contact was perceived to be particularly
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advantageous, enabling practitioners to adopt a more flexible and beneficial treatment approach. In this
regard, both guided self-help and supported cCBT were perceived as viable and acceptable interventions,
capable of enhancing service provision and extending patient choice:
I think it’s good to offer people a variety of options and interventions to meet their needs. And yeah,
just to be flexible with the patient . . . Some people prefer the online programs than seeing somebody
one-to-one.
06, female, > 2 years
Key to ensuring PWP acceptance of low-intensity interventions was the ability to offer flexibility in one-to-one
support. The frequency of support sessions were discussed repeatedly and were subject to contrasting
views across both interventions, specifically in relation to patients’ motivations for treatment engagement.
Although some practitioners perceived that weekly contact with patients was necessary for them to maintain
therapeutic focus, others alluded to the possibility that patient uptake of one-to-one support may, for some
clients, be a consequence of its availability rather than necessity:
It [weekly sessions] keeps people’s focus, so I don’t tend to . . . and you know whether they’re not
engaging, so you can help them to engage. If you leave it 2 weeks you can . . . well, if you left
something with me for 2 weeks I’d forgotten the whole lot, you know what I mean, it’s gone!
40, female, > 2 years
. . . it’s funny actually because . . . with the cCBT obviously the . . . you have six sessions with . . . six
sessions, 10 minutes each, but actually despite the much level of support people . . . clients really took
to that. They didn’t complain about not having enough support whereas the guided self-help it does
offer people more support and I feel that people take what they’re given, and I think it made me
realise that actually some people are motivated enough, can get on with the program, and just have
very little support from a clinician.
205, female, > 2 years
Ambiguity surrounding the impact of regular support on patient motivation was often superseded by
concerns regarding the negative impact of excessive appointments. A number of practitioners discussed
the difficulties that some patients may experience in fitting weekly sessions into busy and chaotic lifestyles.
Others viewed less frequent sessions not only as more convenient but also vital for skill consolidation and
optimal therapeutic pacing:
. . . all the documentation says weekly therapy is seen to be more effective. I’m not certain it is,
especially if you’re talking in a CBT format, because patients have to learn set techniques and start
practising them, which can often take, I think, longer to understand and interpret the information
and nibble away into forming that practice of the techniques and repeating it.
158, male, > 2 years [reproduced from Gellatly et al.88 This article is distributed under the terms
of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/
licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium,
provided you give appropriate credit to the original author(s) and the source, provide a link to the
Creative Commons license, and indicate if changes were made]
Fit with existing service protocols
Although the notion of delivering effective psychological interventions for OCD was attractive to PWPs,
the ease of integrating the OCTET interventions into routine service provision was deliberated. Some
practitioners alluded to potential resistance from high-intensity, accredited therapists who they feared may
question changes to long-standing, embedded working practices and assumptions:
. . . well, I don’t really know, I can’t speak for them, can I, I don’t really know. I think that some CBT
therapists think that the self-help with OCD wouldn’t work, I think there would be resistance from
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CBT therapists, the high workers. I think . . . it seems that that’s a view they still hold about OCD,
that maybe it’s not the type of condition you should be working with at step 2.
84, female, > 2 years
For others, operational support was seen as key. Ongoing effort was deemed necessary to enhance
practitioner competencies, maintain organisational standards and ensure an equitable and high-quality patient
experience. Specifically, the availability and standardisation of disorder-specific training for low-intensity
workers was considered a prerequisite to a national roll-out of low-intensity interventions for OCD:
I hope so [that low-intensity interventions could be implemented for OCD at step 2] . . . I think
hopefully showing them the effects of perhaps the trial and also making sure that all of us as step 2
practitioners have consistent training again because I think that’s the reason why it was kept to step 3
because some hadn’t had any training. Some had had some training so I think say for example it
wouldn’t be fair if a client went to one step 2 practitioner to get treatment around OCD when, if they
were assessed by another person, they’d be stepped up. So I think as long as the consistency of
training across step 2 was there . . .
89, female, > 2 years
Central to participant discourse was the recognition that research trial conditions often remained distinct
from those experienced in routine clinical practice. Thus, although the trial had demonstrated the feasibility
of both PWP training and low-intensity interventions for OCD, some major challenges to implementation
were likely to remain. Potential incompatibility between the intervention delivery protocols specified for the
trial and the resources available to deliver them on the ground was a key concern:
It depends, because if I’m speaking in regards to my manager at the moment, there’s no way she’d
allow us to do 12 sessions, so I’d say, no, to that, but if there was any way of cutting it down so it
wasn’t 12 sessions, then I think she’d be a bit more open to that. So I really don’t know, if it was
12 sessions, I’d say, no, because I think would be the answer that she’d give me.
88, female, > 2 years
Fit with intervention objectives and purpose
Guided self-help and supported cCBT both fall under the umbrella of self-managed therapy packages.
These packages, by definition, are supported by limited amounts of contact with a paraprofessional.
Practitioners’ perspectives on the acceptability of these two interventions were thus frequently influenced
by the extent to which the two interventions facilitated efficient therapeutic care. Contrasting the breadth
and depth of the resources provided under trial conditions with those normally available to practitioners
in routine services, PWPs acknowledged the value they placed on having a ready-made therapy manual
and the assurance that this provided in terms of optimising the quality and safety of their work:
I think because it’s having a tailored manual and a tailored online program, it’s had a lot of thought and
evidence, and work go into it, and I think what can happen at times is the techniques might be the
same, or the method might be the same but you’re scrambling to find information and get things
together that are appropriate. And, actually having a ready-made manual that can be used in a session,
and is very self-explanatory, and it’s something that the client has access to, and the practitioner has
access to, I think it just makes it a much more safe and effective way of working at step 2.
09, female, 1–2 years
From a patient’s perspective, practitioners perceived multiple benefits to having a well-structured therapy
package. At a micro level, interesting materials were advocated to encourage patient engagement,
while at the meso level, much emphasis was placed on the potential impact of presentational style on
service credibility:
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I think the structure of the book in particular, because that was her first comment when she came
back, she read the whole thing and then came back and she was like oh, her excitement helped,
she goes I’m looking forward to this . . . she likes the look of the book and she could see the therapy
behind it.
53, female, > 2 years
. . . it helps towards them having . . . this looks like a professional, serious . . . is going to work, but . . .
yeah. Even if you didn’t show them the book and you worked through and went through it section by
section and they never saw the book, I think they’d still benefit. But this adds to the credibility of the
delivery of this intervention at this level, and that it’s taken seriously and it’s being invested in and it’s
not just a bit of paper.
40, female, > 2 years
Discourse focusing on the perceived functionality of the two interventions revealed some specific
differences in the acceptability of guided self-help and supported cCBT. Although guided self-help was
seen as directly fulfilling the remit of a self-managed therapy package, procedural delays in accessing the
cCBT program reduced its usability from both patient and practitioner perspectives. Lock-out time points,
automatically imposed after the completion of specific therapy steps, were viewed as a specific barrier to
user engagement:
One guy pointed out, if I don’t finish one step until 9 o’clock at night, he said it’s not going to be
available to me again until 9 o’clock the following night. He said it should be 24 hours from when he
starts the program, because by the time nine o’clock the next night comes round, he said ‘I’m too
tired to go on to it’. He’s then got to wait another day to get on to it, so he loses the flow, which I
thought was a fair point really.
130, female, > 2 years [reproduced from Gellatly et al.88 This article is distributed under the terms
of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/
licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium,
provided you give appropriate credit to the original author(s) and the source, provide a link to the
Creative Commons license, and indicate if changes were made]
Although such lock-out points were deliberately sanctioned on the basis that they would facilitate client
learning, other ad hoc difficulties in supported cCBT access were also reported. For some PWPs, these
unanticipated complications were sufficient to render supported cCBT ineffectual, slowing patient progress
and demanding more time-intensive support than delivery protocols allowed:
They, kind of, lost interest because they’d got so frustrated with it . . . I don’t think any of my cCBT
people have actually stayed the course . . . a lot of them weren’t able to do anything. They weren’t
able to move on from that first section.
130, female, > 2 years
Oh gosh . . . let’s see, it was that they couldn’t access it because they only had a tablet, they couldn’t
access it because they were using the wrong . . . wrong Internet Explorer . . . sometimes the video
would just stop, and then they’d have to watch it all over again. And I did have that happen to me a
couple of times. But I think it was my internet connection. The most annoying thing was that I
couldn’t access it at work.
127, female, > 2 years
Fit with practitioner skills
The PWP role predominantly focuses on supporting patients through low-intensity interventions,
case-managing referrals and signposting to other relevant services, dependent on patient need. Minimum
quality standards of training are in place within IAPT services to ensure that the needs are met to enable
practitioners to perform their role competently and confidently. Although a small minority of PWPs believed
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that the knowledge and skills they had developed previously could be drawn upon to deliver low-intensity
interventions for OCD, the vast majority initially lacked self-confidence in supporting patients with this
diagnosis at step 2:
It’s that, kind of, the feeling of unknown, really. I hadn’t got any experience in it at all, but I think also
perhaps a bit of the stigma that we have with regard to the step 2 and the step 3. We’ve always
stepped it [OCD] up. It’s always been something that’s been out of our remit. So you just think, well,
if that’s always been the case, then this might not work and you’re going to struggle with it.
130, female, > 2 years
Equipping professionals with the necessary skills, knowledge and awareness through additional training
was vital. PWPs reflected upon the benefits of training they had received as part of OCTET and the positive
impact that this had upon their confidence. The importance of having the opportunity to become familiar
with the interventions and practise the associated techniques was consistently regarded as important:
I think it’s just time really, and once you’re familiar with the techniques, and have a really good
understanding of why we’re delivering those techniques and how they can work for people. When
you’ve also seen that it has been helpful to other people as well, I think confidence in delivering them
grows, and even though I didn’t work with many people with OCD in the trial, I think that really
understanding the techniques, and actually having that practice in delivering the techniques it helped
quite a lot, then those expectations soon changed.
09, female, 1–2 years
Differences in the levels and nature of support permitted under guided self-help and supported cCBT
protocols emerged as a key influence on practitioners’ readiness to deliver the two interventions in practice.
Growth in practitioner confidence was most evident in the guided self-help intervention, where the availability
of written resources (i.e. a self-help manual) generated a greater sense of safety and security in therapy
delivery. With greater scope for therapeutic interaction, the written resources that accompanied the guided
self-help intervention were viewed as particularly valuable, serving not only as a mechanism to keep patients
‘on track’ but also as a direct source of practitioner reassurance and skill development:
Yeah, definitely, that was always good to refer back to. But I mean I had it with me in the sessions
anyway. It did help in case . . . because obviously the anxiety around treating a new condition,
but having it there was reassuring . . . That really helped, because obviously I needed to know where
I needed to be at each session. I was going at the right pace but it was nice to know that I had
the cues there to fall back on. I mean if I had got to use it more than once then each time it would’ve
been easier and easier.
53, female, > 2 years
Fit with the practitioner role
Psychological wellbeing practitioners play a vital role within psychological services. Under IAPT service and
training models, practitioners are explicitly trained to work collaboratively with patients, developing and
maintaining therapeutic alliances and being responsive to individual needs.
Entrenched professional roles were a key factor influencing practitioner support for the two interventions
delivered within OCTET. Most practitioners agreed that increasing service choice and accessibility would
ultimately be of benefit to patients, yet several also voiced concerns regarding the extent to which
these new interventions may denigrate their own practice. The majority of practitioners perceived direct
therapeutic contact with a patient as a central tenet of their professional remit and one that could not
easily be reduced:
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I have to say I found it quite difficult, because it was, it was quite a strange experience really where
I found I was ringing people up to see how they were getting on, with really no indication or idea
of their problems at all.
111, female, > 2 years
With less scope for practitioner input, supported cCBT was typically viewed with a higher level of suspicion
than guided self-help and divergent discourses reflected disagreement regarding the true role of the
practitioner in this intervention. Several PWPs described ‘being absent’ or ‘taking a back seat’ in the cCBT
intervention, which left them feeling at worst devalued and at best unanchored in their professional role:
I think it takes the one-to-one therapist relationship out of therapy, because it’s a computer . . . we’re
saying the therapeutic relationship is key to any kind of improvement patients make, isn’t it? That’s
the thing they always write on the feedback form; patient . . . therapist listened to me, therapist was
nice, therapist helped me.
53, female, > 2 years
Those who had the opportunity to support guided self-help patients face to face highlighted the benefits
of the approach, indicating that they worked more effectively and suggesting that patients’ needs were
often better met. Guided self-help was frequently perceived as a ‘practitioner-led’ model (173, female,
> 2 years), with many interviewees emphasising a preference for this intervention from the outset:
Certainly there is a bit more of me invested in that [guided self-help]. And I think that’s the case even
with the sessions being different lengths as well. 10 minutes means you only have . . . you don’t
really have that opportunity to develop a deep level of a therapeutic relationship with somebody in
10 minutes really. It’s more of a, oh, how are you? Check in. Any problems? Anything that you’re
stuck with? OK, and you take good care and that’s about it really. Whereas I could see if you’re seeing
someone especially face to face there is something different about that.
111, female, > 2 years
With the vast majority of PWPs emphasising a need for client contact, choice in the delivery mode of
low-intensity interventions became paramount. Practitioners’ views of both supported cCBT and guided
self-help were often challenged by remote working, leading to an additional layer of complexity in their
appraisals of intervention acceptability. Despite alternative delivery approaches, such as telephone or
web-based support, being advocated with existing stepped-care models, PWPs repeatedly raised concerns
regarding the normalisation of these media, often in terms of the personal fears or socioindividual
responses that these new delivery models engendered:
I prefer working with human beings, not telephones, not machines. I’ve always been interactive with
other people.
158, male, > 2 years
In a small number of cases, negativity towards remote working was found to reduce over the course of the
trial. PWPs who initially expressed a preference for delivering face-to-face support later contradicted this
view, emphasising the vital role that remote facilitation could play in maintaining patient engagement.
Such data raise the possibility that professional resistance to new working methods may be partially fuelled
by a lack of experience of alternative delivery models and hint at a potential incongruity between
acceptability judged from the practitioner perspective and acceptability judged on behalf of the patient:
We did an initial assessment appointment face-to-face and then we did the first treatment face to face,
and the rest were delivered via the phone, and it was also during a late appointment, so it was quarter
to six when I contacted the client, which was fantastic for her because otherwise she wouldn’t
have been able to attend the treatment because she couldn’t have got off work. She had work
commitments, and especially the amount of sessions that we were offering, it would have been really
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difficult for her to be able to access that treatment if it was nine to five . . . There were no problems
over the telephone at all. The client prefers it. It was more accessible for her, and delivering the
treatment was no different to face to face really.
89, female, > 2 years
Summary of findings
This qualitative study aimed to explore PWP perceptions of two low-intensity interventions, guided
self-help and supported cCBT, for OCD. Intervention acceptability was judged both from the perspective
of the professionals concerned, and their personal interpretations of patient need. Practitioners were
consistent in acknowledging the advantages of low-intensity interventions at a population level. Both
guided self-help and supported cCBT were advocated to overcome long-standing barriers to the delivery
and receipt of mental health care, improving accessibility via enhanced service flexibility and patient choice.
At an individual level, differences in practitioners’ perceptions of patient need emerged as a key factor
influencing their intervention acceptability judgements. Group consensus identified OCD as a complex and
chronic mental health disorder with variable symptoms profiles and presentations. Concerns were thus
initially raised regarding the ability of low-intensity interventions to meet the needs of this client group,
with different levels of professional confidence generating different levels of readiness to deliver these
treatments. Dedicated training and the provision of essential therapist resources were regarded as vital
precursors of a service roll-out, and a particularly advantageous element of OCTET. Practitioner training
was perceived to be instrumental in changing practitioner attitudes, reducing fears and ensuring the
fidelity and delivery of the trialled interventions.
Potential challenges to national implementation nonetheless remain. Practitioners in the current study
often referred to their own professional role and responsibilities, contrasting these with the remit of
higher-intensity, accredited cognitive–behavioural therapists. Differentiation between these two service
levels gave rise to a distinction in the types of patients and disorders traditionally seen by each group and
thus to a prospect of wider professional resistance. A shared fear among several PWPs was that OCD was
a disorder that conventionally fell within the remit of higher-intensity psychological services and thus
was unlikely to be sanctioned for treatment by paraprofessionals. Even within the context of entrenched
models of PWP, existing service philosophies and protocols appeared to affirm the importance and
centrality of the therapeutic relationship, and thus sometimes brought into question the legitimacy of
reduced client contact achieved via the instigation of self-managed therapy packages. Trial protocols
stipulated the amount and nature of contact permitted for the guided self-help and supported cCBT
intervention. Longer-term integration into services demanding remote working practices or seeking
additional resource efficiency savings may only exacerbate this problem.
Studies of remote psychiatric consultations suggest that the normalisation of any new health technology
into statutory health care is likely to be mediated both by the properties of the technology itself and the
sociological orientation of its users.89 With the two low-intensity interventions differing in the amount of
professional support available, guided self-help aligned more readily with practitioners’ own expectations
of their role. Differences in the presentation and functioning of guided self-help and supported cCBT
resources exacerbated this effect, influencing the perceived suitability of the two different intervention
models for the tasks in hand. Although supported cCBT was initially perceived to be an innovative
solution to service access, technical difficulties were found to limit its reach. The importance of providing
high-quality intervention resources was a key theme emerging from practitioner discourse, and a key
feature influenced the perceived credibility and acceptability of low-intensity interventions. Future
generations of supported cCBT and guided self-help must, therefore, ensure that they are optimised in
this regard.
Strengths and limitations of qualitative study 2
Qualitative exploration of the views of practitioners provides insight into the experiences of delivering
low-intensity psychological intervention to adults with OCD. All practitioners taking part in this qualitative
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study had already consented to deliver these interventions as part of OCTET. It may be argued that these
individuals are not representative of the broader professional population working in statutory psychological
services. It is important to acknowledge, however, that not all practitioners participating in the trial did so
voluntarily, and a substantial proportion was required to do so by their employing NHS trust.
By employing a purposive sampling approach, we ensured that we recruited only practitioners who had
delivered a trial intervention to at least one service user. Three-quarters of the practitioners taking part in
our qualitative study had already accumulated ≥ 2 years of professional experience as a PWP working
within IAPT services. This proportion was slightly higher than that observed across the whole sample
of practitioners trained to deliver OCTET interventions. It is therefore possible that this enhanced level of
experience was reflected in the data obtained. Notably, fewer than half of interviewees had received
OCD-specific training prior to joining OCTET. Their perceived self-confidence in treating adults with this
diagnosis may thus not be too dissimilar to other practitioners working in a non-research context.
Treatment delivery protocols and training for the low-intensity interventions evaluated within OCTET were
distinct from routine practice. Nesting a qualitative evaluation of practitioner views within this trial enabled
us to gain a critical insight into to the potential challenges and tensions that may be encountered in
statutory implementation.
The majority of the interviews were conducted by a single researcher who had prior experience both of
working as a PWP and a practitioner delivering treatments within the trial. Although this may have risked
a loss of objectivity, the a priori development of a semistructured interview schedule and independent
data coding, undertaken by four academic researchers, goes some way to negating this concern.
The researchers’ understanding of service provision and of trial procedures may equally have facilitated
deeper examination of the salient issues.
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Chapter 6 Discussion and conclusions
Principal outcomes
The Obsessive–Compulsive Treatment Efficacy randomised controlled Trial explored three core aims:
1. the clinical effectiveness and cost-effectiveness of low-intensity interventions (guided self-help and
supported cCBT) versus a waiting list for high-intensity CBT in the management of OCD at 3 months
2. the clinical effectiveness and cost-effectiveness of low-intensity interventions (guided self-help and
supported cCBT) plus high-intensity CBT versus a waiting list plus high-intensity CBT in the
management of OCD at 12 months
3. acceptability of supported cCBT and guided self-help among patients and professionals.
The main results are illustrated diagrammatically in Figure 23, which shows the standardised effect sizes
at 3 (Y-BOCS and satisfaction) and 12 months (Y-BOCS, quality of life and costs) for each of the two
low-intensity treatments compared with the waiting list for high-intensity CBT group.
In the short term, prior to access to high-intensity CBT, guided self-help demonstrated statistically
significant benefits over waiting list for high-intensity CBT. These differences did not meet the prespecified
criterion for clinical significance. In contrast, supported cCBT did not demonstrate any significant benefit.
Over a 12-month period, access to guided self-help and supported cCBT prior to high-intensity CBT did not
lead to differences in outcomes compared with access to high-intensity CBT alone. Access to either of the
low-intensity interventions does not significantly augment the effect of high-intensity CBT in the longer
term.
The effects of the low-intensity interventions did not generalise to other outcomes other than symptoms of
OCD. The short-term benefit of supported cCBT on anxiety is noted, but does not seem plausible given the
wider pattern of results.
Early access to either of the low-intensity interventions led to significant reductions in uptake of
high-intensity CBT over the full 12 months of OCTET, with 86% of the patients allocated to a waiting list
for high-intensity CBT starting CBT by the end of the trial, compared with 62% in supported cCBT and
57% in guided self-help. Access to either of the low-intensity interventions may reduce demand on
psychological therapy services by reducing the number of patients who access high-intensity CBT.
These reductions in high-intensity therapy utilisation do not seem to compromise patient outcomes at
12 months. The modest effect of guided self-help plus high-intensity CBT compared with the waiting list
for high-intensity CBT found at 3 months was broadly maintained at 12 months, although the effects
again did not meet the prespecified criterion for clinical significance. This suggests that low-intensity
interventions can reduce demand on high-intensity services, while still achieving similar outcomes over the
longer term (as there were no statistically significant differences between group at 12 months). We note
that the lack of statistically significant differences between arms at 12 months is not a formal test of their
equivalence or non-inferiority, which OCTET was not designed to assess.
Of course, one concern is that these average group effects mask more variable outcomes. Of specific
concern is the suggestion that early access to either of the low-intensity interventions might inappropriately
deflect patients from access to high-intensity CBT, and that initial good outcomes from low-intensity
interventions at 3 months might not be maintained in the subgroup that has those interventions alone.
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Comparison
FIGURE 23 Summary of the main comparisons in OCTET. All adjusted outcomes (continuous and dichotomous) from OCTET have been translated onto a common ‘standardised
mean difference’ metric. All outcomes have been coded so that a good outcome (lower symptoms, high quality of life, reduced utilisation and costs) is coded as a positive
effect size.
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We presented descriptive data on the mean scores of patients in the low-intensity arms according to their
pattern of later CBT use. Comparisons do not have the benefit of randomisation, but the data do not
suggest that those who accessed low-intensity treatments did not demonstrate markedly different
outcomes than those who accessed both.
In terms of the economic analysis, guided self-help was a more expensive low-intensity treatment to deliver
than supported cCBT. As noted above, both low-intensity interventions were associated with reductions in
uptake of high-intensity CBT over 12 months. The net effect was that health- and social-care costs across
the three groups did not differ significantly, despite the additional cost of the low-intensity interventions.
Differences in EQ-5D-3L and associated QALY scores were minor in magnitude and mostly non-significant.
Nevertheless, when costs and quality of life were jointly analysed, both low-intensity interventions
dominated waiting list plus high-intensity CBT in the cost-effectiveness analysis, with lower costs and
better outcomes.
Taking a decision-making approach, which focuses on which decision has a higher probability of being
cost-effective, rather than statistical significance of the results, there was little evidence that supported
cCBT and guided self-help were more cost-effective at the 3-month follow-up compared with the waiting
list. However, by the 12-month follow-up (primary end point), the data suggest that the probability that
guided self-help was more cost-effective than the waiting list was 60% from the health- and social-care
perspective and 80% from the societal perspective and the probability of supported cCBT being more
cost-effective than the waiting list was 70% from both perspectives.
The data suggested some small differences in satisfaction at 3 months, with patients most satisfied with
guided self-help and least satisfied with supported cCBT. However, only the difference between guided
self-help and supported cCBT was statistically significant.
The pattern of results in OCTET is complex and reflects, in part, differences in the analysis and
interpretation of clinical, economic and patient experience outcomes.
To readers more interested in the assessment of clinical outcomes, the focus will be on the additional
benefit provided to patients through access to low-intensity interventions prior to high-intensity CBT.
OCTET demonstrated that neither low-intensity intervention was responsible for clinically significant
improvements in OCD symptoms at 3 months prior to high-intensity CBT. In the absence of such clinical
benefit over a passive waiting list strategy, such readers may have concerns about reductions in use of
high-intensity CBT over 12 months, as it might reflect substitution of an evidence-based high-intensity
treatment with low-intensity alternatives showing no evidence of clinically significant benefit.
The analyses of clinical effectiveness and cost-effectiveness in OCTET are not directly comparable.
The cost-effectiveness analysis has as its primary focus the longer-term assessment over 12 months,
assesses patient outcome through health-related quality of life rather than OCD symptoms and jointly evaluates
the effects of the low-intensity interventions on quality of life and costs. The analytical method underlying the
cost-effectiveness analysis is also not based on notions of clinical or statistical significance. Rather, the decision
to adopt one intervention over another should be based on the expected cost-effectiveness of the intervention,
or the probability of making the correct decision.79,80 The analyses of OCTET suggest that, despite the lack of
clinically significant improvement in OCD symptoms at 3 months, both low-intensity treatments are likely to be
cost-effective over 12 months and thus reflect a better use of NHS resources.
Indeed, it should be noted that, in the analysis of cost-effectiveness, the supported cCBT intervention
performed better than guided self-help. This occurred, despite supported cCBT failing to demonstrate
statistical or clinically significant improvements on OCD symptoms at 3 months, and performing worse
than guided self-help on patient satisfaction.
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The presence of qualitative and quantitative data on patient experience adds additional complexity to the
interpretation of OCTET. Many readers may feel that such patient experience data are important, but
secondary to clinical and economic outcomes. However, patient experience may be more important where
interventions demonstrate broadly similar clinical and economic outcomes. The NHS is also placing more
importance on patient experience as a key measure of the quality of services.90
Strengths and weaknesses
The Obsessive–Compulsive Treatment Efficacy randomised controlled Trial represents the largest trial of
psychological treatments for OCD worldwide. The trial recruited to target and retention in the short term
was high (81%), with acceptable levels of follow-up of clinical outcomes over the longer term.
Recruitment occurred across multiple sites and involved a very large number of PWPs, all of whom received
standardised training. This was an advantage in terms of external validity, in that delivery was not
restricted to either a small number of specialised sites or to a small number of highly selected therapists,
highlighting the pragmatic nature of the study. The clinical effectiveness and cost-effectiveness demonstrated
should be representative of the sorts of outcomes that might be found in routine services in the wider NHS.
However, the size of the recruitment and delivery platform for OCTET also has disadvantages. As with
many mental health trials, there will always be concerns about the potential bias in the small proportion of
patients who agree to participate in research. The nature of the recruitment process did mean it was
difficult to get accurate estimates of the numbers of patients who were offered the trial across multiple,
dispersed sites, in organisations without a primary focus on research.
Many PWPs saw few patients, which restricted the scope for formal analysis of therapist effects, and may
have provided insufficient opportunity to practise the skills learned in the OCTET training sessions.
Uptake of the two self-managed therapies was reasonable (66% guided self-help and 61% supported
cCBT), with some evidence of greater engagement with guided self-help. The analysis of fidelity provides
some evidence that the delivery of the two trial interventions was in line with the protocols provided.
However, the relatively low proportion of PWPs providing recordings means that we cannot be sure that
all PWPs were delivering interventions according to protocol.
The geographical spread of OCTET did make data collection more logistically complex. These difficulties
were most clearly demonstrated in the collection of the economic data, where levels of complete data
were fairly low. As with many trials, we focused on primary outcomes when patients were resistant to
fuller assessments, and detailed economic data are always more challenging to collect when patient
resistance is high and time is short. Although there were a significant number of missing data, analyses
using imputed data did suggest that the results were fairly robust and remain useful for decision-makers.
A significant issue in the interpretation of the results of OCTET concerns the high level of access
to high-intensity CBT during the waiting list period. Around 40% of patients allocated to waiting list for
high-intensity CBT started to receive some contact with their high-intensity CBT therapist prior to the
3-month assessment, compared with around 20% in the two low-intensity groups. As there is evidence
that high-intensity CBT is effective, this would tend to reduce any positive effects of the two low-intensity
interventions, meaning that the 3-month results of OCTET are conservative with respect of the likely
effects of the interventions under test. This may be of importance, given that the 3-month outcomes of
guided self-help were statistically significant, but under the criterion for clinical significance. It should be
noted that the percentages quoted above regarding access to CBT relates to those who had any contact
with a HIT prior to the 3-month assessment, which in many cases (given the timelines involved in OCTET)
would have involved an initial session or two, rather than a full ‘dose’.
DISCUSSION AND CONCLUSIONS
NIHR Journals Library www.journalslibrary.nihr.ac.uk
98
This threat to validity reflects the nature of provision in the UK at the time of delivery of OCTET, as many
services were taking active steps to reduce their waiting lists for CBT. The problems were compounded by
the fact that few services were willing to ask patients to actively delay their high-intensity CBT until they
had completed the OCTET interventions, which reflects both service pressures in terms of managing
demand and ethical concerns about delaying access to a proven treatment.
As noted above, these issues mean that the estimates of clinical effectiveness at 3 months will be
conservative. However, the longer-term outcome and cost data are less affected, as all patients were
expected to receive both their low-intensity interventions and high-intensity CBT over the timeline of
OCTET (12 months). Therefore, decision-makers can have high confidence in the cost-effectiveness
analyses, which provide the broadest assessment of the value of low-intensity interventions in a
stepped-care system.
In terms of wider international relevance, the delivery of OCTET did rely on features of psychological
therapy services (such as PWPs) that are fairly unique to the UK IAPT model. The economic results
especially will reflect aspects of service delivery (such as waiting times and staff costs), which may be
particular to the UK.
Nevertheless, interest in low-intensity interventions and stepped care is international,91–93 and the broad
findings (that low-intensity interventions delivered prior to conventional treatments can reduce later service
utilisation without compromising outcomes) remain important.
Possible mechanisms and explanations
In designing OCTET, we hypothesised that giving patients on the waiting list access to low-intensity
interventions prior to high-intensity CBT could have two positive effects:
1. augmenting patient outcomes through either:
i. more rapid improvement in clinical outcomes prior to high-intensity CBT or
ii. augmenting the effect of high-intensity CBT in the longer term
2. increasing efficiency of service delivery either by reducing the number of patients who need to access
high-intensity CBT or by reducing general health-care utilisation in the short and longer term, without
compromising patient outcomes.94
We found limited evidence that low-intensity interventions led to more rapid improvements than a waiting
list, prior to high-intensity CBT. Only guided self-help demonstrated statistically significant benefits on the
primary outcome at 3 months, and the effect did not meet the prespecified threshold for clinically
significant effects (3 points on the Y-BOCS).
We did not find strong evidence that low-intensity interventions augmented the effects of high-intensity
CBT over the longer term, as the outcomes in the three groups did not differ significantly at 12 months on
the primary outcome. The difference between guided self-help plus high-intensity CBT and the waiting
list plus high-intensity CBT remained reasonably large, but not formally clinically or statistically significant
according to the criteria adopted in OCTET. Analysis of ‘response’ and ‘remission’ also demonstrated
potential augmentation, but this form of analysis of the Y-BOCS was not a primary outcome of OCTET.
In terms of service efficiency, both low-intensity interventions were also associated with a lower uptake
of high-intensity CBT. Reductions in the uptake of high-intensity CBT would reduce any augmentation of
clinical outcomes from the compound effects of multiple treatments.
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The lack of differences in clinical outcomes over 12 months suggests that, on average, provision of
low-intensity interventions is potentially efficient and does not lead to poor outcomes.
When outcomes and costs are considered jointly, evidence suggests that both low-intensity interventions
have a higher probability of being cost-effective than the waiting list for high-intensity CBT, at
conventional levels of willingness to pay for QALYs. Supported cCBT continues to dominate when the
perspective is restricted to health- and social-care costs, and guided self-help is likely to be cost-effective.
It is important to consider the patient satisfaction evidence. It is noteworthy that neither low-intensity
intervention demonstrated significantly greater satisfaction than the waiting list for high-intensity CBT at
3 months, although patients allocated to guided self-help reported significantly greater satisfaction than
those allocated to supported cCBT. The qualitative data reported in Chapter 5 identified characteristics of
‘good’ therapy and identified some reasons why guided self-help may have been preferred to supported
cCBT, although it should be noted that the comparison of the technologies (written self-help vs.
web-based therapy) is confounded by differences in therapist time associated with their delivery.
Implications
The design of OCTET is an analogue of a stepped-care model, in which patients are offered low-intensity
interventions in the first instance, with a smaller proportion going on to higher-intensity options. However,
a conventional stepped care was not formally implemented in OCTET, as the offer of low-intensity
interventions was made on the basis that high-intensity CBT would then be available for all, not as part of
a ‘stepping’ mechanism.
The effects of low-intensity interventions demonstrated in OCTET may be improved in a formal
stepped-care system, where patients might not be given an expectation of high-intensity CBT, and only
those failing to benefit from the low-intensity interventions according to agreed criteria would continue on
to the more-intensive intervention.
As noted previously, during the internal pilot, the Department of Health requested that sites improve
access to treatment as part of their commitment to IAPT, which led to a reduction in waiting lists and
subsequently increased pressure on recruitment. Given that long waiting lists were one of the core
rationales for OCTET, it might be supposed that the relevance of OCTET has been lessened.
However, it is critical to note that a response of many services to the Department of Health request
was that patients were ‘removed’ from the waiting list and offered access to interventions other than
high-intensity CBT. In many cases, these interventions were in line with current ‘good clinical practice’, but
were not evidence based (i.e. OCD specific or recommended by NICE guidelines). For example, patients may
have been offered generic groups for managing anxiety. The evaluation of the low-intensity interventions in
OCTET has provided exactly the sort of evidence-based intervention that would make such a waiting list
management strategy robust. Thus, the results of OCTET remain highly relevant to demand management in
NHS psychological therapy services and place current practice on a far firmer evidential base.
The OCTET results would support an important role for low-intensity interventions in the care pathway for
OCD. Rapid access to guided self-help leads to modest improvements in clinical outcomes in the shorter
term. Following receipt of either low-intensity intervention, a proportion of patients do not progress on the
pathway to high-intensity CBT. There is no evidence that this leads to poor outcomes in this group of
patients, and the overall health- and social-care costs associated with these patients do not differ.
Providing low-intensity interventions as part of a care pathway may reduce pressure on high-intensity CBT
services, without any obvious disbenefit for patients. This may allow psychological therapy services to
deliver a greater total amount of therapeutic benefit from the same resource, with low-intensity
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interventions providing effective outcomes for some patients and higher-intensity CBT more accessible for
those who require this service. However, it should be noted that the overall costs to the NHS (including
costs outside the psychological therapy service) would likely not be significantly different with the
introduction of low-intensity interventions.
The two low-intensity interventions differ in the pattern of results they show. Guided self-help showed
statistically significant reductions in OCD symptoms, and patients receiving guided self-help were more
satisfied than those receiving supported cCBT. However, supported cCBT showed statistically significant
longer-term benefits in quality of life and a slight advantage over guided self-help in terms of
cost-effectiveness at 12 months.
From a service perspective, focusing on one low-intensity intervention would simplify delivery and the
associated training and infrastructure needs, which might lead decision-makers to prefer the supported
cCBT model. However, we would caution against a focus on supported cCBT alone. Supported cCBT did
not perform well on the primary clinical outcome, and the quantitative data on satisfaction suggested that
guided self-help was significantly more likely to satisfy patients. The qualitative data confirmed the broad
findings from the quantitative satisfaction measure, and suggest that providing options may be important
to meet the variation in patient preferences for low-intensity interventions that reflect individual differences
in the ways patients interact with interventions.95
Suggestions for further research
As noted above (see Implications), although the design was relevant to the evaluation of stepped care,
OCTET did not introduce a formal stepped-care system. If services are to implement low-intensity
interventions for OCD into routine practice as part of a stepped-care system, high-quality health services
and delivery research is required to explore how best to introduce these interventions.96
For example, it will be important to determine what information and preparation patients require
concerning low-intensity interventions to ensure that they understand the role of these interventions.
Effective use of digital technology (combined with relevant patient experience material) may provide an
effective and efficient method of preparation for many patients.
As well as provision of low-intensity treatments, stepped care is based on effective flow of patients through
the system depending on their outcomes. It will be necessary to ensure that patients understand the
content and process of the decision-making that will determine access to high-intensity CBT.97 Although
OCTET did not suggest that access to low-intensity treatments alone was associated with poor outcomes on
average, there will be the need for the development of appropriate procedures to monitor OCD outcomes
and ensure safety for individual patients who do not access or respond to low-intensity interventions.
The Obsessive–Compulsive Treatment Efficacy randomised controlled Trial has also highlighted the
importance of training and support for staff delivering low-intensity interventions, given their limited
experience in managing OCD to date. There is a great deal of research on ‘complex interventions’ and
their mechanisms of effect, but comparatively little research on effective ways of training staff to deliver
such interventions and ways of maintaining and enhancing their skills. The training materials developed
for OCTET provide a useful basis for further development and evaluation of training materials for the
workforce delivering low-intensity interventions.
Although the high levels of uptake of high-intensity CBT would have lessened the comparative benefit of
low-intensity interventions at 3 months, neither intervention showed clinically significant effects at
3 months, which suggests that further development of more effective low-intensity interventions is required.
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We were unable to find methodologically rigorous research on clinically significant differences on the
Y-BOCS to inform the sample size calculation and the interpretation of trial. Providing a robust threshold
for clinical significance would improve future research on OCD.
Research into the ‘active ingredients’ of low-intensity interventions is at a relatively early stage, with
most of the evidence relating to depression rather than OCD. As the evidence base for low-intensity
interventions in OCD grows, appropriate use of techniques such as metaregression98 and mediational
analysis99 may provide useful insights into key ‘active ingredients’ that might enhance their effectiveness.
Equally, better understanding of the sorts of patient groups most likely to benefit100 may enable better
targeting of interventions as part of a combined stepped- and stratified-care model.96
The qualitative data in Chapter 5 may also provide useful insights into aspects of the interventions that
might benefit from modification to enhance uptake. The next generation of low-intensity interventions
might also be able to take advantages of improvements of technology to enhance outcomes. This might
involve improved use of multimedia within cCBT or development of other aspects of low-intensity
interventions (such as text reminders to enhance uptake and adherence, or access to appropriate social
networking sites to develop social support). All such enhancements will require appropriate patient input
and ongoing evaluation.
If more effective low-intensity interventions can be developed, there may be a case for trials to actively
compare low-intensity interventions with high-intensity CBT head to head (rather than the sequential
delivery tested within OCTET). This could evaluate whether or not enhanced low-intensity interventions
can achieve equivalent (or at least non-inferior) outcomes to high-intensity CBT. This was the subject of a
commissioning brief prior to OCTET, and could be informed by the ongoing Cost and Outcome of
Behavioural Activation (COBRA) non-inferiority trial.101
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Appendix 1 Pilot recruitment graph
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Appendix 2 Unit costs
Resource Unit Cost (£) Source Notes
Inpatient services
ENT and dental Per day 531 NHS Reference
Costs 2013/1470
Calculated from NHS reference
costs non-elective long stay
Respiratory system Per day 370 NHS Reference
Costs 2013/1470
Calculated from NHS reference
costs non-elective long stay
Cardiac surgery and primary
cardiac conditions
Per day 533 NHS Reference
Costs 2013/1470
Calculated from NHS reference
costs non-elective long stay
Digestive system Per day 482 NHS Reference
Costs 2013/1470
Calculated from NHS reference
costs non-elective long stay
Hepatobiliary and pancreatic
system
Per day 434 NHS Reference
Costs 2013/1470
Calculated from NHS reference
costs non-elective long stay
Musculoskeletal system Per day 523 NHS Reference
Costs 2013/1470
Calculated from NHS reference
costs non-elective long stay
Urinary tract and male
reproductive system
Per day 389 NHS Reference
Costs 2013/1470
Calculated from NHS reference
costs non-elective long stay
Female reproductive system and
assisted reproduction
Per day 644 NHS Reference
Costs 2013/1470
Calculated from NHS reference
costs non-elective long stay
Obstetrics Per day 931 NHS Reference
Costs 2013/1470
Calculated from NHS reference
costs non-elective long stay
Haematology, chemotherapy,
radiotherapy and specialist
palliative care
Per day 496 NHS Reference
Costs 2013/1470
Calculated from NHS reference
costs non-elective long stay
General Per day 483 NHS Reference
Costs 2013/1470
Calculated from NHS reference
costs non-elective long stay
Outpatient services
Asthma clinic Per contact 150 NHS Reference
Costs 2013/1470
Total outpatient attendances tab:
service code 340
Clinical haematology Per contact 160 NHS Reference
Costs 2013/1470
Total outpatient attendances tab:
service code 303
Dental medicine Per contact 119 NHS Reference
Costs 2013/1470
Total outpatient attendances tab:
service code 450
ENT Per contact 92 NHS Reference
Costs 2013/1470
Total outpatient attendances tab:
service code 120
General medicine Per contact 157 NHS Reference
Costs 2013/1470
Total outpatient attendances tab:
service code 300
Mental health Per contact 233 NHS Reference
Costs 2013/1470
Total outpatient attendances tab:
service code 710
Obstetrics Per contact 120 NHS Reference
Costs 2013/1470
Total outpatient attendances tab:
service code 501
Orthopaedics Per contact 113 NHS Reference
Costs 2013/1470
Total outpatient attendances tab:
service code 110
Pain management Per contact 135 NHS Reference
Costs 2013/1470
Total outpatient attendances tab:
service code 191
Physiotherapy Per contact 46 NHS Reference
Costs 2013/1470
Total outpatient attendances tab:
service code 650
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Resource Unit Cost (£) Source Notes
Plastic surgery Per contact 93 NHS Reference
Costs 2013/1470
Total outpatient attendances tab:
service code 160
Diagnostic imaging Per contact 93 NHS Reference
Costs 2013/1470
Index tab: IMAG
Phlebotomy Per contact 3 NHS Reference
Costs 2013/1470
DAPS tab: DAPS08
Infectious diseases Per contact 219 NHS Reference
Costs 2013/1470
Total Outpatient Attendances tab:
service code 350
MRI Per contact 145 NHS Reference
Costs 2013/1470
IMAG tab: RA01A
Ultrasound Per contact 52 NHS Reference
Costs 2013/1470
IMAG tab: RA23Z
Psychology Per contact 177 NHS Reference
Costs 2013/1470
Total outpatient attendances tab:
service code 656
Interventional radiology Per contact 192 NHS Reference
Costs 2013/1470
Total outpatient attendances tab:
service code 811
Stroke medicine Per contact 212 NHS Reference
Costs 2013/1470
Total outpatient attendances tab:
service code 328
Vascular surgery Per contact 149 NHS Reference
Costs 2013/1470
Total outpatient attendances tab:
service code 107
Midwifery service Per contact 71 NHS Reference
Costs 2013/1470
Total outpatient attendances tab:
service code 560
ECG Per contact 167 NHS Reference
Costs 2013/1470
IMAG tab: RA60A
General surgery Per contact 125 NHS Reference
Costs 2013/1470
Total Outpatient Attendances tab:
service code 100
Rehabilitation service Per contact 138 NHS Reference
Costs 2013/1470
Total Outpatient Attendances tab:
service code 314
Colonoscopy Per contact 334 NHS Reference
Costs 2013/1470
OPROC tab: FZ51Z
Endoscopy Per contact 64 NHS Reference
Costs 2013/1470
OPROC tab: FZ42A
A&E
A&E without ambulance Per contact 135 NHS Reference
Costs 2013/1470
Total outpatient attendances tab –
service code 180 – accident &
emergency
A&E with ambulance Per contact 366 NHS Reference
Costs 2013/1470
A&E plus ambulance (AMB tab –
ASS02 – see and treat and convey –
£231)
Community-based contacts
GP in GP surgery Per contact 38 PSSRU71 Per-patient contact lasting
11.7 minutes; including direct care
staff costs; without qualifications
GP at home Per contact 77 PSSRU71 Based on £3.30 per minute for
11.4 minutes per home visit plus
12 minutes travelling; including
direct care staff costs; without
qualifications
GP on telephone Per contact 23 PSSRU71 Per-patient contact lasting
7.1 minutes; including direct care
staff costs; without qualifications
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Resource Unit Cost (£) Source Notes
Practice nurse in GP surgery Per contact 11 PSSRU71 £44 per hour of face to face
(excluding qualifications), based on
a 15.5-minute contact
District nurse/health
visitor/midwife
Per contact 15 PSSRU71 £57 per hour of face to face
(excluding qualifications), based on
a 15.5-minute contact from
practice nurse (location 10.6)
NHS walk-in clinic Per contact 56 PSSRU71 Per clinic contact lasting 17.2 minutes;
including direct care staff costs;
without qualifications
Community psychiatric nurse Per contact 33 PSSRU71 £66 per hour of face to face
(excluding qualifications); based on
a 30-minute contact from assertive
outreach team (location 12.4)
Psychiatrist in the community Per contact 66 PSSRU71 £103 per hour (excluding
qualifications) plus patient contact
ratio taken from Curtis102 (£266);
based on an assumption of a
15-minute contact
Occupational therapist Per contact 27 PSSRU71 £32 per hour (excluding
qualifications) plus client contact
ratio added from Curtis102 (£53);
based on a 30-minute contact (based
on data from Curtis103)
Marriage counselling
(e.g. Relate)
Per contact 46 PSSRU71 £50 per hour (excluding
qualifications); based on a
55-minute contact
Art/drama/music therapy Per contact 27 PSSRU71 Occupational therapist
Social worker Per contact 28 PSSRU71 £55 per hour of patient-related
work (excluding qualifications);
based on the assumption of a
30-minute contact
Advice service (e.g. Citizen’s
Advice Bureau/housing
association)
Per contact 27 PSSRU71 Occupational therapist
Helpline (e.g. Samaritans/Mind) Per contact 4 Samaritans104 Based on £3.88 cost per contact in
2010–11, inflated to 2013–14
prices using retail price index from
Curtis71
Day centre/drop-in centre Per contact 30 PSSRU71 £30 per client session
Complementary therapy
(e.g. homeopathy/acupuncture)
Per contact 58 Cancer Research
UK105
Complementary therapies range
from £15 to £100, so used the
mid-point
Psychological therapies
CBT Per contact 93 PSSRU71 Cost per session
Counselling Per contact 50 PSSRU71 Cost per hour, assume 1 hour
Psychotherapy Per contact 100 NHS Reference
Costs 2013/1470
Total Outpatient Attendances tab:
service code 713
IAPT Per contact 97 NHS Reference
Costs 2013/1470
MHSTIAPTA – mental health tab.
Coded as general IAPT as unclear if
level 2 or 3
Community psychiatric nurse Per contact 33 PSSRU71 Assume 30-minute contact;
£66 per hour of face-to-face contact
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Resource Unit Cost (£) Source Notes
Group therapy Per contact 14 PSSRU71 Based on mindfulness group
therapy
GP nurse Per contact 11.37 PSSRU71 Assume 15.5-minute contact, face
to face
Mind Per contact 50 PSSRU71 Cost per hour, assume 1 hour
Clinical psychologist Per contact 138 PSSRU71 Per hour of face to face, assume
1 hour
Psychiatrist Per contact 51.5 PSSRU71 £103 per contact hour, assume
30 minutes
Behavioural therapy Per contact 93 PSSRU71 Cost per session
Occupational therapy Per contact 64 NHS Reference
Costs 2013/1470
Total outpatient attendances tab:
service code 651
Crisis team Per contact 38 PSSRU71 Per hour, per team member,
assume one team member for
1 hour
GP Per contact 38 PSSRU71 Per-patient contact lasting
11.7 minutes, without qualifications
Mindfulness Per contact 14 PSSRU71 Based on mindfulness group
therapy
A&E, accident and emergency; AMB, ambulance; DAPS, Directly Accessed-Pathology Services; ECG, electrocardiogram;
ENT, ear, nose and throat; IMAG, diagnostic imaging; MHSTIAPTA, IAPT, Adult and Elderly; MRI, magnetic resonance
imaging; OPROC, Outpatients-Procedures; PSSRU, Personal Social Services Research Unit.
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Appendix 3 Psychological wellbeing practitioner
unit cost per minute
Delivery mode
Mean number of
treatment sessions
Mean total treatment
duration (minutes)
Mean session
cost (£)74
Cost per
minute (£)74
Face to face 3.88 207 118.75 2.225845
Over the telephone 3.93 140 79.19 2.222976
Average PWP unit cost per minute (2009/10 prices) 2.22
Inflated to 2013/1471 2.40
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Appendix 4 Psychological wellbeing practitioner
training costs
Components Details Unit cost
Total
cost (£)
Cost per
therapist
(£)
Cost per
OCD-related
session (£) Source
Trainer’s time One band 6 nurse for
3 days for 7.5 hours,
divided by average of
7 trainees per training
session
£ 50 per hour including
qualifications
1125.00 160.71 – PSSRU71
Trainee’s
time
One band 5 nurse for
3 days for 7.5 hours
£ 39 per hour including
qualifications
– 877.50 – PSSRU71
Manual One GSH manual plus
CCBT therapist guide
plus photocopied sheets
per therapist
£ 1.87 + £ 5.20+ £ 0.23 – 7.30 – OCTET
team
Total training cost per therapist – 1045.51 –
Total training cost per OCD-related sessionsa – – 8.38
a Based on 124.74 OCD-related sessions over 3 years; see table below for assumptions.
Assumptions Details Source
Working days per annum 210 days PSSRU71
Average patient contacts per day 9 contacts Nolan106
Percentage of caseload with OCD 2.2 Health and Social Care
Information Centre107
Training valid over years 3 years Ekers et al.108
Number of OCD-related sessions 124.74 OCD-related sessions (210 × 9 × 3 × 2.2%)
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Appendix 5 Full Consolidated Standards of
Reporting Trials diagram
E
n
ro
lm
e
n
t
Trusts’ waiting lists searched
(n = 14)
Returned consent to contact
(n = 779)
• Not contactable, n = 25
• Declined to participate, n = 96
Ineligible (n = 89)
• Accessing CBT, n = 40
• Patient reported no OCD, n = 9
• Patient aged < 18 years, n = 7
• No OCD, n = 6
• Patient not on CBT waiting list, n = 5
• Patient accessing other interventions, n = 5
• Alcohol dependence, n = 4
• Risk concerns, n = 3
• Patient unable to access intervention, n = 3
• Psychosis, n = 2
• Reading age < 11 years, n = 2
• Unwilling to participate, n = 2
• GP advised not to participate, n = 1
Ineligible (n = 94)
• Y-BOCS-SR score of < 16, n = 36
• Alcohol dependence, n = 12
• Accessing CBT, n = 11
• Substance dependence, n = 8
• No OCD, n = 8
• Reading age < 11 years, n = 7
• Risk concerns, n = 6
• Patient reported no OCD, n = 2
• Not in primary care, n = 1
• Requested other support, n = 1
• Unsuitable for study, n = 1
• Unwilling to participate, n = 1
Screening for eligibility; telephone
(n = 658)
Assessed for eligibility; baseline interview
(n = 569)
FIGURE 24 The CONSORT diagram for OCTET. a, Did not continue with PWP support and unknown if intervention was
accessed independently; b, post-randomisation exclusion required resulting from a participant aged < 18 years (n= 1;
cCBT), and risk issues relating to increased risk and not a change in supervisor decision (n= 1; waiting list). (continued)
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Randomised
(n = 475)
Allocated to waiting list (n = 159)
Top of waiting list (n = 1)
Post-randomisation exclusionb
(n = 1)
Allocated to guided self-help
(n = 158)
• Received guided self-help, 
   n = 124
• Did not receive guided 
   self-help, n = 34
Top of waiting list before 
intervention (n = 15)
PWP unable to contacta (n = 12)
Participant unwilling to 
continue with intervention 
(n = 3)
Participant declined intervention
(n = 3)
Participant unwilling to 
continue in trial (n = 1)
Allocated to cCBT (n = 158)
• Received cCBT, n = 125
• Did not receive cCBT, n = 33
PWP unable to contact, no 
access of intervention (n = 13)
Top of waiting list before 
intervention (n = 9)
Unable to access intervention
(n = 7)
Participant declined 
intervention (n = 2)
Participant unsuitable for 
intervention: no OCD (n = 1)
Post-randomisation exclusiona 
(n = 1)
Randomisation to 3 months
Discontinued waiting list (n = 7)
• Reached top of CBT waiting list, 
   n = 6
• Accessed another treatment, 
   n = 1
Randomisation to 3 months
Discontinued guided self-help
(n = 44)
• PWP unable to contact,a n = 12
• Participant requested another 
   treatment, n = 11
• Reached top of CBT waiting
   list, n = 10
• Participant unwilling to 
   continue with intervention, 
   n = 6
• Participant no longer required 
   treatment, n = 2
• Participant opted out of PWP 
   calls, n = 2
• Participant did not have OCD, 
   n = 1
Randomisation to 3 months
Discontinued cCBT (n = 48)
• PWP unable to contact, no 
   further intervention access, 
   n = 12
• Reached top of CBT waiting 
   list, n = 11
• Unable to access intervention 
   and/or experienced technical 
   issues, n = 11
• Participant unwilling to 
   continue with intervention, 
   n = 7
• Participant requested another 
   treatment, n = 5
• Participant no longer required 
   treatment, n = 1
• Participant did not have OCD 
   (self-diagnosis), n = 1
FIGURE 24 The CONSORT diagram for OCTET. a, Did not continue with PWP support and unknown if intervention was
accessed independently; b, post-randomisation exclusion required resulting from a participant aged < 18 years (n= 1;
cCBT), and risk issues relating to increased risk and not a change in supervisor decision (n= 1; waiting list). (continued)
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3 months
Lost to follow-up/visits not 
completed (n = 25)
• Declined visit, n = 1
• Visit unable to be completed,
   n = 9
• Postal measures not returned, 
   n = 8
• Withdrawn from follow-up, 
   n = 7
Post-randomisation exclusionb
(n = 1)
3-month data collection
• Y-BOCS-OR completed, n = 121
• Y-BOCS-SR completed only, 
   n = 12
3 months
Lost to follow-up/visits not 
completed (n = 28)
• Declined visit, n = 1
• Lost to follow-up, n = 1
• Visit unable to be completed, 
   n = 10
• Postal measures not returned,
   n = 8
• Withdrawn from follow-up, 
   n = 8
3-month data collection
• Y-BOCS-OR completed, n = 117
• Y-BOCS-SR completed only, 
   n = 11
3 months
Lost to follow-up/visits not 
completed (n = 36)
• Declined visit, n = 1
• Lost to follow-up, n = 1
• Visit unable to be completed,
   n = 11
• Postal measures not returned, 
   n = 11
• Withdrawn from follow-up, 
   n = 12
Post-randomisation exclusionb
(n = 1)
3-month data collection
• Y-BOCS-OR completed, n = 106
• Y-BOCS-SR completed only, 
   n = 15
6 months
Lost to follow-up/visits not 
completed (n = 35)
• Declined visit, n = 3
• Lost to follow-up, n = 2
• Visit unable to be completed,
   n = 7
• Postal measures not returned, 
   n = 7
• Withdrawn from follow-up, 
   n = 16
Post-randomisation exclusionb 
(n = 1)
6-month data collection
• Y-BOCS-OR completed, n = 108
• Y-BOCS-SR completed only, 
   n = 15
6 months
Lost to follow-up/visits not 
completed (n = 36)
• Lost to follow-up, n = 4
• Visit unable to be completed,
   n = 5
• Postal measures not returned,
   n = 11
• Withdrawn from follow-up,
   n = 16
6-month data collection
• Y-BOCS-OR completed, n = 106
• Y-BOCS-SR completed only, 
   n = 15
6 months
Lost to follow-up/visits not 
completed (n = 45)
• Declined visit, n = 3
• Lost to follow-up, n = 1
• Visit unable to be completed,
   n = 3
• Postal measures not returned,
   n = 16
• Withdrawn from follow-up,
   n = 22
Post-randomisation exclusionb 
(n = 1)
6-month data collection
• Y-BOCS-OR completed, n = 93
• Y-BOCS-SR completed only, 
   n = 19
3–6 months
Discontinued waiting list (n = 2)
• Unwilling to continue with 
   trial, n = 1
• Unable to continue in trial, n = 1
3–6 months
Discontinued guided self-help
(n = 22)
• PWP unable to contact,a n = 7
• Participant required another 
   treatment, n = 6
• Participant unwilling to 
   continue with intervention, 
   n = 4
• Reached top of CBT waiting list,
   n = 2
• Participant requested another 
   treatment, n = 2
• Deemed clinically inappropriate
   to continue with treatment, 
   n = 1
3–6 months
Discontinued cCBT (n = 24)
• PWP unable to contact, no 
   further intervention access, 
   n = 8
• Unable to access intervention 
   and/or experienced technical 
   issues, n = 4
• Participant unwilling to 
   continue with intervention, 
   n = 3
• Reached top of CBT waiting 
   list, n = 3
• Participant no longer required 
   treatment, n = 2
• Participant unable to commit 
   time to intervention, n = 2
• Treatment deemed 
   inappropriate for condition, 
   n = 1
• Participant requested another, 
   treatment, n = 1
FIGURE 24 The CONSORT diagram for OCTET. a, Did not continue with PWP support and unknown if intervention was
accessed independently; b, post-randomisation exclusion required resulting from a participant aged < 18 years (n= 1;
cCBT), and risk issues relating to increased risk and not a change in supervisor decision (n= 1; waiting list). (continued)
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6–12 months
Discontinued waiting list (n = 1)
• Accessed another treatment,
   n = 1
6–12 months
Discontinued guided self-help
(n = 3)
• PWP unable to contact,a n = 2
• Participant unwilling to 
   continue with intervention, 
   n = 1
6–12 months
Discontinued cCBT (n = 1)
• PWP unable to contact, n = 1
Y-BOCS-OR
3 months
Analysed (n = 121)
Excluded from analysis (n = 38)
All fields missing (n = 37)
Post-randomisation exclusionb
(n = 1)
6 months
Analysed (n = 108)
Excluded from analysis (n = 51)
All fields missing (n = 50)
Post-randomisation exclusionb
(n = 1)
12 months
Analysed (n = 99)
Excluded from analysis (n = 61)
All fields missing (n = 60)
Post-randomisation exclusionb
(n = 1)
Y-BOCS-OR
3 months
Analysed (n = 117)
Excluded from analysis (n = 41)
Minimum entry requirements 
not met (n = 2)
All fields missing (n = 39)
6 months
Analysed (n = 106)
Excluded from analysis (n = 52)
Minimum entry requirements 
not met (n = 1)
All fields missing (n = 51)
12 months
Analysed (n = 100)
Excluded from analysis (n = 58)
All fields missing (n = 58)
Y-BOCS-OR
3 months
Analysed (n = 106)
Excluded from analysis (n = 52)
All fields missing (n = 51)
Post-randomisation exclusionb
(n = 1)
6 months
Analysed (n = 93)
Excluded from analysis (n = 65)
All fields missing (n = 64)
Post-randomisation exclusionb
(n = 1)
12 months
Analysed (n = 84)
Excluded from analysis (n = 74)
All fields missing (n = 73)
Post-randomisation exclusionb 
(n = 1)
12 months
Lost to follow-up/visits not 
completed (n = 43)
• Declined visit, n = 1
• Lost to follow up, n = 5
• Visit unable to be completed,
   n = 1
• Postal measures not returned,
   n = 16
• Withdrawn from follow-up, 
   n = 20
Post-randomisation exclusionb
(n = 1)
12-month data collection
• Y-BOCS-OR completed, n = 99
• Y-BOCS-SR completed only, 
   n = 16
12 months
Lost to follow-up/visits not 
completed (n = 44)
• Lost to follow-up, n = 11
• Postal measures not returned,
   n = 13
• Withdrawn from follow-up, 
   n = 20
12-month data collection
• Y-BOCS-OR completed, n = 100
• Y-BOCS-SR completed only, 
   n = 14
12 months
Lost to follow-up/visits not 
completed (n = 52)
• Declined visit, n = 2
• Lost to follow up, n = 7
• Postal measures not returned, 
   n = 17
• Withdrawn from follow-up, 
   n = 26
Post-randomisation exclusionb
(n = 1)
12-month data collection
• Y-BOCS-OR completed, n = 84
• Y-BOCS-SR completed only, 
   n = 21
FIGURE 24 The CONSORT diagram for OCTET. a, Did not continue with PWP support and unknown if intervention was
accessed independently; b, post-randomisation exclusion required resulting from a participant aged < 18 years (n= 1;
cCBT), and risk issues relating to increased risk and not a change in supervisor decision (n= 1; waiting list). (continued)
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Y-BOCS-SR
3 months
Analysed (n = 116)
Excluded from analysis (n = 12)
• All fields missing, n = 11
• Post-randomisation exclusion,b
   n = 1
6 months
Analysed (n = 104)
Excluded from analysis (n = 15)
• All fields missing, n = 14
• Post-randomisation exclusion,b
   n = 1
12 months
Analysed (n = 92)
Excluded from analysis (n = 16)
• All fields missing, n = 15
• Post-randomisation exclusion,b
   n = 1
Y-BOCS-SR
3 months
Analysed (n = 115)
Excluded from analysis (n = 13)
• Minimum entry requirements 
   not met, n = 2
• All fields missing, n = 11
6 months
Analysed (n = 103)
Excluded from analysis (n = 16)
• Minimum entry requirements 
   not met, n = 1
• All fields missing, n = 15
12 months
Analysed (n = 96)
Excluded from analysis (n = 13)
• All fields missing, n = 13
Y-BOCS-SR
3 months
Analysed (n = 104)
Excluded from analysis (n = 16)
• All fields missing, n = 15
• Post-randomisation exclusion,b
   n = 1
6 months
Analysed (n = 91)
Excluded from analysis (n = 20)
• All fields missing, n = 19
• Post-randomisation exclusion,b
   n = 1
12 months
Analysed (n = 80)
Excluded from analysis (n = 22)
• All fields missing, n = 21
• Post-randomisation exclusion,b
   n = 1
FIGURE 24 The CONSORT diagram for OCTET. a, Did not continue with PWP support and unknown if intervention was
accessed independently; b, post-randomisation exclusion required resulting from a participant aged < 18 years (n= 1;
cCBT), and risk issues relating to increased risk and not a change in supervisor decision (n= 1; waiting list).
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Appendix 6 Individual point resource use
TABLE 46 Resource use at 6 months (in previous 3 months)
Resource use Unit
Intervention
cCBT (n= 95)
Guided self-help
(n= 107) Waiting list (n= 108)
n users
Mean
use SD n users
Mean
use SD n users
Mean
use SD
Hospital
Inpatient Nights 2 1.00 0.00 3 2.67 2.89 1 10.00 –
Outpatient Attendances 15 2.13 2.07 17 2.65 3.16 25 2.29 2.38
A&E Attendances 4 1.00 0.00 11 1.82 0.60 12 1.00 0.00
Community
GP at surgery Contacts 64 2.08 1.16 76 2.37 1.85 71 2.61 2.93
GP at home Contacts 1 2.00 – 0 – – 0 – –
GP by telephone Contacts 5 1.60 0.89 4 1.75 0.96 11 1.27 0.47
Practice nurse Contacts 13 1.54 0.66 18 3.39 7.92 13 1.62 1.39
District nurse Contacts 5 1.20 0.45 3 1.00 0.00 4 1.75 0.96
NHS walk-in clinic Contacts 4 1.25 0.50 3 1.00 0.00 4 2.50 1.73
Community
psychiatric nurse
Contacts 2 13.50 17.68 2 2.50 0.71 1 6.00 –
Psychiatrist in
community
Contacts 2 2.50 2.12 2 2.00 1.41 4 4.25 5.25
Occupational
therapist
Contacts 0 – – 0 – – 1 5.00 –
Marriage
counselling
Contacts 1 1.00 – 0 – – 0 – –
Art/music/drama
therapy
Contacts 0 – – 0 – – 0 – –
Social worker Contacts 1 3.00 – 1 2.00 – 2 3.00 1.41
Advice service Contacts 3 4.33 4.93 2 5.50 6.36 6 2.83 2.71
Helpline Contacts 0 – – 1 1.00 – 3 4 4.20
Day centre/drop-in Contacts 0 – – 3 7.33 10.97 0 – –
Complementary
therapy
Contacts 4 1.75 0.96 2 2.00 1.41 1 7.00 –
Self-help groups Contacts 0 – – 0 – – 0 – –
Other
psychological
therapies
60 – – 57 – – 94 – –
Psychotropic
medication
Yes/no 46 – – 56 – – 42 – –
Time off work Days 5 26 26.94 3 45 34.06 6 18 26.73
A&E, accident and emergency.
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TABLE 47 Resource use at 12 months (in previous 6 months)
Resource use Unit
Intervention
cCBT (n= 88)
Guided self-help
(n= 100) Waiting list (n= 100)
n users
Mean
use SD n users
Mean
use SD n users
Mean
use SD
Hospital
Inpatient Nights 3 1.00 0.00 3 1.00 0.00 5 2.45 1.12
Outpatient Attendances 15 3.87 3.78 23 1.98 1.76 30 3.33 4.06
A&E Attendances 3 1.67 0.58 9 1.00 0.00 12 1.25 0.62
Community
GP at surgery Contacts 59 3.29 3.12 80 3.21 2.00 74 4.46 6.23
GP at home Contacts 0 – – 1 1.00 – 0 – –
GP by telephone Contacts 7 1.14 0.38 14 1.43 0.76 12 2.33 1.78
Practice nurse Contacts 24 1.63 1.01 27 1.44 0.64 24 2.25 3.50
District nurse Contacts 1 6.00 – 5 3.8 5.72 5 1.80 1.30
NHS walk-in clinic Contacts 1 1.00 – 3 1.33 0.58 7 1.29 0.49
Community
psychiatric nurse
Contacts 0 – – 2 2.00 1.41 4 1.75 0.96
Psychiatrist in
community
Contacts 2 1.00 0.00 3 1.00 0.00 5 2.40 2.19
Occupational
therapist
Contacts 1 1.00 – 1 3.00 – 2 2.00 1.41
Marriage
counselling
Contacts 0 – – 1 1.00 – 0 – –
Art/music/drama
therapy
Contacts 0 – – 0 – – 0 – –
Social worker Contacts 2 2.00 1.41 1 6.00 – 1 5.00 –
Advice service Contacts 1 2.00 – 4 2.50 1.91 4 8.00 10.92
Helpline Contacts 0 – – 2 1.50 0.71 1 6.00 –
Day centre/drop-in Contacts 0 – – 2 3.00 0.00 1 7.00 –
Complementary
therapy
Contacts 4 5.50 8.35 3 4.67 1.15 4 3.00 1.83
Self-help groups Contacts 0 – – 0 – – 0 – –
Other
psychological
therapies
64 62 76
Psychotropic
medication
Yes/no 44 53 44
Time off work Days 3 48 71.51 6 28 38.02 4 67 72.49
A&E, accident and emergency.
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